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1. Summary 
 
To characterize lipid uptake pathways in cultured cells, uptake and metabolism of different 
isotope-labeled lipid probes were investigated in human skin fibroblasts, a mouse 
macrophage-like cell line (RAW264.7), human hepatocellular carcinoma cells (HepG2 cells) 
and a human squamous carcinoma cell line (A431 cells). As lipid probes, we used different 
fatty acids, cholesterol, a cholesteryl ester, a triacylglycerol, and the phospholipids 
phosphatidylcholine and sphingomyelin. The uptake and metabolism of exogenously added 
lipid probes differed with cell type, lipid structure, and mode of delivery. Cationic 
amphiphilic drugs (CADs) are widely used drugs that are known to interfere with lipid 
metabolism and to induce phospholipidosis in human patients. We investigated the influence 
of the desipramine, imipramine, chlorpromazine, chloroquine, and FTY720 as representative 
CADs on uptake and processing of the phospholipid probes. Desipramine was found to have 
drastic and cell-type specific effects on FA processing. Lipid processing was also impaired in 
a genetic phospholipidosis, Niemann-Pick disease, type A. 
 
Fatty acids: to study the uptake and processing of C-18 fatty acids in cultured cells, uptake 
and incorporation of four FA probes in membrane phospholipids and in nonpolar lipids were 
monitored. We used FA probes that differed in the degree of unsaturation: stearic acid (18:0), 
oleic acid (18:1,ω-9), linoleic acid (18:2, ω-6), and linolenic acid (18:3, ω-3). These FA were 
applied in complex with bovine serum albumin (BSA) to the four different types of cultured 
cells. Significant differences were found between uptake and metabolism of these fatty acids, 
when fatty acid class and cell type were varied. FA uptake by fibroblasts and macrophages 
was highest with 18:1, and lowest with 18:3, and 18:0, respectively. Uptake by A431 cells 
and HepG2 cells was lowest with 18:0, and highest with 18:2 and 18:3, respectively. In 
macrophages, stearic acid and oleic acid are predominantly incorporated into nonpolar lipid 
droplet (LD) lipids, while linoleic and linolenic acid are predominantly incorporated into 
polar lipids. Also in HepG2 cells, the level of FAs incorporated into polar lipids was much 
greater for unsaturated FAs than for saturated FAs. In fibroblasts, only a minor incorporation 
of FAs into neutral lipids and a major incorporation into polar lipids were observed. In A431 
cells, 18:2 was best incorporated into neutral lipids, followed by 18:3, 18:1, and 18:0. The 
impact of a cationic amphiphilic drug (CAD, FIASMA = functional inhibitor of acid 
sphingomyelinase), desipramine, on this process was also analyzed. Treatment with 
desipramine caused a tremendous reduction of FA-incorporation into triacylglycerols of 
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macrophages and A431 cells, but only a slight decrease in HepG2 cells. Fibroblasts showed 
an unexpected increase in the incorporation of FAs into triacylglycerol (TAG) and 
diacylglycerol (DAG). We also measured the uptake of [
3
H]desipramine by different types of 
cells, which was lowest in fibroblasts. 
 
Cholesterol, cholesteryloleate, and triolein: to characterize the uptake pathways for these 
lipids, we investigated the effect of different lipid delivery methods. The exogenous lipid 
probes were applied to the four different types of cultured cells either in complex with bovine 
serum albumin (BSA), or as components of low density lipoprotein (LDL) particles. 
Significant differences in uptake and metabolism after application of these two methods were 
found. When incorporated into LDL, uptake of cholesterol, cholesterol ester, and 
triacylglycerol was 2-4-fold higher than when delivered by BSA. Furthermore, the uptake of 
cholesterol presented as BSA-complexes was best for A431 cells, while uptake of the other 
lipids presented as LDL- and BSA-complexes were higher in fibroblasts than the other cell 
types. Also the metabolic incorporation of cholesterol and oleate derived from cholesterol 
ester and triacylglycerol was higher. These findings indicate that LDL-associated lipid is 
incorporated into cultured cells via a pathway that differs significantly from that of BSA-
lipid. 
 
Cholesterol and phosphatidylcholine processing in Niemann-Pick disease, type A: to 
investigate the role of Niemann-Pick disease, type A (NPA), one of the lysosomal storage 
diseases, on the processing of [
14
C]cholesterol and [
14
C]phosphatidylcholine, we applied the 
methods mentioned above to human fibroblasts and to fibroblasts from patients with NPA 
disease. Incubation with LDL-associated [
14
C]phosphatidylcholine and LDL-associated 
[
14
C]cholesterol show reduced processing of [
14
C]phosphatidylcholine and [
14
C]cholesterol 
by 25, and 21%, respectively. This study indicates that in NPA disease, also nutrient delivery 
via the endolysosomal system is impaired. 
 
Phosphatidylcholine (PC) and sphingomyelin (SM) processing in drug-treated cells: to 
investigate the influence of cationic amphiphilic drugs on uptake and processing of 
exogenously added choline-containing phospholipids, the influence of five cationic 
amphiphilic drugs, desipramine (DMI), imipramine (IM), chlorpromazine (CPZ), chloroquine 
(CQ), and fingolimod (FTY720), were studied. The lipid probes were delivered as 
components of LDL-particles, and the metabolic fate of their isotope-labeled fatty acid 
moieties was monitored in the four different cell types mentioned before. Concentrations of 
3 
10μM had slightly to no apparent effect on [14C]-SM and [14C]-PC processing for all CADs 
tested. Profound changes were observed when CADs were administered in high concentration 
(20µM, and 40µM). In macrophages, all investigated drugs lead to an impaired processing of 
SM and PC. Incorporation of the fatty acids released from PC and SM into diacylglycerols, 
triacylglycerols, and glycerophospholipids was drastically reduced in the presence of 20µM 
of the drugs. Furthermore, each cell type showed a characteristic neutral lipid and 
phospholipid pattern. The effect of the investigated CADs on SM and PC processing in terms 
of pmol per μg cell protein depend on the concentration of the investigated CADs, the cell 
type, and the identity of the FA in lipid probes. For example, 20µM FTY720 caused a 
drastically reduced incorporation of sphingomyelin-derived stearic acid into triacylglycerols 
in macrophages, fibroblasts and A431 cells, but not in HepG2 cells. While 20µM FTY720 
caused a slightly reduced incorporation of phosphatidylcholine-derived palmitic acid into 
triacylglycerols in macrophages. Therefore, our method is able to detect metabolic steps that 
are affected in the presence of CADs and to predict the potential of CADs to induce 
phospholipidosis. 
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2. Introduction 
 
In this work, the uptake and metabolism of different isotope-labeled lipid probes in 
fibroblasts (which can be obtained also from the patients), macrophages (which can 
eat/consum, or engulf/digest cellular debris), HepG2 cells (that are derived from the liver 
tissue which play a major role in lipid metabolism) and A431 cells (which have a high 
content of lipid droplets) were compared, to characterize lipid uptake pathways by cultured 
cells.  
 
2.1. Cell culture 
 
The cell is the basic structural and functional unit of all known living organisms. It is the 
smallest unit of life that is classified as a living thing, and is often called the building block 
of life. Organisms can be classified as unicellular (consisting of a single cell; including most 
bacteria) or multicellular (including plants and animals). Humans contain about 10
14
 cells, for 
every 10 of those, about one is actually human and the remainder from bacteria and other 
microorganism. The cell is size ranging from 135µm in the anterior horn in the spinal cord to 
4µm in granule cells in the cerebellum, but a typical cell size is 10µm and a typical cell mass 
is 1ng. Cell culture is a term referred to the growth and maintenance of prokaryotic or 
eukaryotic cells under sterile and appropriate conditions (typically, 37 °C, 5% CO2 for 
mammalian cells) out of their natural environment. Some cells can naturally survive in 
suspension cultures without being attached to a surface, such as cells that exist in the 
bloodstream. Adherent cells require a surface to continue to divide and fill the available area, 
such as a standard culture plastic dish. Sterile techniques are generally performed to avoid 
contamination with bacteria, yeasts, or other cells. To exclude contaminating 
microorganisms, antibiotics (e.g. penicillin and streptomycin) are added to the growth media, 
and the cell culture is carried out in a biosafety hood. Cell culture conditions can vary widely 
from one cell type to another. The growth medium is the most commonly varied factor 
among the culture conditions. It can vary in pH, glucose concentration, growth factors such 
as calf serum, and the presence of other nutrients. Cultured cells of different types serve as 
model systems of reduced complexity for living cells in their physiological surroundings. 
Although lipids of different classes have been applied to different types of cultured cells, a 
systematic study is missing that shows how different cells types take up and utilize lipids of 
different classes. In the present work, I provide a systematic comparison of four different cell 
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types towards their capacity to incorporate and metabolize different classes of lipids from the 
culture medium. This is part of a larger program to determine the kinetics by which 
exogenously applied lipids of different classes are taken up by cultured cells and processed to 
lipid droplets (LDs) constituents. LDs are intracellular storage organelles for nonpolar lipids 
(Goodman, 2008; Thiele, et al. 2008). They play a crucial role for lipid metabolism and 
homeostasis (Fujimoto, et al. 2008) and for diseases like obesity, metabolic syndrome, 
diabetes, and others (LeLay, et al. 2009). However, to make confident comparisons among 
studies using cells from different sources, the following cells were compared. 
 
2.1.1. A macrophage-like cell line 
 
In 1893 Metchnikoff was the first who used the term “macrophage”. Human macrophages are 
about 21µm in diameter. Macrophages are derived from monocytes that circulate in the 
blood. The most convenient source of macrophages are CD34 positive bone marrow 
progenitors that shed their progeny after proliferation and differentiation to promonocytes in 
the bloodstream. They then further differentiate into monocytes and extravasate into tissues 
(Ross, et al., 2002). Macrophages develop from the division of monocytes that migrate from 
the blood into many tissues throughout the body, including connective tissues, liver, lung, 
lymph nodes, spleen, bone marrow, skin, and others. The type of macrophage that results 
from monocyte differentiation depends on the type(s) of cytokines that these cells encounter. 
Cytokines are peptides and proteins produced by immune cells that can influence cell 
behavior and affect interactions between cells. They act as antimicrobial mediators and play 
critical roles in immune regulation and wound-healing. 
Macrophages have a wide range of cellular functions; they engulf and destroy cellular debris, 
ingest foreign invaders of the body, damaged macromolecules, bacteria, and infected or dead 
body cells by phagocytosis. After infection, damaged tissue is repaired and the remaining 
macrophages and other leukocytes move out of the tissue and reenter the circulation. In 
atherosclerosis, macrophages migrate to inflamed areas of the vessels of the cardiovascular 
system, where they can endocytose substantial amounts of cholesterol from lipoproteins, and 
accumulate within the artery wall under some circumstances (Lucas, et al. 2001). As the 
imported cholesterol is converted into the esterform, they accumulate cholesteryl esters in 
lipid droplets. These lipid-filled macrophages are called foam cells because the lipid droplets 
have a foamy appearance. As macrophage foam cells accumulate in an artery wall, they 
initially form an early fatty streak, the first unique step in atherosclerosis. RAW 264.7 (Fig. 
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2.1B), a mouse leukaemic monocyte macrophage cell line, is the most commonly used 
monocyte-derived line. These cell lines show fundamental differences to the primary cells in 
that they grow continuously in culture due to permanent alterations in their genes that may 
have an effect on the signaling cascades that are activated by microbial ligands (Hartley, et al. 
2008). 
 
2.1.2. Human skin fibroblasts 
 
The skin is the largest organ system in the body, acting as the protective barrier against the 
damaging effects of the environment. The skin consists of two basic layers, the epidermis, 
which is largely composed of keratinocytes, and the dermis. Fibroblasts have a branched 
cytoplasm surrounding an elliptical, speckled nucleus having one or two nuclei that often 
locally align in parallel cluster when crowded. Fibroblasts are large and flat with elongated 
cells possessing processes extending out from the ends of the cell body (Fig. 2.1A). 
Fibroblasts produce collagen proteins in order to maintain structural framework integrity for 
many tissues. They also appear to play an important role in the pathophysiology of fibrotic 
diseases as well as in cutaneous wound-healing tissues (Cevikbas, et al. 2011; Diegelmann, et 
al. 2004) by migrating to the site of damage, where they deposit new collagen and facilitate 
the healing process. Fibroblasts are morphologically heterogeneous with diverse appearances 
depending on their location and activity. Fibroblasts show distinct phenotypes in different 
anatomical locations, such as fibroblast-like cells that are found between the cartilaginous 
fibers in the synovial membrane of joints and are called synoviocytes. Fibroblasts produce 
one type of the extracellular protein fibronectin. This fibronectin is able to adhere fibroblasts 
to the extracellular matrix. Fibronectins are essential for the migration and differentiation of 
many cell types in embryogenesis. These proteins are also important for wound-healing 
because they promote blood clotting and facilitate the migration of macrophages and other 
immune cells into the affected area. 
 
2.1.3. A human epidermoid carcinoma cell line (A431 cells) 
 
A431 cells are a model cell line derived from a human epidermoid carcinoma from an 85 year 
old female patient (Giard, et al. 1973), which has been used for a variety of studies in cell 
biology. A431 cells (Fig. 2.1C) were found to have high levels of the epidermal growth factor 
receptor (EGFR) on its cell surface, nearly 3 million receptor sites per cell, and amplification 
of the EGF receptor gene (Merlino, et al. 1984). Therefore, they are used as a positive control 
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for EGFR expression, furthermore, they are used in studies of the cell cycle and cancer-
associated cell signaling pathways. The growth of A431 cells has been shown to be inhibited 
by high concentrations of EGF (Kamata, et al. 1986), and paradoxically to stimulate A431 
cell proliferation at low concentrations of EGF (Kawamoto, et al. 1983). This is in marked 
contrast to normal human fibroblasts, which have a much more reduced EGF receptor 
density. 
 
2.1.4. Human liver hepatocellular carcinoma cells (HepG2 cells) 
 
The HepG2 cell line was established by D.P. Aden, (Aden, et al. 1979) and is the most 
commonly used cell line for a variety of biochemical and cell biological studies of hepatocyte 
functions (Fig. 2.1D). This cell line is derived from a 15 year old male patient with primary 
liver cancer with differentiated hepatocellular carcinoma. In morphology, these cells are 
epithelial as monolayers and in small aggregates, have a model chromosome number of 55, 
and are not tumorigenic in nude mice. HepG2 cells exhibit numerous functions, including the 
synthesis and secretion a variety of major plasma proteins (Knowles, et al. 1980) such as 
albumin, transferrin and the acute phase proteins fibrinogen, alpha 2-macroglobulin, alpha 1-
antitrypsin, and plasminogen, and enzymes of carbohydrate metabolism (Verspohl, et al. 
1984). HepG2 cells appear to be a useful model of the human hepatocyte and are widely used 
as an in vitro model of human hepatic lipid metabolism (Javitt, et al. 1990). 
 
2.1.5. Niemann-Pick diseases, type A (NPA) 
 
Niemann-Pick diseases, type A (NPA) is one of a group of metabolic diseases classified as 
lysosomal storage disorders (LSD’s) in which lipids accumulate in certain tissues, caused by 
mutations in the sphingomyelin phosphodiesterase 1 gene (SMPD1) encoding for acid 
sphingomyelinase (Ferlinz, et al. 1991). NPA is a severe neurodegenerative disorder of 
infancy. It usually begins in the first few months of life; symptoms are an enlarged liver and 
spleen, enlarged lymph glands, swelling of the skin of the face, and brain and nervous system 
impairment. Acid sphingomyelinase (ASM) is the lysosomal enzyme affected by the gene 
defects. Its function is to degrade sphingomyelin (SM) into ceramide and phosphorylcholine, 
and is found in every cell of the body. The enzyme defect leads to sphingomyelin and 
cholesterol accumulation within the lysosomal compartment inside cells, causing cell death in 
early childhood. NPA occurs in all races and ethnicities, but higher rates are seen in the 
Ashkenazi (Eastern European) Jewish population. In this study, the uptake and subsequent 
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metabolism of both LDL-associated [
14
C]cholesterol and LDL-associated 
[
14
C]phosphatidylcholine into cultured skin fibroblasts from controls (healthy probands), and 
from a patient with Niemann-Pick diseases, type A was also examined. 
 
 
Figure 2.1: Morphological aspects 
of A: fibroblasts (Lysy, et al. 2007); 
B: RAW 264.7 macrophage (Cox, et 
al. 2009); C: A431 cells (Veldman, 
et al. 2005); and D: HepG2 cells 
(Reynaert, et al. 2004) that were 
used in the present study.  
 
 
 
 
2.2. The biological membrane 
 
Membranes in cells typically define enclosed spaces or compartments in which cells may 
maintain a chemical or biochemical environment that differs from the outside. Biological 
membranes are asymmetric structures. Both the lipids and the proteins of membranes exhibit 
lateral (when lipids or proteins of particular types cluster in the plane of the membrane) and 
transversal asymmetries. In eukaryotic cells, also the lipid composition of the membranes of 
different organelles is heterogeneous. For example, the plasma membrane is highly enriched 
in cholesterol and glycosphingolipids, which are nearly absent from the endoplasmic 
reticulum (ER) (Prinz, 2002; Munro, 2003). In addition, there is a transbilayer lipid 
compositional asymmetry within the same membrane (Pomorski, et al. 2001), and in 
polarized cells, apical and basolateral membrane have different lipid and protein composition. 
Biological membranes and their components serve a number of essential cellular functions: 
They act as a selective barrier within or around a cell, where many reactions and processes 
occur; function as a platform for signal transduction; allow cell recognition; provide 
anchoring sites for cytoskeletal filaments or components of the extracellular matrix; 
compartmentalize cells; regulate the fusion of the membrane with other membranes in the 
cell and provide a passage way across the membrane for certain molecules. 
9 
The major components of all biological membranes are lipids, proteins and small amount of 
carbohydrates (as part of glycolipids and glycoproteins) of less than 10% of the mass of most 
membranes in variable proportion. Membranes proteins mediate and regulate transport of 
metabolites, macromolecules, and ions in and out of cells or subcellular organells (Shkulipa, 
2006). The lipids of cell membranes play a crucial role in the function and properties of cell 
membranes. The membrane lipids consist of many different lipid species, classified according 
to head-group and backbone structures. These include glycerophospholipids, sphingolipids 
and cholesterol (Pomorski, et al. 2001; Edidin, et al. 2003; Holthuis, 2001; Fahy, et al. 2005). 
The carbohydrate moieties attached to some proteins and lipids are particularly abundant on 
the extracellular surface of the plasma membrane where they form the glycocalyx. The 
function of this layer is to prevent uncontrolled membrane fusion and to participate in 
recognition phenomena. In endothelial tissues, the glycocalyx serves to shield the vascular 
wall from the shear stresses of blood flow, impede leakage of blood constituents across the 
endothelial lining, and prevent adhesion of leucocytes and platelets to the endothelium 
(Rehm, et al. 2004). 
Many subcellular organelles in eukaryotes are surrounded by membranes (Voet, et al. 2011) 
such as nuclei, mitochondria, chloroplasts, endoplasmic reticulum, and Golgi apparatus. 
These organelles continually exchange biomolecules by a variety of membrane trafficking 
mechanisms (Sprong, et al. 2001; Mellman, 1996).  
In 1972, S.J. Singer, and G.L. Nicolson proposed the fluid mosaic model for membrane 
structure (Fig. 2.2), a widely accepted model of biological membranes. They suggested that 
membranes are dynamic structures composed of proteins and phospholipids. In this model, 
the phospholipids form a fluid bilayer (Singer, et al. 1972) in which the nonpolar regions of 
the lipid molecules in each layer face the core of the bilayer and their polar head groups face 
outward, interacting with the aqueous phase on either side. The hydrophobic nature of lipid 
molecules allows membranes to form spontaneously, and to act as effective barriers to polar 
molecules. The fluidity of the hydrocarbon core of the bilayer increases with increasing 
content of unsaturated or branched alkyl chains or with decreasing alkyl chain length. 
Membrane proteins can be embedded in the bilayer by hydrophobic interactions between the 
membrane lipids and hydrophobic domains of the proteins. Some proteins protrude from only 
one side of the membrane; others have domains exposed on both sides. The orientation of 
proteins in the bilayer is asymmetric, giving the membrane “sidedness”: the protein domains 
exposed on one side of the bilayer are different from those exposed on the other side, 
reflecting functional asymmetry. The individual lipid and protein units in a membrane form a 
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fluid mosaic because most of the interactions among its components are noncovalent, leaving 
individual lipid and protein molecules capable of rotational degrees of freedom and to move 
laterally in the plane of the membrane, but movement of either from one face of the bilayer to 
the other is restricted. 
Singer and Nicolson defined two classes of membrane proteins: peripheral (or extrinsic 
proteins) and integral proteins (or intrinsic proteins). The first includes those proteins that do 
not penetrate the bilayer to any significant degree and are associated with the membrane by 
virtue of electrostatic interactions and hydrogen bonds between the polar groups on the 
membrane surface and the surface of the protein. Furthermore, peripheral proteins can easily 
be dissociated from the membrane by treatment with salt solutions or by changes in pH. 
Integral proteins, in contrast, possess hydrophobic surfaces that can readily penetrate the 
matrix of the phospholipid bilayer itself as well as surfaces that prefer contact with the 
aqueous medium. In eukaryotic cells, almost all integral membrane proteins are synthesized 
on the surface of the rough ER (Gilmore, et al. 2012). Integral membrane proteins are 
strongly associated with bilayer lipids that influence specific function of certain membrane 
proteins. Because of these interactions, integral proteins can only be removed from the 
membrane by agents capable of breaking up the hydrophobic interactions within the lipid 
bilayer itself such as detergents and organic solvents.  
 
 
Figure 2.2: The fluid-mosaic model of membrane structure proposed by (Singer, S.J. and Nicolson, 
G.L. 1972). In this model, a lipid bilayer is composed of phospholipids, cholesterol, glycolipids, and 
proteins. Peripheral proteins are embedded in either the outer or inner leaflet of the lipid bilayer, while 
integral proteins are firmly embedded in the lipid layers. Many of the proteins and lipids have 
externally exposed oligosaccharide side chains (Nelson, et al. 2005). 
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2.2.1. Lipid bilayers 
 
Amphipathic lipids spontaneously form a variety of supramolecular structures when added to 
an aqueous medium. They can aggregate into one of three forms: spherical micelles, 
liposomes, and sheetlike, two-molecule-thick bilayers (Fig. 2.3). All these structures form in 
ways that minimize the surface area in contact between the hydrophobic lipid chains and the 
aqueous milieu. For example, when small amounts of a fatty acid are mixed with an aqueous 
solution, a monolayer is formed at the air–water interface, with the polar head groups in 
contact with the water surface, shielding their hydrophobic tails from the water in contact 
with the air (Shkulipa, 2006). Micelles formed from an amphipathic lipid in water position 
the hydrophobic tails in the center of the lipid aggregate with the polar head groups facing 
outward. Micelles are the preferred form of aggregation in water for detergents and soaps. 
Phospholipids prefer to form bilayer structures in aqueous solution because their pairs of fatty 
acyl chains do not pack well in the interior of a micelle. Phospholipid bilayers form rapidly 
and spontaneously when phospholipids are added to water, and they are stable structures in 
aqueous solution. Extensive bilayers normally wrap around themselves and form closed 
vesicles. The nature and integrity of these vesicle structures are very much dependent on the 
lipid composition. Phospholipids can form either unilamellar vesicles (with a single lipid 
bilayer) known as liposomes, or multilamellar vesicles which are reminiscent of the layered 
structure of onions. 
The lipid bilayer thickness is about 3nm, 30Å thick (Heimburg, 2009), and is defined by the 
length, degree of saturation, and packing of the fatty acid chains. The thickness of bilayers is 
not a static number since thickness can vary over the surface of a membrane if microdomains 
of lipids are formed with different alkyl chain lengths. For example, addition of cholesterol or 
increasing chain length causes membrane thickening, whereas increased chain unsaturation or 
the strength of head group repulsions causes the bilayer to thin (Cantor, 1999).  
An important property of the lipid bilayer heterogeneity is that it contributes to membrane 
fluidity. The bilayer's fluidity allows lateral mobility within the lipid bilayer. It depends on 
the membrane phase and changes with the temperature. This fluidity is biologically 
important, influencing membrane transport. For example, the membranes of mammalian 
spermatozoa are composed of a complex mixture of lipids that provide the correct 
infrastructure and fluidity for the membrane mediated events that lead to fertilization (Ladha, 
1998). Other roles for lipid diversity are the storage of precursors that can be metabolized to 
potent second messengers, e.g., diacylglycerol, ceramide, sphingosine, inositol trisphosphates 
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and eicosanoids. In addition, several phosphoinositides (phosphatidylinositol 3-phosphate 
(PI3P), phosphatidylinositol 4-phosphate (PI4P), phosphatidylinositol-4,5-biphosphate 
(PI45P2), phosphatidylinositol-3,4,5-triphosphate (PI345P3)) act as membrane recognition 
and attachment sites for protein complexes involved in protein traffic and membrane fusion 
events (Simonsen, et al. 2001; Barlow, et al. 2010).  
 
2.2.2. Transmembrane lipid asymmetry 
 
The fluidity of the lipid bilayer of biological membranes has been established by biophysical 
studies. The lipids can rotate freely about their axis perpendicular to the plane of the 
membrane and diffuse readily within the lateral plane. Movement of polar lipids from one 
leaflet of the bilayer to the other is severely constrained and is measured in half times of 
hours or days. This constraint results from the requirement of free energy to move a hydrated 
polar moiety from the aqueous interface through the hydrocarbon interior of the structure. As 
a consequence of this restricted motion, an asymmetric distribution of lipids can be created 
and maintained across biological membranes. In many naturally occurring bilayers, the 
external monolayer of the mammalian cell membrane is made up almost exclusively of the 
neutral zwitterionic phospholipids phosphatidylcholine (PC), and sphingomyelin (SM), 
together with some phosphatidylethanolamine (PE). Phosphorylcholine is the most common 
head group accounting for about half of the phospholipids in most mammalian cells. In 
contrast, the internal monolayer contains anionic phospholipids as a major component which 
account for about 30% of cell phospholipids (Verkleij, et al. 1973; Buckland, et al. 2000; 
Chaurio, et al. 2009), mainly phosphatidylserine, phosphatidylethanolamine, and the 
phosphatidylinositols are much more abundant in the inner (cytoplasmic) leaflet (Chaurio, et 
al. 2009; Quinn, 2002). This is illustrated in figure 2.4, which shows the percentage 
distribution of the major lipid classes between the cytoplasmic and outer leaflet of the human 
erythrocyte membrane.  
Lipid asymmetry is maintained by translocases (Flippases) (Van Meer, et al. 2008). The 
aminophospholipid translocase is an ATPase II type enzyme that requires Mg
2+
 and 
specifically transports phosphatidylserine and phosphatidylethanolamine from the outer to the 
cytoplasmic leaflet of the membrane, while choline phosphatides are transported from the 
cytoplasmic to the outer leaflet. 
 
13 
 
Figure 2.3: Variety of structures of amphipathic lipid that aggregates in water. (a) In micelles, the 
hydrophobic fatty acid chains are sequestered at the core of the sphere with only small amounts of 
water in the hydrophobic interior. (b) In an open bilayer, all fatty acids acyl side chains are protected 
from interaction with water except those at the edges of the sheet. (c) When a bilayer folds on itself, it 
forms a closed bilayer (liposome) enclosing an aqueous cavity (Nelson, et al. 2005). 
 
Figure 2.4: In erythrocyte plasma membrane, 
percentage asymmetric distribution of the major 
phospholipids between the cytoplasmic and outer 
monolayers leaflets. This distribution is 
determined by treating the intact cell with 
phospholipase C, which removes the head groups 
of lipids in the outer monolayer, but cannot reach 
lipids in the inner monolayer (leaflet). In the outer 
monolayer, the proportion of each head group 
released provides an estimate of the fraction of 
each lipid (Nelson, et al. 2005). 
 
2.2.3. Membrane phospholipids 
 
Lipids are a class of biological molecules defined by low solubility in water and high 
solubility in nonpolar solvents (Fahy, et al. 2005). The lipids found in biological systems are 
either hydrophobic or amphipathic. Phospholipids are the primary building blocks of most 
biological membranes. In eukaryotic cells, phospholipids are synthesized by enzymes located 
on the surface of the endoplasmic reticulum (ER). The membranes of mammalian cells 
contain more than 1,000 different phospholipid species (Vance, 2008). Phospholipids are 
abundant in all biological membranes and are derived from either glycerol or sphingosine, a 
long-chain unsaturated amino alcohol (Berg, et al. 2003). Phosphoglycerides (Fig. 2.6) 
consist of a glycerol backbone to which two residues (Fahy, et al. 2005), mostly fatty acids 
and a phosphorylated alcohol are attached in ester linkage. The fatty acid constituents are 
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usually even-numbered, most commonly of 16 or 18 carbons. Naturally occurring 
phospholipids contain a saturated fatty acid (such as stearic acid or palmitic acid) in position 
sn-1, whereas an unsaturated one (such as oleic acid, linoleic acid or arachidonic acid) in sn-2 
position. The length and the degree of unsaturation of fatty acids in the membrane have an 
important effect on the fluidity (Chaurio, et al. 2009). 
The major phosphoglycerides arise from phosphatidate through the formation of an ester 
bond between the phosphate group of phosphatidate and the hydroxyl group of one of several 
alcohols. The simplest phosphoglyceride is phosphatidic acid, which is sn-1,2-diacylglycerol 
3-phosphate, a key intermediate in the formation of all other phosphoglycerides. In other 
phosphoglycerides, the 3-phosphate is esterified to an alcohol such as ethanolamine, choline, 
serine, glycerol, or inositol (Fig. 2.5). The second major class of phospholipids is 
sphingomyelin, which contains a sphingosine backbone rather than glycerol. A fatty acid is 
attached by an amide linkage to the amino group of sphingosine, forming ceramide.  
The content of phospholipids also varies among organelles. For example, cardiolipin is a 
major constituent of the inner membrane of mitochondria, but is absent from other organelles 
(Van Meer, et al. 2008), whereas bis(monoacylglycero)phosphate is largely confined to late 
endosomes and lysosomes (Kolter, et al. 2010; Matsuo, et al. 2004; Kobayashi, et al. 2002). 
In mammalian cells, glycerophospholipids account for approximately 70% of the total 
membrane lipid content and thus play key roles in the structure and function of mammalian 
membranes; the other 30% consists of cholesterol, sphingomyelin, and glycosphingolipids 
(Leventis, et al. 2010). Among the phospholipids derived from glycerol, phosphatidylcholine 
(PC) is the most prevalent and accounts for 40-50% of the total phospholipids (Vance, 2008; 
Matsuo, et al. 2004). Of this amount, 76% is found in the outer monolayer, and 24% is found 
in the inner monolayer. Phosphatidylethanolamine (PE) is the next most abundant, which 
ranges from 20-45% of the total phospholipids, depending on the tissue (Vance, 2008; 
Murphy, et al. 2000), and is the major phospholipid in bacteria. Phosphatidylinositol (PI) (2-
8% of the total PL), phosphatidylserine (PS) (2-10% of the total PL), phosphatidic acid (PA) 
(1% of the total PL), phosphatidylglycerol (PG) (<1% of the total PL), and 
bis(monoacylglycero)phosphate (BMP) (<1% of the total PL) (Kolter, et al. 2005) are 
present, but in lesser amounts (Leventis et al. 2010).  
Most cells continually degrade and replace their membrane lipids. For each hydrolyzable 
bond in a glycerophospholipid, there is a specific hydrolytic enzyme in the lysosome and 
other subcellular compartments (Fig. 2.7). Phospholipases of the A type remove one of the 
two fatty acids at the sn-1 position, producing a lysophospholipid. Phospholipases A2 
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hydrolyze the ester bonds of intact glycerophospholipids at sn-2 of glycerol. Phospholipases 
C and D each split one of the phosphodiester bonds in the head group.  
 
 
Figure 2.5: Structure of glycerol 
phosphate-based lipids. The lipid 
structures are shown with head 
group from top to bottom, 
phosphatidic acid (PA), 
phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), 
phosphatidylserine (PS), 
phosphatidylinositol (PI), and 
phosphatidylglycerol (PG).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: A phosphoglyceride showing 
the fatty acids (R1 and R2), glycerol, and 
phosphorylated alcohol components. In 
phosphatidic acid, R3 is hydrogen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: The specificities of phospholipases. The 
ester bonds of intact glycerophospholipids at sn-1 and 
sn-2 of glycerol are hydrolyzed by phospholipases A1, 
and A2, respectively. PLB cleaves both the sn-1 and 
sn-2 ester bonds.  Phospholipases C and D each split 
one of the phosphodiester bonds in the head group. R1 
and R2, (CH2)nCH3; R3, various head groups.  
(Richmond, et al. 2011). 
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2.3. Endocytosis  
 
2.3.1. Entry pathways into cells 
 
In eukaryotic cells, endocytosis is a process by which cells take up large molecules, such as 
proteins, from the environment to the inside of the cell by engulfing them.  In this process, 
plasma membrane lipids, integral proteins, and extracellular fluid become fully internalized 
into the cell (Doherty, et al. 2009). It is used by all cells of the body since many substances in 
the environment are large polar molecules that cannot pass through the hydrophobic plasma 
membrane. The endocytic pathway consists of distinct compartments that receive internalized 
molecules from the plasma membrane and recycle them back to the surface in early 
endosomes, or sort them to degradation in late endosomes and lysosomes. 
Many endocytic entry pathways into cells have been identified, which differ in the cargoes 
they take up and in the protein machinery that mediates the endocytic process (Mayor, et al. 
2007). Extracellular materials can enter the cell depending on the nature and size of the 
molecules either by endocytosis, phagocytosis, or macropinocytosis (Aderem, et al. 1999). 
The basic steps of the endocytic pathway are summarized in figure 2.8. 
A few specialized cell types (e.g., macrophages and granulocytes) can ingest whole bacteria 
and other large particles whose size exceeds about 0.5μm such as viruses, cells debris, micro-
organisms, and even apoptotic cells by phagocytosis. Phagocytosis is a nonselective, actin-
mediated process and is usually independent of clathrin in which extensions of the plasma 
membrane envelop the ingested material, forming large vesicles called phagosomes. Once 
inside the phagocyte, the phagosome contains the pathogenic microorganism such as 
mycobacterium avium or mycobacterium tuberculosis. It appears to fuse well with early and 
poorly with late endocytic organelles, since the pH of phagosomes was precisely that of the 
early endosomes (≈ 6.3) (Kuehnel, et al. 2001). Macrophages are extremely active in this 
regard and may ingest 25% of their volume/hour. Thus, phagocytosis by macrophages is 
critical for the uptake and degradation of infectious agents and senescent cells, and it 
participates in tissue remodeling and inflammation. 
Macropinocytosis is another form of endocytosis, a mainly actin-dependent endocytic process 
that usually starts from highly ruffled regions of the plasma membrane and is used to 
internalize nonspecifically large amounts of fluid, growth factors and small droplets of 
extracellular fluid to form an external macropinocytic structure that is then enclosed and 
internalized, forming discrete vacuoles, the macropinosomes, which are accumulated within 
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the cell (Lim, et al. 2011). Vesicles mediating this form are filled with a large volume of 
extracellular fluid and molecules. The formation of these vesicles is an extremely active 
process. It is highly active in macrophages and dendritic cells; for example, fibroblasts 
internalize their plasma membrane at about one-third of the rate of macrophages. The vesicle 
then travels into the cytosol and fuses with other vesicles such as endosomes and lysosomes 
(Falcone, et al. 2006).  Internalized macropinosomes share many features with phagosomes 
and both are distinguished from other forms of endocytic vesicles by their large size, 
morphological heterogeneity, and the lack of coat structures (Jones, et al. 2007). 
In clathrin-mediated endocytosis, clathrin subunits form a three limbed structure called a 
triskelion, with each limb being made up of one light and one heavy chain of clathrin. The 
clathrin is polymerized into a basket by assembly particles, composed of four adapter 
proteins. These interact with certain amino acid sequences in the cytoplasmic domain of 
membrane-bound receptors that become endocytosed, ensuring selectivity of uptake. The 
clathrin lattice grows as more receptors are occupied by target proteins, until a complete 
membrane-bound endocytic vesicle buds off the plasma membrane mediated by the protein 
dynamin and enters the cytoplasm. Clathrin coated pits make up about 2% of the surface of 
cells such as hepatocytes and fibroblasts. The clathrin is quickly removed by uncoating 
enzymes, and the individual vesicles fuse with each other to form early endosomes. Coated 
pits can concentrate large extracellular molecules that have different receptors responsible for 
the receptor-mediated endocytosis of ligands, such as low-density lipoprotein (LDL); the 
iron-carring protein transferrin; many protein hormones (e.g., insulin); and certain 
glycoproteins. Coated pits also involved in desensitizing of G-proteins coupled receptors 
(Kobilka and Lefkowitz, 2012). 
Caveolae are dynamin-dependent and non-clathrin-coated plasma membrane buds. Caveolae 
are 50-80nm flask shape pits in the plasma membrane that resemble the shape of a cave 
(hence the name caveolae). They exist on the surface of many cell types, especially in 
endothelial cells and adipocytes. They consist of the cholesterol-binding protein caveolin, 
eventually in a putative domain enriched in cholesterol and sphingolipids (Simons, et al. 
1997), signaling proteins and clustered glycosyl phosphatidylinositol-anchored proteins (GPI-
Aps) (Aboulaich, et al. 2004; Lemaitre, et al. 2005; Sprenger, et al. 2004) and have several 
functions in signal transduction (Anderson, R.G. 1998). They also play a role in endocytosis, 
oncogenesis, and the uptake of pathogenic bacteria and certain viruses (Frank, et al. 2004; Li, 
et al. 2005; Pelkmans, 2005). Caveolar cargoes are diverse, ranging from lipids, proteins and 
lipid-anchored proteins to pathogens.  
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ATPases in the endosomal membranes reduce the pH in the endosomal lumen, facilitating 
dissociation of receptors from their target ligands. The imported ligands and receptors 
dissociate in the late endosome, the ligand is released, and the receptors recycle back to the 
cell surface. Ligands are then transported from late endosomes and are delivered to the 
lysosomes for degradation.  
 
Figure 2.8: Endocytic entry pathways into cells. Phagocytosis can take up large particles, whereas 
fluid uptake occurs by macropinocytosis. The size of the vesicles formed by phagocytosis and 
macropinocytosis is much larger, compared with the other endocytic pathways. Some vesicles derived 
from the plasma membrane such as clathrin- or caveolin-coated vesicles and tubular intermediates 
internalize cargoes (known as clathrin-and dynamin-independent carriers (CLICs)) and deliver it to 
the early endosome. Some cargo may traffic first to intermediate compartments, such as the 
caveosome or glycosyl phosphatidylinositol-anchored protein enriched early endosomal 
compartments (GEEC), before it moves to the early endosome (Mayor, et al. 2007). 
 
2.3.2. Lysosomes  
 
Lysosomes are acidic organelles enriched with catabolic enzymes for the degradation of 
various products of cellular turnover (Pastores, 2006) that have been taken up from the 
outside or have become obsolete for the cell. Lysosomes vary in size (0.1–1.2μm; Kuehnel, 
2003) and shape. Lysosomes are found exclusively in animal cells, while in yeast and plants 
the same roles are performed by lytic vacuoles (Samaj, et al. 2005). The process by which an 
aged organelle is degraded in a lysosome is called autophagy. Lysosomes contain a group of 
enzymes that degrade polymers into their monomeric subunits. For example, nucleases 
degrade RNA and DNA into their mononucleotide building blocks; proteases degrade a 
variety of proteins and peptides; phosphatases remove phosphate groups from 
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mononucleotides, phospholipids, and other compounds; still other enzymes degrade complex 
polysaccharides and glycolipids into smaller units. All the lysosomal enzymes work most 
efficiently at acidic pH values (pH 4.8) and collectively are termed acid hydrolases, 
compared to the slightly alkaline cytosol (pH 7.0 - 7.3). The lysosome maintains this pH by 
vacuolar proton pumps. The acid pH helps to denature proteins, making them accessible to 
the action of the lysosomal hydrolases, which themselves are resistant to acid denaturation. 
Lysosomal enzymes are poorly active at the neutral pH of cells and most extracellular fluids.  
Mutations within the genes that encode distinct acid hydrolases lead to the progressive 
accumulation of incompletely metabolized substrates within various tissues, and ultimately a 
disruption of organ function (Beck, 2010; Pastores, 2006). Characteristic disease 
manifestations may include distinctive facial features, organomegaly, skeletal problems and 
central nervous system (CNS) dysfunction. As a group, these disorders are commonly 
referred to as the lysosomal storage diseases (LSDs); inborn errors of metabolism that have 
traditionally been classified according to the biochemical nature of the incompletely degraded 
tissue deposits (Futerman, et al. 2004). Furthermore, phospholipidosis is another lysosomal 
storage disorder that is characterized by the excess accumulation of phospholipids in tissues. 
A large number of approved catonic amphiphilic drugs (CADs) can induce phospholipidosis 
(drug-induced phospholipidoses) that may interfere with cellular functions, such as increased 
autophagy and loss of nuclei leading to chronic disease or even death. CADs might also bind 
to phospholipids, creating a complex which is trapped in the form of lysosomal lamellar 
bodies (Nioi, et al. 2008) that are resistant to degradation by phospholipases (Reasor, et al. 
2006). The identification of the potential to induce phospholipidoses at early stages of drug 
discovery can be advantageous for selecting improved drug development candidates 
(Kasahara, et al. 2006; Nonoyama, et al. 2008; Nioi, et al. 2008), since drug-induced 
phospholipidosis is one of the major reasons for the retraction of drug candidates (Reasor, et 
al. 2006). In cultured cells treated with CADs, phospholipids can accumulate intracellularly 
with the formation of lysosomal multi-lamellar bodies within only a few hours of exposure 
(Nonoyama, et al. 2008). In addition, the chemical modification of lipoproteins, 
enzymatically degraded LDL (eLDL) and oxidized LDL (oxLDL), induce lipid storage in 
different compartments. While eLDL preferentially induces rapid formation of large 
cytoplasmic lipid droplets, oxLDL provokes endolysosomal phospholipidosis and impaired 
cholesterolester hydrolysis (Orso, et al. 2011).  
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2.4. Lipoproteins 
 
Lipoproteins are soluble complexes of proteins (apolipoproteins) and lipids that transport 
hydrophobic, water-insoluble lipids and other fat soluble nutrients like vitamins A, K, D and 
E to different organs (liver) and tissues (adipose and other cells) in the circulation of all 
vertebrates. In vertebrates, dietary triacylglycerols are solubilized by amphipathic bile salts 
such as taurocholic acid, which are synthesized from cholesterol in the liver. They convert 
dietary fats into mixed micelles of bile salts and triacylglycerols. Micelle formation 
enormously increases the fraction of lipid molecules accessible to the action of water-soluble 
lipases in the intestine, and lipase action converts triacylglycerols to monoacylglycerols, free 
fatty acids, and glycerol. These products of lipase action diffuse into the epithelial cells lining 
the intestinal surface, the intestinal mucosa. There, they are reconverted to triacylglycerols 
and packaged with dietary cholesterol and specific proteins into lipoprotein aggregates called 
chylomicrons and enter the blood stream, which carries them to muscle and adipose tissue.  
Chylomicrons are the largest of the lipoproteins and the least dense, containing a high 
proportion of triacylglycerols and other lipid soluble nutrients, e.g, vitamins. Chylomicrons 
are synthesized in the ER of epithelial cells that line the small intestine, then move through 
the lymphatic system and enter the bloodstream via the left subclavian vein. The 
apolipoproteins of chylomicrons include apolipoprotein B-48 (apoB-48) unique to this class 
of lipoproteins, apoE, and apoC-II. ApoB-48 is the major protein which has a molecular 
weight of 240kDa and forms an amphipathic shell around the spherical fat globule. ApoB-48 
is formed from the first 48% of apoB-100 and arises from the posttranscriptional editing of 
apoB-100 mRNA in the intestine. Chylomicrons carry dietary fats to the target tissues where 
they are consumed (muscle) or stored (adipose tissue) after cleavage by the extracellular 
enzyme lipoprotein lipase. The remnants of chylomicrons, which are depleted of most of their 
triacylglycerols, but still contain cholesterol, apoE, and apoB-48, then move through the 
blood stream to the liver. Receptors in the liver bind to the apoE in the chylomicron remnants 
and mediate their uptake by endocytosis. In the liver, the remnants release their cholesterol 
and are degraded in lysosomes. Triacylglycerols that enter the liver by this route are cleaved 
into glycerol and fatty acids, which may be oxidized to provide energy, or to provide 
precursors for the synthesis of ketone bodies. When the diet contains excess carbohydrate and 
more fatty acids than are needed as fuel, they are converted to triacylglycerols in the liver and 
packaged with specific apolipoproteins into very-low-density lipoprotein (VLDL, or pre-β-
lipoproteins). In addition to triacylglycerols, VLDLs contain some cholesterol and cholesteryl 
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esters, as well as apoB-100, apoC-I, apoC-II, apoC-III, and apo-E. These lipoproteins are 
transported in the blood from the liver to muscle and adipose tissue, where the free fatty acids 
are released from the VLDL triacylglycerols through lipoprotein lipase activated by apoC-II. 
Adipocytes take up these fatty acids, reconvert them to triacylglycerols, and store them in 
intracellular lipid droplets. The size and lipid composition of chylomicrons and VLDLs vary 
according to the nutritional status of the animal. Most VLDL remnants are removed from the 
circulation by hepatocytes. The uptake, like that for chylomicrons, is receptor-mediated and 
depends on the presence of apoE in the VLDL remnants. The loss of triacylglycerol converts 
some VLDL to VLDL remnants (also called intermediate density lipoprotein, IDL), by the 
action of lipases associated with capillary surfaces and their consequent enrichment in 
cholesterol esters. These intermediate-density lipoproteins may be taken up by the liver and 
further processed or converted into low-density lipoproteins (LDLs) by hydrolysis of more 
triacylglycerol, representing a final stage in the catabolism of VLDL. LDLs are very rich in 
cholesterol and cholesteryl esters and contain apoB-100 as their major apolipoprotein. LDLs 
carry cholesterol to extrahepatic tissues that have specific plasma membrane receptors that 
recognize apoB-100. These receptors mediate the uptake of cholesterol and cholesteryl esters. 
The fourth major lipoprotein type, high-density lipoprotein (HDL), originates in the liver and 
small intestine as small, protein-rich particles. HDLs contain apoA-I, apoC-I, apoC-II, and 
other apolipoproteins, as well as the enzyme lecithin-cholesterol acyl transferase (LCAT). 
LCAT is a glycoprotein of 67kDa on the surface of nascent HDL particles, converts the 
cholesterol and phosphatidylcholine of chylomicrons and VLDL remnants to cholesteryl 
esters, which begin to form a core, transforming the disk-shaped nascent HDL to a mature, 
spherical HDL particle. This cholesterol-rich lipoprotein then returns to the liver for 
metabolism and excretion. Some of this cholesterol is converted to bile salts in a process 
referred to as reverse cholesterol transport. LCAT uses preferentially PC species with 18:2 or 
18:1 fatty acids in the sn-2 position (by the action of PLA2), thus enriching cholesteryl esters 
in these fatty acids. In contrast, PC containing 18:0 or 20:4 fatty acids is a poor substrate for 
LCAT, explaining the decreased contents of these fatty acids in the cholesteryl esters.  
ApoA, apoC and apoE are referred to as exchangeable apolipoproteins (Saito, et al. 2004) and 
they are responsible for regulating the traffic of lipids into and out of a cell by acting as 
cofactors for plasma enzymes and ligands for cell-surface receptors. The classification into 
chylomicrons (CM), very low-density (VLDL), low-density (LDL), and high-density (HDL) 
lipoproteins is based on their relative contents of protein and lipid that determine the densities 
of these lipoprotein classes. Chylomicrons have only 1-2% protein while HDL has about 50% 
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protein by weight. The diameters of lipoproteins are inversely correlated with their densities 
and range from about 1200nm for CM down to 8nm for the smallest HDL. 
 
2.4.1. Low density lipoprotein (LDL) 
 
Low density lipoprotein (LDL), the most abundant cholesterol-carrying lipoprotein in human 
plasma, is one of the five major groups of lipoproteins which are synthesized in the intestine 
and the liver. The particles are usually spherical in shape and are classified according to their 
buoyant density. Subclasses of LDL in the density range from 1.027 - 1.060 g/mL and size 
range from 270 - 210 Å (27 – 21nm in diameter) have been obtained and shown to have 
different metabolic properties (Shen, et al. 1981). LDL contains an amphipathic monolayer 
shell surrounding a hydrophobic lipid core (Fig. 2.9), which is typically composed of about 
170 TAG molecules, and 1600 CE molecules per LDL esterified mainly with linoleate. The 
surface monolayer comprises about 700 phospholipids, the majority of which is PC, about 
450 molecules per LDL, 600 molecules of unesterified cholesterol, and also a single copy of 
apolipoprotein B-100 (apoB-100). ApoB-I00 is an amphipathic protein, which has 4536 
amino acids residues and a mass of 514kDa (Hevonoja, et al. 2000). Human apoB-100 
contains 25 cysteine residues of which 16 exist as intramolecular disulfide bonds: 14 of these 
are clustered in the N-terminal region, disulfide bonds in this region are critical for the correct 
folding and secretion of apoB. The type of fatty acid supplied to hepatocytes influences the 
secretion of apoB-containing lipoproteins. For example, when oleate is added to HepG2 cells, 
the synthesis of TAG and phospholipids is stimulated and the amounts of apoB and TAG 
secreted are increased (Dixon, et al. 1991). Thus, an increased lipid supply enables a larger 
proportion of newly synthesized apoB to be translocated across the ER membrane and enter 
the secretory pathway. In contrast, compared to oleic acid, the (n-3) fatty acids 
eicosapentaenoic acid (20:5) and docosahexaenoic acid (22:6), found in fish oils, decrease 
plasma TAG levels in humans and decrease the secretion of apoB-containing lipoproteins 
from rat hepatocytes and hepatoma cells.  
Once in the circulation, LDL may either take up free cholesterol from cells or deliver free or 
esterified cholesterol to cells. The cholesterol bound to LDL is referred to as bad cholesterol 
because it is thought to have deleterious health impacts (Brunzell, et al. 2008). For example, 
increasing levels of LDL-cholesteryl esters (LDL-CE) were associated with elevated risk of 
atherosclerosis, leading to cardiovascular diseases, including heart attack and stroke (Scott, 
2004; Rosenson, 2004).  
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Figure 2.9: A schematic molecular model of an LDL 
particle. The colour coding for the molecules is: dark 
blue – phosphatidylcholine, light blue – sphingomyelin, 
dark yellow – cholesterol ester, red – cholesterol, green 
– triglyceride, and grey – apolipoprotein B-100. The 
molecular shapes and scales are derived from molecular 
dynamics simulations (Hevonoja, et al. 2000). The 
showed particle has a diameter of 20nm, including a 
surface monolayer of 2nm (yellowish background). 
 
 
 
 
2.4.2. Lipoprotein uptake and trafficking 
 
Lipoprotein receptors play an important role in lipoprotein metabolism and in cellular 
cholesterol homeostasis. The affinity and specificity of these receptors for the different 
lipoproteins facilitate the uptake and metabolism of lipoproteins in various tissues and cells. 
Each receptor can handle only one particle of LDL at a time. Brown and Goldstein in the 
1970s identified the details of the uptake and metabolism of LDL following receptor-
mediated endocytosis. When radiolabeled LDL was investigated to compare its uptake from 
the circulation of experimental animals into various tissues, high levels of hepatic LDL 
receptors were observed. Steinberg and co-workers and Dietschy and co-workers (Pittman, et 
al. 1982; Spady, et al. 1983) demonstrated that about 70% of the total-body uptake of 
radiolabeled LDL took place in the liver by LDL receptor-dependent pathways. 
Most mammalian cells produce cell-surface receptors that specifically bind to the apoB-100 
protein embedded in the phospholipid outer layer of LDL particles. In 1985, Brown and 
Goldstein were awarded with the Nobel Prize for their identification of the low density 
lipoprotein receptor (LDLR). LDLR complexes are present in clathrin-coated pits (or buds) 
on the cell surface, which when bound to LDL via adaptin, are pinched off to form clathrin-
coated vesicles inside the cell. This allows LDL to be bound and internalized in a endocytosis 
process and prevent the LDL just diffusing around the membrane surface. Once the vesicle 
coat is shed, the uncoated endocytic vesicle (early endosome) fuses with an acidic late 
endosome. The acidic pH in this compartment causes a conformational change in the LDL 
receptor that leads to release of the bound LDL particle. The late endosome eventually fuses 
with the lysosome, and then the proteins and lipids of the free LDL particle are broken down 
to their constituent parts by lysosomal hydrolases that could easily digest all of the 
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components of LDL releasing cholesterol and fatty acids into the cytosol. Cholesterol that 
enters cells by this path may be incorporated into membranes or re-esterified by Sterol O-
acyltransferase (SOAT) for storage within cytosolic lipid droplets. The apoB-100 of LDL is 
also degraded to amino acids that are released to the cytosol. The LDL receptor, which 
dissociates from its ligands in the late endosome, is either destroyed or can be recycled via an 
endocytic cycle back to the cell surface. The neutral pH of the exterior medium enables the 
receptor to undergo a conformational change so that it can function again in LDL uptake 
(Brown, et al. 1986; Rudenko, et al. 2002). ApoB-100 is also present in VLDL, but its 
receptor-binding domain is not available for binding to the LDL receptor. Conversion of 
VLDL to LDL exposes the receptor-binding domain of apoB-100. 
Furthermore, various ligands including not only native lipoproteins (LDL, HDL, VLDL, and 
chylomicrons) but also modified lipoproteins (acetylated LDL, oxidized LDL, and oxidized 
HDL), anionic phospholipids, and maleyated BSA (Haberland, et al. 1985) can bind to 
specific amino acid residues of a cell surface transmembrane protein, the scavenger receptor 
glass B type I (SR-BI) (Trigatti, et al. 2003; McNutt, et al. 2007). Moreover, Ueda and 
colleagues have shown a reduction in plasma apoB in mice overexpressing SR-BI (Ueda, et 
al. 1999). In addition, CD36 is an integral membrane protein found on the surface in a variety 
of cells. In macrophages, CD36 binds oxidized LDL, acetylated LDL, native lipoproteins, 
oxidized phospholipids (Wang, et al. 2007) and long chain FA (Baillie, et al. 1996). 
 
2.4.3. Regulation of LDL receptors 
 
When cellular free cholesterol increases, the production of LDL receptors is reduced (Brown, 
et al. 1975). Together with the reduction in 3-hydroxy-3-methylglutaryl-CoA reductase 
(HMG-CoA reductase), this regulatory response decreases cholesterol input from plasma as 
well as from endogenous synthesis. The mechanism that mediated regulation of LDL 
receptors for this dual regulation was clarified by the discovery of sterol regulatory element-
binding proteins (SREBPs) (Brown, et al. 1999). SREBPs are synthesized as membrane-
bound proteins attached to the endoplasmic reticulum. In the presence of cholesterol, SREBP 
is bound to the protein SCAP (SREBP-cleavage-activating protein). In cholesterol-depleted 
cells, the complex migrates to the Golgi apparatus, where SREBP is cleaved by two 
proteases, S1P and S2P (site-1 and -2 protease). These two enzymes are activated by SCAP, 
to release a soluble fragment that enters the nucleus and acts as a transcription factor. It binds 
to the sterol response element (SRE) and it stimulates the transcription of many genes. 
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Among these are HMG CoA reductase and all the other enzymes of cholesterol biosynthesis 
as well as the LDL receptor (Horton, et al. 2002). LDLR mRNA is translated by ribosomes 
on the endoplasmic reticulum and the protein is modified in the Golgi apparatus before 
traveling in vesicles to the cell surface. The newly produced LDL receptors remove LDL 
from the blood, and deliver it to the interior of the cell where the LDL is digested and its 
released cholesterol becomes available for metabolic purposes. When LDL-derived 
cholesterol enters cells, it blocks the transport of SREBPs to the Golgi complex. By inhibiting 
the SREBP pathway, LDL also suppresses transcription of the LDL receptor gene (Brown, et 
al. 1999) which allows cells to adjust the number of LDL receptors to provide sufficient 
cholesterol for metabolic needs without producing cholesterol over accumulation (Brown, et 
al. 1975). The net effect is that the amount of cholesterol in the liver is maintained at a 
normal level while at the same time the level of LDL-cholesterol in blood is kept low 
(Brown, et al. 2004). 
 
2.4.4. Bovine serum albumin (BSA) 
 
In mammals, the blood plasma protein serum albumin is the most abundant plasma protein. In 
addition to its lipid transport properties, it plays a role in the regulation of lipid metabolism 
and it maintains the “osmotic pressure” needed for proper distribution of body fluids between 
intravascular compartments and body tissues, which causes fluid to remain within the blood 
stream instead of leaking out into body tissues. Its binding function in blood has been 
associated mostly with the transport of a wide varity of endogenous and exogenous 
compounds including fatty acids (Simard, et al. 2005), metal ions, amino acids, steroids and 
drugs (Carter, et al. 1989).  
Bovine serum albumin (BSA) is a large globular protein (66kDa) with a single chain of 583 
amino acid residues, and contains 17 pairs of disulfide bonds (Peters, 1985). BSA is a lipid-
free soluble protein of the circulatory system and has many physiological functions (Carter, et 
al. 1994). It contains a limited number of saturable binding sites for lipids (Bhattacharya, et 
al. 2000) that are able to bind anionic and cationic ligands via both hydrophilic and 
hydrophobic interactions (Charbonneau, et al. 2010). In contrast to the many other proteins, 
bovine serum albumin has high affinity binding sites for anions with hydrophobic side chains 
(Choi, et al. 2002). However, the fatty acid binding affinity of albumin increases with 
increasing chain length, because of an increase in hydrophobic interactions (Choi, et al. 
2002). BSA at pH 7.3 and molar ratio ≤ 1.5 has three equivalent binding sites for fatty acids 
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at temperatures from 0 
0
C to 38 
0
C (Bojesen, et al. 1994). It has long been known to serve as 
an extremely versatile transporter protein for a variety of compounds (Shcharbin, et al. 2007; 
Shcharbin, et al. 2005). BSA is considered as a ‘soft’ protein (Peters, 1985) because it does 
not have a high degree of structural stability. Therefore, conformational changes occur upon 
adsorption to a surface (Norde, et al. 1992; Kondo, et al. 1991; Giacomelli, et al. 2001).  
There are marked similarities between BSA and human serum albumin (HSA) in their 
conformation due to 76% of amino acid sequence homology. BSA contains three 
homologous α-helical domains I, II and III, each domain contains two subdomains (A, and B) 
that share common structural motifs. HSA has only one tryptophan residue Trp-214, while 
BSA contains two tryptophans (Fig. 2.10), Trp-134 in the first domain located on the surface 
of the molecule and Trp-212 in the second domain located within a hydrophobic binding 
pocket of the protein (Tayeh, et al. 2009). Trp-212 in BSA and Trp-214 in HSA are located in 
a similar hydrophobic microenvironment in the sub-domain IIA (Peters, 1985).  
The choosing of BSA in our experiments is based on its structural homology with HAS and 
due to the wide information available on BSA properties in solution (Doherty, et al. 1974; 
Bendedouch, et al. 1983). In addition, it is produced at industrial scale, therefore, it has been 
one of the most extensively studied member of this group of proteins (Charbonneau, et al. 
2010). 
Stremmel et al. 1983 showed that in rat liver, plasma membranes do not contain a specific 
albumin receptor of sufficient binding affinity to be detected or isolated by techniques that 
have been used for other kinds of cell surface receptors. It has been shown that lipid-BSA 
probes behave as reliable markers for fluid phase endocytosis in hepatocytes (Stromhaug, et 
al. 1997; Synnes, et al. 1999).  
 
 
 
 
Figure 2.10: X-ray structure of bovine serum 
albumin with tryptophan residues in green color 
(Charbonneau, et al. 2010). 
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2.4.5. Interaction between BSA or LDL and lipids  
 
The basis for the interaction between lipids and proteins is related to their amphiphilic nature 
and is due to their influence on the water structure, the so-called hydrophobic effect (Tanford, 
1980).  
Within living organisms, some proteins are adapted to form stable water-soluble complexes 
with lipids and to function in the mobilization of complex lipids. There are two main types of 
complexes; complexes formed between monomeric proteins and lipids and, secondly, large 
lipoprotein complexes. One of the most ubiquitous monomeric proteins that bind lipids is 
albumin. Serum albumin is a flexible protein that can adopt multiple conformations of 
approximately equal energy to accommodate the binding of ligands. One of the primary 
functions of albumin is to bind free fatty acids during mobilization of lipids in the body and 
transport them in the blood stream as a stable water-soluble complex. The protein has at least 
three fatty acid binding sites. The mechanism of binding of the fatty acids to the protein has 
been investigated by NMR methods (Lucas, et al. 2004). The dissociation of fatty acids from 
serum albumin takes place rapidly 0.04 – 0.14s-1 (Weisiger, et al. 1987) with a dissociation 
constant of 1.4 ± 0.2 mM (Dubois, et al. 1993). Their dissociation from the complex at the 
site of entry into cells is assisted by the presence of proteins in the plasma membrane with a 
high affinity for fatty acids (McArthur, et al. 1999).  
On the other hand, serum lipoproteins are specifically adapted to form structures designed to 
transport lipids throughout the body. These lipoproteins are circulating in the mammalian 
blood stream to distribute a cargo of lipids from their site of synthesis or uptake to the 
peripheral tissues. The lipids, mainly triacylglycerols, cholesterol, and cholesterol esters, 
occupy a central core surrounded by a shell of polar lipids and proteins. The proteins act to 
stabilize the lipid core and provide recognition sites for targeting the complex to the 
appropriate site of delivery. Moreover, the phospholipids that are associated with LDL are 
known to affect the physicochemical properties of the lipoprotein (Kleinman, et al. 1988) and 
may play a role in LDL metabolism by affecting the interaction between LDL and its receptor 
in the cell membrane (Aviram, et al. 1988). According to the LDL pathway (Goldstein, et al. 
2009), LDL is endocytosed after binding to LDL receptors and transferred to lysosomes as 
mentioned before. Remarkably, LDL-associated PC is not only hydrolyzed in lysosomes, but 
also at other subcellular sites (Ishikawa, et al. 1989). LDL-phospholipids are known to affect 
epitope expression of apoB-100 on the surface of LDL particles (Aviram, et al. 1988), and 
consequently may alter the interaction between LDL and its receptor. It has been suggested 
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that hydrolysis of LDL-derived glycerophospholipids by hepatic lipase enhances the 
interaction between lipolysed LDL and LDL-receptor, might affect the apoB-100 epitope, 
and the cellular uptake of LDL via the receptor (Aviram, et al. 1988).  
 
2.5. Lipid transfer proteins 
 
Both cholesterol ester transfer protein and phospholipid-transfer protein act as specific 
mediators of lipid transfer between lipoproteins and lipoproteins and cells. 
 
2.5.1. Cholesteryl ester transfer protein (CETP) 
 
CETP is a hydrophobic glycoprotein of mass 74kDa, and plays an important role in reverse 
cholesterol transport. It promotes the efflux of cholesterol from peripheral tissues to the liver 
for excretion and degradation to bile acids, so LCAT is of great importance for cholesterol 
homeostasis. It is a suggested target for therapeutic intervention against atherosclerosis. The 
action of CETP is to transfer cholesteryl ester from HDL to the other triacylglyerol-rich 
lipoproteins such as LDL and VLDL, and reciprocal transfer of triacylglycerol from 
triacylglycerol-rich lipoproteins to HDL, and vice versa. Physiologically, the main effect of 
CETP may be to promote the transfer of LCAT derived cholesteryl esters out of HDL (where 
they were formed) into VLDL and LDL, in exchange for triacylglycerol (Fielding, et al. 
2002). Inhibition of CETP offers a new approach to coronary artery disease therapy 
(Brousseau et al. 2004), since high CETP activity lowers the HDL/total cholesterol ratio, 
potentially increasing risk for atherosclerosis (Papp, et al. 2012). 
 
2.5.2. Phospholipid-transfer protein (PLTP) 
 
PLTP is a glycoprotein of mass 55kDa. PLTP is the second lipid transfer protein found in 
human plasma that enhances the transport of phospholipids and cholesterol from 
triacylglyerol-rich lipoproteins such as VLDL to HDL particles and promotes the generation 
of small pre-β-HDL particles that are initial acceptors of cell-derived cholesterol and the 
preferred substrate for LCAT (Jauhiainen, et al. 1993). PLTP has been shown to bind to both 
ApoA-I and ApoA-II (Pussinen, et al. 1998) and enhance CETP (Tollefson, et al. 1988). 
Three major classes of mammalian phospholipid transfer protein were identified, 
phosphatidylcholine transfer protein, phosphatidylinositol transfer protein, and the non-
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specific lipid transfer protein denoted as sterol carrier protein 2 (SCP-2) that can transfer a 
wide range of phospholipids including sterols (Wirtz, 2006).  
 
2.6. Fatty acid functions 
 
Fatty acids have an amphipathic nature and constitute one of the most fundamental classes of 
biological lipids (Fahy, et al. 2005). They serve as the basic building blocks of complex 
lipids. In form of triacylglycerol, they represent a major form of storage energy. As part of 
glycerophospholipids, they provide an essential structural component of membranes, and 
through direct covalent linkage they are used to modify and regulate the properties of many 
proteins. They can also be metabolized to lipid signalling molecules that perform important 
roles as metabolic intermediates used for lipid synthesis and protein modification as well as 
can be broken down through mitochondrial beta-oxidation to generate ATP via oxidative 
phosphorylation (Puzio-Kuter, 2011). FAs directly regulate cellular processes via regulation 
of gene transcription (Jump, 2004), or via binding to membrane-bound receptors (GPR40, 
GPR41, GPR43, GPR84, and GPR120). For example oleic acid binds to GPR43 (Briscoe, et 
al. 2003), and ω3-unsaturated FAs to GPR120 (Oh, et al. 2010; Ichimura, et al. 2012). In 
addition, they regulate cell behaviour also indirectly through their bioactive metabolites 
(Fritsche, 2006; Calder, 2011). It is worth noting that fatty acids can regulate the expression 
of a range of genes involved in lipid metabolism. Recent studies have shown that poly 
unsaturated FA interacts directly with nuclear receptors such as peroxisome proliferator 
activated receptors (PPARs). PPARs are members of a sub-family of the nuclear hormone 
receptors (Montagner, et al. 2011) that act as sensors of fatty acids and fatty acid analogues. 
The PPAR family consists of three isoforms, PPARα, PPARβ (also known as δ) and PPARγ. 
These PPARs play essential roles in the regulation of fatty acid metabolism (Bishop-Bailey, 
2011) and were found to be key regulators of lipid and carbohydrate metabolism (Varga, et 
al. 2011). The affinity of PPAR sub-types to FAs appears to be greatest for PPARα followed 
by PPARγ and PPARβ (Kliewer, et al. 1997). PPARα, the predominant isoform in liver, play 
a major role in the fatty acid-induced regulation of hepatic gene transcription, while PPARβ 
is abundant not only in skeletal muscle but also in adipose tissue, where it is involved in 
general and fundamental cellular processes (Montagner, et al. 2011). Both PPARα and 
PPARβ are activated by saturated and unsaturated fatty acids. PPARγ plays an important role 
in the storage of lipids in adipose tissue and is only activated by long-chain unsaturated fatty 
acid. 
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In a physiological context, the uptake of FAs is a highly regulated process, e.g., in endothelial 
cells, vascular endothelial growth factor B coordinates FA uptake with the energy demands of 
the surrounding tissue (Hagberg, et al. 2010). FA uptake and processing is also required for 
cancer cell survival (Zhan, et al. 2008; Hess, et al. 2010). A diet that is relatively high in 
unsaturated fatty acids, especially polyunsaturated fatty acids, may reduce the risk of heart 
attacks and strokes (Kwak, et al. 2012). By contrast, the incidence of cardiovascular disease 
is correlated with diets high in saturated fatty acids. In the present study, uptake and 
processing of exogenously added FAs by four different cell types were investigated. To avoid 
artefacts caused by the use of fluorescent or chemical reporter groups, labelling by 
radioisotopes was used to distinguish endogenous lipids from those that arose by 
incorporation of FAs of exogenous origin. The four investigated C18-FAs (Fig. 2.11) differ in 
the degree of unsaturation (18:0, 18:1, 18:2, and 18:3) were applied in concentrations of 
10µM. They were added to the culture medium of the cells in complex with bovine serum 
albumin (BSA). After different incubation time ranging from 15–120min, their cellular 
uptake and processing into different lipid classes in the different cell types were monitored. 
 
2.6.1. Fatty acid biosynthesis 
 
The liver and adipose tissue in most animals are the major sites of fatty acid biosynthesis. 
The two pancreatic hormones, insulin and glucagon exert essentially opposite effects on 
energy metabolism. Thus, during feeding, when the ratio of insulin to glucagon increases in 
the blood, the activities of several enzymes in the glycolytic and lipogenic pathways are 
elevated, while the activities of key gluconeogenic enzymes are decreased. As the ratio of 
insulin to glucagon decreases in the blood during prolonged periods of fasting, the activities 
of key enzymes in the glycolytic and lipogenic pathways are decreased, while the activities of 
key gluconeogenic enzymes are increased resulting in a reversal of the process. The fatty acid 
biosynthetic pathway is carried out by the multifunctional fatty acid synthase enzyme that 
catalyzes multiple condensations of malonyl-CoA with acetyl-CoA or the elongating lipid, 
eventually generating palmitate. A first step includes the formation of malonyl-CoA from 
acetyl CoA by the activity of the enzyme acetyl-CoA carboxylase. Formation of malonyl-
CoA is a rate-limiting step of FA biosynthesis, because malonyl-CoA has no metabolic role 
other than serving as a precursor to FAs. Acetyl transacylase (acetyl transferase) and malonyl 
transacylase (malonyl transferase) catalyse the formation of acetyl ACP and malonyl ACP 
from acetyl-CoA and malonyl-CoA, respectively. Acetyl ACP (ACP= acyl carrier protein) is 
31 
condensed with malonyl ACP catalysed by acyl-malonyl ACP to form acetoacetyl ACP. A 
sequence of reactions follows in which the chain is extended to form butanoate. First, the 
reaction is catalysed by β-ketoacyl-ACP synthetase to produce 3-oxobutanoate, this is 
reduced to 3-hydroxy-butanoate by β-ketoacyl-ACP reductase, which is in turn dehydrated to 
E-2-butenoate by β-hydroxyacyl-ACP hydratase before it is reduced to butanoate by enoyl-
ACP reductase. The addition of further six units of malonyl-ACP then continues until 
palmitoyl-ACP is formed. At this step, a thioesterase removes the fatty acyl product as the 
free acid (with the mammalian enzyme), which has to be converted to the CoA-ester before it 
can enter the various biosynthetic pathways for the production of specific lipids. Further 
elongation of palmitoyl-CoA by C2 units occurs to form long- or very-long-chain fatty acids 
by Type III fatty acid synthetases (elongases).  
A great diversity of fatty acid structures is produced by variations of the basic biosynthetic 
process. Fatty acids are either saturated such as stearic acid (18:0) or unsaturated such as 
oleic acid (18:1). Saturated fatty acids are built from two carbon units, initially derived from 
acetate, added to the carboxyl end of the molecule. The number of double bonds in an 
unsaturated fatty acid varies typically from one to six. They are introduced by desaturase 
enzymes at specific positions relative to the carboxyl group (Hunter, 2006). Elongases further 
extend the chain in two carbon units from the carboxyl end. All the possible odd- and even-
numbered homologues with 2 to 36 carbon atoms have been found in nature in esterified 
form, but the most abundant saturated fatty acids in animal and plant tissues are straight-
chain compounds with an even number of 14, 16 and 18 carbon atoms. 
 
Figure 2.11: The 
structures of some 
typical fatty acids A: 
palmitic acid (16:0); 
B: stearic acid (18:0); 
C: oleic acid (18:1, ω9, 
9
); D: linoleic acid 
(18:2, ω6, 9,12); E: α-
linolenic acid (18:3, 
ω3, 9,12,15).  
 
 
2.6.2. Fatty acid uptake and trafficking 
 
In adipose tissue, fatty acids are liberated from triacylglycerol-rich lipoproteins through the 
action of lipoprotein lipase. Released fatty acids are bound by albumin and free fatty acids 
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present in the equilibrium are taken up by cells. From a physiological perspective, it would be 
highly preferable to regulate fatty acid entry into the cell to ensure fatty acid uptake when its 
extracellular concentration is low, to limit uptake when the extracellular concentration is 
high, to potentially select for specific fatty acid types, and to allow rapid adjustments in fatty 
acid provision to meet fluctuations in metabolic demands (Glatz, et al. 2010). 
The solubility of fatty acids in aqueous solutions is low, i.e., in the range of 1–10nM (Vorum, 
et al. 1992). The ability of proteins to bind fatty acids dramatically increases the total amount 
of fatty acids that can be present in the aqueous phase. Albumin and cytoplasmic fatty acid-
binding protein (FABPc) act as extracellular and intracellular buffers for fatty acids, 
respectively. For instance, albumin at a concentration of 300–600mM can accommodate up to 
1–2mM fatty acids in plasma and interstitium (Richieri, et al. 1993), while FABPc inside the 
cell functions as a sink for incoming fatty acids can accommodate up to150–300mM fatty 
acids (Vork, et al. 1993; Richieri, et al. 1994). Scavenging of fatty acids by binding proteins 
play a crucial role to prevent the toxicity of free fatty acids and their intermediates in the 
cytosol by intracellular transport towards their sites of metabolic conversion (Schaap, et al. 
1998). 
There are different pathways for the uptake of FA through the cell membrane (Schwenk, et 
al. 2010) (Fig. 2.12). First, the amphipathic nature of the fatty acid molecule provides it with 
the biophysical properties to pass the phospholipid bilayer of the cell membrane by simple 
diffusion (Fig. 2.12, Path 1). Adsorption from the outer leaflet of the bilayer, flip-flop, and 
desorption of fatty acids functions to transfer protons across the membrane. Several studies 
showed that biological membranes do not form a barrier for fatty acids and that fatty acids 
can rapidly and spontaneously diffuse through phospholipid bilayers without the help of 
membrane proteins (Hamilton, 2007). A second possibility is that plasma membrane fatty 
acid-binding proteins (FABPpm), a family of small, highly abundant proteins that bind tightly 
and sequester free fatty acids (La Londe, et al. 1994), facilitate and regulate transmembrane 
fatty acid transport across the cell membrane and prevent destabilization of the membrane 
(Schwenk, et al. 2010). These fatty acid-binding proteins act as acceptors for fatty acids 
whereafter the fatty acids make their way through the cell membrane by simple diffusion 
(Fig. 2.12, Path 2). Furthermore, CD36 (88kDa; also referred to as ‘fatty acid translocase’) 
alone or together with plasma membrane fatty acid-binding protein (FABPpm) might serve as 
acceptors of albumin-derived extracellular FA to increase their local concentration at the cell 
surface and thus increase the number of FA-diffusion events (Stremmel, et al. 2001) (Fig. 
2.12, Path 3). Additionally, fatty acid transport proteins (FATPs) are thought to accelerate the 
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rate of trans-membrane transport of FA, which are rapidly activated by plasma membrane 
acyl-CoA synthetase (ACS1) to form acyl-CoA esters (Fig. 2.12, Path 4). The colocalization 
of FATP1, FATP6, and CD36 within distinct areas of the plasma membrane makes an 
interaction likely (Gimeno, et al. 2003; Pohl, et al. 2000). Currently, it is not known to which 
extent an interaction of the CD36/FABPpm complex with one or more of the FATP species 
occurs. The mechanisms by which long-chain FAs enter mammalian cells may differ from 
one cell type to others. For example, the incorporation of FAs in fibroblasts depends on the 
structure of the FA: apparently, palmitic acid enters the cell by simple diffusion, while oleic 
acid (OA) uses saturable transport processes (Damyanova, et al. 2010). FATPs preferentially 
transport very-long- chain fatty acids VLC-FA (> C22); and by action of their synthetase 
activity they directly convert them into very-long-chain acyl-CoA esters (Fig. 2.12, Path 5). 
After being taken up, FAs are bound to cytoplasmic FA binding proteins (FABPc) 
(Haunerland, et al. 2004) that transport them to intracellular target locations such as 
mitochondria, peroxisomes, or the endoplasmic reticulum (Storch, et al. 2000). Once inside 
the cell, free fatty acids are minimally soluble in the aqueous cytoplasm. At high enough 
concentrations fatty acids exert a detergent-like effect that would disrupt membranes. In 
addition to these proteins, long-chain acyl-CoA synthetases (ACSLs) are involved in FA 
uptake by converting them into membrane impermeable acyl-CoAs in an ATP-dependent 
reaction, and thus facilitate the import of exogenous FAs by trapping them inside the cells 
(Duttaroy, 2009). The acyl-CoAs have numerous metabolic fates, including donating FAs for 
incorporation into TAGs and membrane phospholipids, as substrates for β-oxidation and 
protein acylation, and as ligands for transcription factors. 
 
 
 
 
Figure 2.12: Proposed different models of 
fatty acid (FA) transport across the cell 
membrane (Schwenk, et al. 2010).  
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2.7. Cholesterol  
 
In 1926, Heinrich Wieland was awarded the Nobel Prize in chemistry who suggested the 
structure of cholesterol and bile acids. Cholesterol (Fig. 2.13), is the most prevalent steriod in 
mammalian cells and serves as precursor of bile acids and steroid hormones. Vitamin D3 is 
derived from 7-dehydrocholesterol, the immediate biosynthetic precursor of cholesterol. 
Cholesterol is a principal component of the plasma membranes of mammalian cells, and 
much smaller amounts of cholesterol are found in the membranes of intracellular organelles 
like mitochondria, Golgi complexes, and nuclear membranes. It intercalates among the 
phospholipids of the membrane, with its hydroxyl group at the aqueous interface and the 
remainder of the molecule within the leaflet. The relatively rigid fused ring system of 
cholesterol and the weakly polar group at the C-3 position have important consequences for 
the properties of plasma membranes. It stabilizes the liquid ordered phase of membranes and 
prevents phase transitions. Furthermore, most endocytic pathways like clathrin-dependent 
and clathrin-independent pathways are inhibited by the loss of cholesterol.  
Cholesterol is also a component of lipoprotein complexes in the blood, and it is one of the 
constituents of plaques that form on arterial walls in atherosclerosis. Excess cholesterol is 
metabolized to oxysterols (Rock, 2008), which are not only blocking SREBP cleavage-
activating protein (SCAP), but also facilitate proteolysis of SREBP and thereby down-
regulate endogenous cholesterol synthesis and LDL receptor levels. Cholesterol has to be 
oxidized to oxysterols before it can leave the brain. In addition, oxysterols further reduce the 
cellular content of unesterified cholesterol by activating bile acid synthesis and cholesterol 
esterification. Rising cholesterol levels cause hydroxy-methylglutaryl-CoA (HMG-CoA) 
reductase to be ubiquitinated and degraded by the proteosome. They cause SREBP cleavage-
activating protein (SCAP) to remain localized to the endoplasmic reticulum rather than 
translocating to the Golgi. Within endolysosomal compartements, cholesteryl esters can be 
hydrolized by acid lipase to fatty acids and free cholesterol required for membrane and 
lipoprotein formation and for hormone synthesis in adrenal cells. The free cholesterol binds 
to the NPC-2 protein, which transports and delivers the cholesterol to the NPC-1 protein, 
located in the perimeter membrane (Abdul-Hammed, et al. 2010). Deficiency of lysosomal 
acid lipase results in Wolman disease (Tanaka, 1995). Cholesterol, however, is insoluble in 
blood and is transported in the circulatory system bound to one of the varieties of 
lipoproteins. Therefore, in our study, we used albumin and low density lipoprotein as a 
carrier for cholesterol.  
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Figure 2.13: The structure of cholesterol, showing 
the rings of the steroid nucleus and carbon 
numbering. 
 
 
2.7.1. Cholesterol and cholesteryl ester biosynthesis 
 
Cholesterol is present in tissues and in plasma either as free cholesterol or combined with a 
long-chain fatty acid as a storage form. Both forms are transported in plasma by lipoproteins. 
More than half the cholesterol of the body is formed by synthesis (about 700 mg/d), and the 
average diet provides the remainder (Mayes, et al. 2003).  
The cholesterol biosynthetic pathway (Fig. 2.14) starts from the cytosolic thiolase that 
catalyzes the Claisen condensation of two molecules of acetyl-CoA to form acetoacetyl-CoA. 
Acetoacetyl-CoA reacts with another molecule of acetyl-CoA in an aldol addition to form 3-
hydroxy-3-methylglutaryl-CoA (HMG-CoA) catalyzed by cytosolic HMG-CoA synthase. 
The next step in this pathway is the rate-limiting step in cholesterol biosynthesis, in which 
HMG-CoA is reduced by two molecules of NADPH to produce mevalonate. The reaction is 
catalyzed by HMG-CoA reductase, a 97kDa glycoprotein that traverses the endoplasmic 
reticulum membrane with its active site facing the cytosol. A series of four reactions converts 
mevalonate to isopentenyl pyrophosphate and then to dimethylallyl pyrophosphate. 
Pyrophosphomevalonate decarboxylase phosphorylates the 3-hydroxyl group, which is 
followed by a trans-elimination of the phosphate and carboxyl groups to form the double 
bond in isopentenyl pyrophosphate. Isomerization of the double bond yields dimethylallyl 
pyrophosphate. Condensation of these two 5-carbon intermediates produces geranyl 
pyrophosphate, a further condensation of 5-carbon isopentenyl pyrophosphate forms farnesyl 
pyrophosphate. Then two molecules of farnesyl pyrophosphates condense to form squalene. 
Before ring closure occurs, squalene monooxygenase, an enzyme bound to the endoplasmic 
reticulum, converts squalene to squalene-2,3-epoxide. This reaction requires NADPH as 
coenzyme and O2. A second ER membrane enzyme, 2,3-oxidosqualene:lanosterol cyclase, 
catalyzes the second reaction to form lanosterol, which involves the transfer of methyl groups 
from C14 to C13 and from C8 to C14 as cyclization occurs. To convert lanosterol to cholesterol, 
another 20 steps are required that take place at the membranes of the endoplasmic reticulum 
and peroxisomes. They involve removal of the methyl groups on C14 and C4 to form 14-
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desmethyl lanosterol and then zymosterol. The double bond at C8–C9 is subsequently moved 
to C5–C6 in two steps, forming desmosterol. Finally, the double bond of the side chain is 
reduced, to produce cholesterol.  
Cholesteryl esters are formed in the liver through the action of Sterol O-acyltransferase 
SOAT (formely called Acyl-CoA cholesterol acyl transferase ACAT). SOAT is the 
intracellular protein on the cytoplasmic face of the ER membrane, which catalyzes the 
transfer of a fatty acid from coenzyme A to the hydroxyl group of cholesterol, converting the 
cholesterol to a more hydrophobic and storage form. In vivo, SOAT plays an important 
physiological role in intestinal absorption of dietary cholesterol, and in control of the cellular 
free cholesterol pool that serves as substrate for bile acid and steroid hormone formation.  
 
Figure 2.14: The biosynthetic pathway of cholesterol.  
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2.8. Di- and tri-acylglycerols 
 
Diacylglycerols are the principal precursors of glycerophospholipids, consisting of two fatty 
acid chains covalently bound to a glycerol molecule through ester linkages. DAG can induce 
structural changes in the lipid bilayer, which may be responsible for the molecular signal 
transduction, such as activation of protein kinase C or to enhance membrane fusion 
processes. Switching off the signal generated by the formation of diacylglycerol is 
accomplished by diacylglycerol kinase, which converts the substrate into phosphatidic acid 
(Stathopoulos, et al. 1990). On the other hand, triacylglycerols are nonpolar, hydrophobic 
molecules, synthesized mainly in adipose tissue, liver, and intestine and serve as the principal 
energy storage molecule in eukaryotes. Although triacylglycerols are insoluble in water, 
mono-and diacylglycerols are able to form lyotropic liquid crystalline structures in water 
(Macierzanka, et al. 2006). Mammalian triacylglycerol synthesis is affected by a large 
number of factors. These include nutritional, hormonal, and pharmacological effects. A major 
function of triacylglycerols in mammalian cells is to allow the transport in the form of the 
serum lipoproteins and storage of acyl moieties in the body. The formation of triacylglycerols 
removes the potentially harmful fatty acids (Brindley, 1991). Moreover, plenty of evidence 
suggests that elevated triacylglycerol levels are an independent risk factor for cardiovascular 
disease (CVD) (Jacobson, et al. 2007; Botham, et al. 2007). Metabolism of triacylglycerols in 
animals requires lipoprotein lipase involved in uptake of FAs from plasma and hormone-
sensitive lipase involved in release of fatty acids from lipid stores. Hormone-sensitive lipase 
is responsible for hydrolysis of the esters at positions 1 and 3 of the triacylglycerol, and 
monoacylglycerol lipase catalyzes hydrolysis of the remaining ester to yield a third free fatty 
acid and glycerol (Bernlohr, et al. 2002). Fatty acids are immediately bound to serum 
albumin and carried in the bloodstream to the liver, muscle, and other tissues for oxidation, 
while glycerol has to be shuttled back to the liver for oxidation or gluconeogenesis.  
 
2.8.1. Di- and tri-acylglycerol biosynthesis 
 
Diacylglycerol can originate from two sources (Fig. 2.16), either it is formed by 
phosphatidate phosphohydrolase (phosphatidic acid phosphatase) that converts phosphatidate 
(phophatidic acid) to 1,2-diacylglycerol (DAG), or it is synthesized by acylation of 
monoacylglycerol (MAG) by monoacylglycerol acyltransferase. Most of the activity of these 
enzymes resides in the endoplasmic reticulum of the cell, but some is found in mitochondria. 
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Phosphatidate phosphohydrolase is found mainly in the cytosol, but the active form of the 
enzyme is membrane-bound. It can be inhibited by some cationic amphiphilic drugs (Koul, et 
al. 1987). Furthermore, diacylglycerol can be transiently formed in cell membranes as a 
consequence of phospholipase C-type enzymes activated by a variety of hormones, growth 
factors, and neurotransmitters.  
Diacylglycerol is a precursor for synthesis of  triacylglycerol (TAG), 
phosphatidylethanolamine (PE), and phosphatidylcholine (PC). Triacylglycerol is formed 
(Fig. 2.16) by the esterification of a third fatty acid to the hydroxy group of diacylglycerol 
under the catalysis of diacylglycerol acyltransferases (DGAT-1, and DGAT-2) located in the 
endoplasmic reticulum (Kolter, Römpp Online). Their activities are especially high in 
lipogenic tissues like adipose and liver. In Caco-2 cells and rat intestinal mucosal 
membranes, 76% and 89% of the in vitro TAG synthesis are initiated from MAG, which is 
mediated by DGAT1, respectively. XP620 (Fig. 2.15) is an inhibitor for DGAT-1 
investigated for the treatment of obesity (Cheng, et al. 2008). However, complete deletion of 
SOAT- or DGAT activity triggers FA-mediated cell death (Garbarino, et al. 2009).  
 
 
 
Figure 2.15: Structure of XP620 
 
 
 
 
 
2.9. Phospholipids 
 
Phospholipids form the essential milieu of cellular membranes and provide a barrier for entry 
of exogenous compounds into cells. Phospholipids act as precursors of second messengers 
such as diacylglycerol (DAG) and inositol-1,4,5-P3. Phospholipids also function as storage of 
energy in the form of fatty acyl components. This function is probably quantitatively 
important only under extreme conditions such as starvation (Vance, 2002).  
Phospholipids are divided into two main classes depending on whether they contain a 
glycerol backbone, glycerophospholipids or contain a sphingosyl backbone, 
sphingophospholipids. 
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2.9.1. Glycerophospholipids 
 
Glycerophospholipids are members of the broader class of lipids known as phospholipids. 
Most of the phospholipids that are derived from glycerol are synthesized on the cytosolic side 
of the endoplasmic reticulum (ER) membrane from water-soluble cytosolic precursors.  
 
2.9.2. Phosphatidic acid biosynthesis 
 
The synthesis of phosphatidic acid (PA), the simplest negatively charged membrane 
phospholipid, is a common pathway that operates in nearly all organisms. PA is a key 
intermediate in the formation of glycerophospholipids (Wang, et al. 2003) and 
triacylglycerols (Mayes, et al. 2003).  
In liver and kidney, glycerol kinase catalyzes the phosphorylation of glycerol to form L-
glycerol-3-phosphate, which is then acylated at both the 1- and 2- positions to yield 
phosphatidic acid (or 1,2-diacylglycerol phosphate) (Fig. 2.16). First, the two molecules of 
acyl-CoA are formed by the activation of fatty acids by acyl-CoA synthetase and both 
glycerol and fatty acids must be activated by ATP before they can be incorporated into 
acylglycerols. The first acylation at position sn-1 is catalyzed by glycerol-3-phosphate 
acyltransferase, while 1-acylglycerol-3-phosphate acyltransferase catalyzes the second 
acylation at position sn-2. Commonly but not invariably, the fatty acid at C-1 is saturated and 
that at C-2 is unsaturated. 
In eukaryotic systems, if the activity of glycerol kinase is absent or low as in muscle or 
adipose tissue, most of the glycerol 3-phosphate is formed from dihydroxyacetone phosphate 
by the action of glycerol-3-phosphate dehydrogenase. Again a specific acyltransferase adds 
the first acyl chain, followed by reduction of the backbone keto group by 
acyldihydroxyacetone phosphate reductase, using NADPH as the reductant. Enzymes on the 
cytosolic face of the ER membrane then catalyze the addition of different polar head groups. 
A phosphatase converts phosphatidic acid to diacylglycerol, as mentioned before. 
 
2.9.3. Phospholipid biosynthesis  
 
Phosphorylethanolamine and phosphorylcholine are formed by phosphorylation by ATP of 
ethanolamine or choline in the presence of the cytosolic enzymes ethanolamine kinase or 
choline kinase, respectively. The following reaction involves the rate limiting step, transfer of 
a cytidylyl group from cytidine triphosphate (CTP) to form cytidine diphosphates (CDP-
ethanolamine or CDP-choline) and pyrophosphate. Pyrophosphate hydrolysis drives this 
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reaction forward. Finally, CDP-ethanolamine:1,2-diacylglycerol phosphoethanolamine 
transferase or CDP-choline:1,2-diacylglycerol phosphocholine transferase then links 
phosphoethanolamine or phosphocholine to the diacylglycerol backbone to form the neutral 
charged phospholipids, PE, and PC, respectively (Renooij, et al. 1981; Gibellini, et al. 2010). 
This sequence of reactions is known as the Kennedy-pathway. CDP-diacylglycerol derived 
from phosphatidic acid can also be used as a precursor for several other negatively charged 
phospholipids, including a phosphatidylinositol (PI), phosphatidylglycerol (PG), and 
cardiolipin (CL) (Hatch, 1994). The enzyme CDP-DAG synthase is largely microsomal, but 
is also found in the mitochondrial inner membrane (Zinser, et al. 1991). 
However, an alternative pathway can convert phosphatidylethanolamine to 
phosphatidylcholine by methylation reactions involving S-adenosylmethionine (Shields, et al. 
2003) catalyzed by PE-N-methyltransferase.  This reaction has been sugested to play an 
important role in the transport of polyunsaturated fatty acids (PUFAs) like docosahexaenoic 
acid (DHA) from the liver to plasma and possibly other tissues (Wijk, et al. 2012). In 
mammals and yeast, PE can also be formed from PS by conversion of serine to ethanolamine 
through an indirect route, in which ethanolamine is formed by mitochondrial PS 
decarboxylase. In animal, PS is synthesized by PS-synthases I and II that exchange the 
choline and ethanolamine head groups of PC and PE for serine, respectively (Arikketh, et al. 
2008; Vance, 2008).  
Biosynthesis of inositol from glucose occurs in the brain, testes, and in other tissues to a 
lesser extent. The rate limiting step appears to be the synthesis of myo-inositol-3-phosphate 
from glucose-6-phosphate (Downes, et al. 1990). Inositol-3-phosphate is hydrolyzed to 
inositol by a phosphatase. Further phosphorylations can take place at different positions of 
myo-inositol (Roeber, 2002) and give rise to several phosphatidylinositol phosphates.  
The biosynthesis of bis(monoacylglycero)phosphate (BMP), (Heravi, et al. 1999; Scherer, et 
al. 2010) involves hydrolysis of PG to 1-acyl-sn-glycero-3-phospho-rac-glycerol (LPG) by a 
lysosomal phospholipase A2 (PLA2). Sn-3:sn1' LPG is then acylated on the glycerol head 
group by a transacylase, using a phospholipid as the acyl donor, to form 
bis(monoacylglycero)phosphate that still retains the sn-3:sn-l' stereo configuration of the 
original PG and a lysophospholipid. The phosphoryl ester from sn-3 to the sn-l is reoriented 
by an enzymatic activity to yield sn-l:sn-l'-LPG. The final product, sn-1:sn-1'-BMP (Fig. 
2.17), is formed upon acylation of the glycerol backbone of sn-1:sn-1'-LPG. BMP is not 
present in the limiting lysosomal membrane (Möbius, et al. 2003), but is required for 
sphingolipid degradation on inner membranes of the acidic compartments (Kolter, et al. 
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2010). In Lands' cycle (Lands, 1958), the rapid turnover of the sn-2 acyl moiety of 
glycerophospholipids by PLA2 liberates lysophospholipids and free FAs. The free FA 
released can be activated to acyl-CoA by acyl-CoA synthetase (ACS). Lysophospholipids are 
then converted to phospholipids in the presence of acyl-CoA by lysophospholipid 
Acyltransferases (LPLAT).  
 
 
Figure 2.16: Synthesis of triacylglycerol and glycerolipids begins with the formation of phosphatidic 
acid, which may be formed from dihydroxyacetone phosphate or glycerol. 
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Figure 2.17: Structure of bis(monoacylglycero)phosphate. The acyl chain residues are on the sn-2 
position of both glycerol backbones. 
 
2.9.4. Sphingophospholipids 
 
Sphingophospholipids represent another class of phospholipids frequently found in biological 
membranes that contain sphingosine ((2S, 3R)-2-aminooctadec-4-ene-1,3-diol) or another 
sphingoid base that forms the backbone of these lipids rather than glycerol in 
glycerophospholipids. The most common phospholipid in this class is the phosphorylcholine 
ester of an N-acylsphingosine (or ceramide) that is more commonly called sphingomyelin. 
Sphingomyelin represents a major lipid of certain membranes in brain and nervous tissue of 
higher animals. The lysosomal hydrolysis of sphingomyelin to ceramide and phosphocholine 
is catalyzed by acid sphingomyelinase, which cleaves the phosphodiester bond of 
sphingomyelin between ceramide and phosphorylcholine (Lansmann, et al. 2003). In humans, 
a rare genetic defect in the enzyme ASMase results in Niemann-Pick disease (Horinouchi, et 
al. 1995), which is associated with the accumulation of sphingomyelin in endosomes and 
lysosomes (Schuchman, 2010). Sphingomyelin accumulates in the brain, spleen, and liver. 
Type A of the disease becomes evident in infants, and causes mental retardation and early 
death. 
Ceramide is the building block of other sphingolipids and glycosphingolipids and plays an 
important role in membrane signaling processes, and membrane fusion (Lopez-Montero, et 
al. 2005). Ceramides are known to be one of the main mediators of apoptosis in cells. 
Increasing the levels of ceramide by inhibition of ceramidases, which convert ceramide to 
sphingosine and free fatty acid, results in cell death (Strelow, et al. 2000). Likewise, 
inhibition of ceramide production by blocking the de novo synthesis pathway (fumonisin B1) 
or inhibiting neutral, (GW 4869), and acid (D606 and desipramine) sphingomyelinase 
activity, slows down apoptosis in response to a variety of factors including chemotherapeutic 
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agents, tumor necrosis factor-ß, angiotensin-II, and B-cell activation (ElBawab, et al. 2002; 
Takahashi, et al. 2006; Huang, et al. 2011).  
 
2.9.5. Sphingolipid biosynthesis 
 
In eukaryotic cells, sphingomyelin and glycosphingolipids are components of the outer leaflet 
of plasma membranes (Kolter, et al. 1999). The membrane-bound enzymes that catalyze the 
de novo biosynthesis of ceramide are localized on the cytosolic leaflet of the endoplasmic 
reticulum (Stiban, et al. 2008; Mandon, et al. 1992). The initial reaction of the de novo 
biosynthesis of sphingolipids (Fig. 2.18) is the condensation of the amino acid L-serine and 
palmitoyl-CoA, catalyzed by serine palmitoyltransferase (Hanada, 2003) to form 3-
ketosphinganine. Reduction of the ketone product to sphinganine is catalyzed by 3-
ketosphinganine reductase, with NADPH as a reductant. Sphinganine is acylated to form 
dihydroceramide by an enzyme family encoded by the lass-genes (longevity assurance genes) 
(Teufel, et al. 2009). These enzymes have different specificities for the fatty acid CoA 
thioesters and are generating different dihydroceramide species (Pewzner-Jung, et al. 2006).  
Dihydroceramide is then desaturated by dihydroceramide desaturase (Rother et al. 1992) to 
form ceramides (N-acylsphingosines). Ceramide is tranported with the aid of the transfer 
protein CERT (Hanada, 2006) from the ER to the Golgi apparatus or the trans-Golgi network. 
Glycosylation of the first hydroxyl group of ceramide by sugar nucleotides yields the 
cerebrosides galactosylceramide (GalCer) on the luminal site of the Golgi apparatus and 
glucosylceramide (GlcCer) on the cytosolic leaflet of the Golgi apparatus by 
galactosyltransferase and glucosyltransferase, respectively. GalCer is a major lipid of myelin, 
which makes up about 15% of the lipids of myelin sheath structures, whereas GlcCer is the 
major glycosphingolipid of extraneural tissues and is a precursor of most of the more 
complex glycosphingolipids. Sphingomyelin, which is both a phospho- and sphingolipid, is 
synthesized through the action of sphingomyelin synthase by transfer of phosphorylcholine 
from phosphatidylcholine to ceramide, liberating diacylglycerol. De novo sphingomyelin 
synthesis occurs mainly on the luminal face of the Golgi apparatus and to a lesser extent in 
the plasma membrane (Tafesse, et al. 2007). Further deacylation of sphingomyelin by 
sphingomyelin deacylase produces sphingosylphosphorylcholine (lysosphingomyelin). 
Phosphorylation of ceramide (another metabolic step) by ceramide kinase forms ceramide-1-
phosphate (Bajjalieh, et al. 2000). In the salvage pathway, attachment of a fatty acid to the 
amino group of sphingosine or other related amino alcohols via an amide linkage gives rise to 
ceramides, which are catalyzed by ceramide synthase. Furthermore, ceramide can also be 
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formed by degradation of sphingomyelin and glycosphingolipids in lysosomes through the 
action of sphingomyelinases (Goni, et al. 2002) and glycosidases, respectively. On the other 
hand, catabolism of ceramide in lysosomes to sphingosine is catalyzed by acid ceramidase. 
Degradation of ceramide by ceramidases is enhanced by a variety of agents including 
cytokines, cell differentiating agents, death receptor ligands, cancer chemotherapeutic agents, 
and ionizing radiation (Sandhoff, et al. 2001). Sphingosine can be phosphorylated at the 1-
position to sphingosine-1-phosphate (S1P). Phosphoethanolamine and hexadec-2-enal can be 
formed by cleavage of S1P via a pyridoxal phosphate dependent lyase.  
 
 
Figure 2.18: Biosynthesis pathway of sphingolipids in animals.  
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2.10. Cationic amphiphilic drugs (CADs) 
 
Many lipids of exogenous origin enter the cell through the endolysosomal system. 
Endosomes and lysosomes are the intracellular sites through which the majority of nutrients 
enter the cell. Furthermore, the uptake and processing of many lipid classes is impaired in 
lysosomal storage diseases or in the presence of cationic amphiphilic drugs that interfere with 
endolysosomal lipid processing, and lead to drug-induced lipidoses (Kolter, et al. 2010; 
Anderson, et al. 2006; Nonoyama, et al. 2008). Long-term treatment of human patients or 
animals with cationic amphiphilic drugs (CADs) can induce the storage of lipids as a severe 
side-effect (Anderson, et al. 2006; Lüllmann-Rauch, et al. 1975; Lüllmann, et al. 1978). In 
the present work, the influence of five selected CADs on uptake and processing of 
phosphatidylcholine (PC) and sphingomyelin (SM) by different types of cultured cells is 
investigated. Furthermore, the influence of desipramine on uptake and processing of four C18 
fatty acids by different cell types was studied. 
Desipramine is a tricyclic antidepressant drug that induces premature degradation of acid 
sphingomyelinase, which is mainly localized in endosomes and lysosomes, and leads to 
endolysosomal storage of SM (Hurwitz, et al. 1994; Kölzer, et al. 2004). Desipramine 
interferes with the interaction of the positively charged protein with the negatively charged 
luminal membranes. This leads to the release of this enzyme from the surface of 
intraendosomal and intralysosomal membranes and its subsequent premature degradation. 
Drugs with such properties have been named functional inhibitors of acid sphingomyelinase 
(FIASMAs) (Kornhuber, et al. 2010). Also acid ceramidase activity is apparently reduced by 
desipramine in SCC-14A cells and the mouse fibroblast cell line L929 (Zeidan, et al. 2006), 
5637 cells, and HeLa cells (Elojeimy, et al. 2006). In addition, desipramine increased 
cytoplasmic Ca
2+
 ion concentration in PC3 human prostate cancer cells (Huang, et al. 2007) 
and human osteosarcoma MG63 cells (Jan, et al. 2003) by causing Ca
2+
 release from the 
endoplasmic reticulum in a phospholipase C-independent fashion and by inducing Ca
2+
 
influx. Furthermore, desipramine inhibits protein kinase C (PKC) activity in rat brain 
(Morishita, et al. 1997).  
Imipramine is also a tricyclic antidepressant drug that acts as an apparent inhibitor of acid 
sphingomyelinase in cultured cells (Jensen, et al. 1999). Also imipramine induces 
phospholipidosis upon prolonged administration in animals (Lüllmann-Rauch, et al. 1975). 
Chlorpromazine is a cationic amphiphilic phenothiazine derivative, and has been widely 
used as an antipsychotic neuroleptic drug. It antagonizes receptors for dopamine (D2), 
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serotonin (5-HT2A), histamine (H1), and others, and due to its multiple side-effects, it had to 
be rejected from the market. Chlorpromazine also inhibits the formation of clathrin-coated 
pits (Nawa, et al. 2003) and disrupts clathrin-mediated endocytosis by inhibiting the 
relocation of clathrin and adaptor protein 2 complexes (Yao, et al. 2002) from the plasma 
membrane. It binds to the cytoplasmic tail of the cell surface receptors that recruit clathrin 
(Sorkin, 2004), and also inhibits LDL receptor recycling. It causes clathrin lattices to 
assemble on endosomal membranes and at the same time it prevents coated pit assembly at 
the cell surface of human fibroblasts (Wang, et al. 1993). Microscopy and transport studies 
revealed that chlorpromazine perturbs membrane properties of cellular organelles and leads 
to a blockage of the secretory pathway (De Filippi, et al. 2007). It can form stoichiometric 
1:1-complexes with acidic phospholipids such as phosphatidic acid (PA) (Stuhne-Sekalec, et 
al. 1987) and phosphatidylinositol (PI) (Schwendener, 1988), but not with neutral 
glycerophospholipids such as phosphatidylcholine (PC). Previous studies have shown that 
chlorpromazine and other amphiphiles cause pronounced perturbation of membranes 
(Burack, et al. 1994) and induce the expression of a number of genes in both bacteria and 
mammalian cells (Vigh, et al. 1998). Since the activity of membrane-bound proteins 
(receptors, channels, and enzymes) can be dependent on the lipid composition of the 
membranes (Lee, 2003), CADs such as chlorpromazine might influence the activity of such 
proteins even without direct interaction between the protein and the CAD (Gjerde, et al. 
2004; Chen, et al. 2005).  
Chloroquine is a CAD used in the treatment of malaria, and acts as a potent inducer of 
lysosomal storage of phospholipids in both cell cultures and in vivo (Hostetler, et al. 1985). 
Chloroquine also inhibits the recycling of the LDL-receptor, but not of the scavenger receptor 
BI to the plasma membrane (Minahk, et al. 2008). Also chloroquine leads to an apparent 
inhibition of acid sphingomyelinase activity (Yoshida, et al. 1985). It has been suggested that 
chloroquine inhibits degradation of complex endocytosed molecules indirectly by inhibiting 
the transport from endosomes to lysosomes (Tolleshaug, et al. 1979; Berg, et al. 1980). 
Chloroquine (Kodavanti, et al. 1990), like Chlorpromazine (Pappu, et al. 1984) has been 
reported to inhibit lysosomal phospholipases A and C. Similar to desipramine, chloroquine 
and chlorpromazine were able to reduce apparent acid ceramidase activity (Elojeimy, et al. 
2006), presumably according to the same mechanism as acid sphingomyelinase (Hurwitz, et 
al. 1994). Such drugs also interfere with P-glycoprotein involved in multidrug resistance 
(Jaffrezou, et al. 1995). 
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FTY720, is an immunosuppressant, and has been approved for the treatment of multiple 
sclerosis. It behaves as a prodrug of a functional antagonist of sphingosine phosphate 
receptors (Chun, et al. 2010). In addition, FTY720 shows multiple effects, e.g. as cannabinoid 
receptor antagonist (Paugh, et al. 2006), as cPLA2 inhibitor (Payne, et al. 2007), ceramide 
synthase inhibitor (Berdyshev, et al. 2009; Dawson, et al. 2011), or inhibits lysosomal acid 
sphingomyelinase but not neutral sphingomyelinase activity (Dawson, et al. 2011). It 
decreases cholesterol toxicity in primary human macrophages, and stimulates 27-
hydroxycholesterol production (Blom, et al. 2010). 
 
 
Figure 2.19: Structure of different cationic amphiphilic drugs 
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3. Aim and concept of the present study 
 
The aim of this work is to characterize lipid entry pathways in cultured cells.  Cultured cells 
of different types serve as model systems of reduced complexity for living cells in their 
physiological surroundings. Although lipids of different classes have been applied to different 
types of cultured cells before, a systematic study is missing that compares quantitative 
differences between different cell types towards uptake and processing of different lipids. We 
were interested in this question also to determine the impact of lipid delivery methods, and of 
different amphiphilic drugs on cellular lipid entry processes. 
We investigated the capacity of four different cell types to incorporate and metabolize 
various lipids including complex lipids with different fatty acid moieties from the culture 
medium such as fatty acids (FAs), triacylglycerols (TAGs), cholesterol esters (CE), 
cholesterol (Chol), phosphatidylcholine (PC), and sphingomyelin (SM).  
In this work, also two different lipid delivery methods have been compared. Uptake and 
processing of exogenous lipid probes were determined that were either added to cultured cells 
in complex with bovine serum albumin (BSA), or as components of low density lipoprotein 
(LDL) particles. Based on our results, it will be possible in the future to select the optimal 
cell type, delivery method, and read-out to evaluate the impact of the endolysosomal system 
on uptake and processing of a certain lipid. 
We analyzed the role of Niemann-Pick disease, type A (NPA) on the uptake and processing 
of [
14
C]cholesterol and [
14
C]phosphatidylcholine compared to normal fibroblasts. 
We also investigated the influence of representative cationic amphiphilic drugs, desipramine, 
imipramine, chlorpromazine, chloroquine, and FTY720 on the processing of selected lipids 
and their ability to induce phospholipidosis in cultured cells. For the first time, we could 
demonstrate a drastic and cell type-specific effect of the antidepressant desipramine on 
uptake and metabolism of fatty acids. 
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4. Results 
 
4.1. Uptake and processing of C-18 fatty acids in cultured cells 
 
Uptake and processing of four different FAs with C18 chain length were investigated. They 
differ in the degree of unsaturation (18:0, 18:1, 18:2, or 18:3), and were applied in 
concentrations of 10µM. They were added to the different types of cultured cells in complex 
with bovine serum albumin (BSA) (Pütz, et al. 1995). After different incubation time ranging 
from 15 - 120min, their cellular uptake and processing into different lipid classes were 
determined. All fatty acid that have been tested are readily taken up by cultured cells and 
incorporated into both nonpolar and polar lipid fractions. In addition, the impact of a 
representative CAD, desipramine, on this process was investigated. 
 
4.1.1. Fatty acid uptake and processing  
 
Fibroblasts, macrophages, A431 cells, and HepG2 cells were cultured as described in the 
materials and methods section (Chapter 6). 1-[
14
C]FAs (stearic acid, oleic acid, linoleic acid, 
and linolenic acid) were delivered to cultured cells as BSA-complexes in concentrations of 
10µM for 15, 30, and 120min (Table 4.1).  
The FAs were added as complexes with BSA to mimic the physiological situation, to avoid 
possible toxic effects of the free acids, and to avoid addition of a solvent that had to be used 
to increase their solubility. The molar ratio between FA and albumin in the medium has been 
found to influence the uptake kinetics of FAs in rat hepatocytes (Sorrentino, et al. 1989). The 
molar FA/BSA ratio was maintained at 1:1; the physiological ratio rarely exceeds 2:1 
(Spector, 1986). We used a maximal value of 2h as incubation time since elongation and 
desaturation rates, which are slow compared to the esterification rates, can be neglected 
within this time frame. For example, 80% of radiolabeled palmitic acid added to cultured 
hamster fibroblasts underwent no desaturation or elongation within 2h incubation time 
(Maziere, et al. 1982). 80-90% of the FAs metabolically incorporated into phosphoglycerides 
had not been altered in chick embryo fibroblasts (Daniel, et al. 1980) and human fibroblasts 
(Spector, et al. 1979). In our experiments, the cell viability in the presence of FA showed no 
significant indications of decreased cell integrity and amount of cellular protein.  
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4.1.2. Differences between fatty acids uptake of different structure 
 
Stearic acid (SA), oleic acid (OA), linoleic acid (LA) and linolenic acid (LOA) were added to 
four different types of cultured cells, human fibroblasts, macrophages, A431 cells, and 
HepG2 cells. The different FAs were taken up to a similar degree by macrophages, 
fibroblasts, and HepG2 cells. In A431 cells, however, uptake of LA and OA was higher than 
of SA and LOA. From the FAs present in the medium, (1-15) % were taken up after 15min, 
and (5-44) % after 120min incubation time by the four cell types. 
In A431 cells and HepG2 cells, when cultured with FAs for 120min incubation time, the 
lowest amount was observed for SA, and the highest for LA and LOA, respectively. The 
highest amounts were observed for OA, and the lowest for SA and LOA in macrophages and 
fibroblasts, respectively (Table 4.1). 
 
4.1.3. Differences between cell types 
 
FA uptake differed between the investigated cell types: the average uptake of FA during 15, 
30, and 120min incubation time is shown in Table 4.1. In HepG2 cells, uptake of LOA was 
highest, followed by that of LA. Compared to the other cells types (fibroblasts, macrophages, 
and HepG2 cells), uptake of the saturated and unsaturated FAs from the medium was highest 
by A431 cells (123 pmol/mg protein for SA, and 154 pmol/mg protein for LA), followed by 
fibroblasts. In the other cell types, uptake was almost in the same range. No significant 
differences were noted in cellular FA uptake among 18:0, 18:1, 18:2, and 18:3 in all 
investigated cell types. 
Hence, uptake of 1-[
14
C]FAs depends both on the investigated cell type and the identity of the 
FAs. Uptake was not linear with time over 120min (Fig. 4.1, Fig. 4.2), but appears to follow 
saturation kinetics. The results are in agreement with a report on the uptake of SA, OA, LA, 
and LOA by HepG2 cells (Dokko, et al. 1998), when 0.25-1.0mM of FA-albumin complexes 
with a molar ratio of 4:1 during a 4h incubation period were applied. 
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Figure 4.1: Uptake of FA (10µM) delivered in complex with BSA (1:1) by cultured cells. A. stearic 
acid, B. oleic acid, C. linoleic acid, and D. linolenic acid. The uptakes were measured 15, 30, and 
120min after addition of the FA-BSA complexes. These diagrams were determined by scintillation 
counting of the lipid extract after different incubation time. 
 
Figure 4.2: Uptake of different FA by A. fibroblasts, B. macrophages, C. A431 cells, D. HepG2 cells. 
These diagrams were determined by scintillation counting of the lipid extract after different 
incubation time. 
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4.1.4. Utilization of fatty acids 
 
Incorporation of radiolabeled FAs into different lipid classes was investigated after lipid 
extraction and separation of the polar and nonpolar lipid fractions (Chapter 6). Lipid classes 
were separated by thin layer chromatography (TLC; Chapter 6). The incorporation of FAs 
into lipid classes after 120min incubation time of four cell types is shown in table 4.2. The 
incorporation of FAs into the various lipid classes differed considerably among the cell types, 
and with the identity of the FA added to the cells. 
 
Table 4.1: FA uptake by four different types of cultured cells. 
 
Table 4.2: Metabolic incorporation of exogenously added FAs into lipid classes. 
Incorporation of 
FA into cellular 
lipids (pmol /mg 
of protein) after 
2h incubation 
Fibroblasts Macrophages A431 cells HepG2 cells 
ST OA LA LOA ST OA LA LOA ST OA LA LOA ST OA LA LOA 
Cholesterol ester 0.75 0.39 1.43 3.07 6.0 2.3 0.1 0.1 2.1 1.9 2.7 2.4 0.2 0.2 0.1 0.4 
TAG 2.17 0.96 1.25 2.75 20.0 8.6 0.1 0.1 7.7 9.6 7.0 3.8 2.2 2.6 4.4 8.8 
FA 12.8 2.48 3.89 10.4 9.8 6.8 0.5 0.6 13.4 9.6 7.0 6.3 5.1 5.5 5.5 11.4 
DAG 4.05 8.42 7.13 7.23 5.6 3.3 0.6 0.8 3.6 12.9 24.6 24.1 1.4 2.5 3.1 4.0 
Cer 1.71 1.15 1.17 1.41 1.0 0.4 0.2 0.3 0.9 0.7 1.5 2.6 0.2 0.2 0.3 0.4 
Glccer 0.77 2.19 1.20 1.15 0.1 0.9 0.3 0.3 0.6 2.5 2.8 3.8 0.1 0.6 0.6 0.6 
PE, BMP 11.4 5.88 8.24 12.1 3.9 3.8 8.9 19.1 6.1 5.8 6.2 4.8 4.7 3.8 4.2 6.2 
PG 8.96 22.9 4.44 4.03 0.9 1.9 2.3 3.1 20.8 28.7 10.7 9.9 1.4 3.1 2.4 2.4 
PC, PA 38.7 44.8 55.4 45.2 10.8 17.3 29.8 18.9 22.3 33.2 49.9 29.9 4.9 5.5 15.9 15.1 
PI 7.41 5.18 7.50 7.15 6.4 4.7 9.4 12.8 10.9 7.3 15.3 7.2 2.8 1.4 2.6 2.5 
SM 10.7 6.98 5.28 3.97 3.4 3.5 4.1 4.2 9.2 9.3 12.7 9.9 1.6 0.9 2.6 1.9 
Sum 99.5 101 96.9 98.6 68.2 59.5 56.3 60.7 98.2 121 140 109 25.2 26 41.3 54.0 
 
Fibroblasts, macrophages, A431 cells, and HepG2 cells were cultured as described in the materials 
and methods section in serum-free medium supplemented with 10µM [
14
C]-FAs (added as a BSA-FA 
complex; the BSA/FA ratio was 1:1). After different incubation time (15, 30, and 120min), cells were 
harvested, and lipids were extracted. FAs incorporated into nonpolar and polar lipids were determined 
as pmol of lipid per mg of protein. 
 
 
 
 
Cellular lipid 
uptake (pmol/ 
mg of protein)  
Fibroblasts Macrophages A431 cells HepG2 cells 
15min 30min 120min 15min 30min 120min 15min 30min 120min 15min 30min 120min 
Stearic acid 22.1 35.7 114 20.3 30.3 69.1 33.1 49.1 123 9.8 13.0 28.7 
Oleic acid 23.6 35.3 122 16.6 25.1 71.5 40.7 56.2 132 12.5 19.6 32.4 
Linoleic acid 18.1 36.0 113 24.2 33.1 70.9 36.3 48.8 154 9.5 20.5 51.6 
Linolenic acid 24.8 38.5 103 20.4 28.1 70.2 43.6 61.1 124 18.5 24.7 56.1 
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4.1.5. FA processing in macrophages 
 
When macrophages were cultured in the presence of the FAs, a major incorporation of FAs 
into TAG and CE was observed. 1-[
14
C]SA and 1-[
14
C]OA were predominantly incorporated 
into TAG, DAG and CE. On the other hand, the incorporation of 1-[
14
C]LA and 1-[
14
C]LOA 
into TAG, DAG and CE was significantly lower when compared to SA and OA (Fig. 4.3B). 
The major FAs incorporated in the nonpolar lipid fraction of macrophages were OA and SA; 
they comprised 44 % and 60 %, respectively, of the total FAs that where incorporated into the 
nonpolar lipid fractions (TAG, DAG, and CE), or were found as free FAs.  
In the same cell types, LA and LOA (Fig. 4.4B) were preferentially incorporated into polar 
lipids (PLs). OA was only modestly incorporated into polar lipids, and SA showed the lowest 
incorporation into polar lipids compared to the other FAs. 
In the PL fraction of macrophages cultured in the presence of FA-BSA complexes, the major 
incorporated FAs were LA and LOA. They each comprised 94.1% and 94.4%, respectively, 
of the total FAs incorporated into PLs and sphingolipids (Table 4.2). FAs are selectively 
incorporated into polar lipids depending on the degree of unsaturation (SA<OA<LA<LOA). 
The results show that in macrophages, more unsaturated FAs are predominantly incorporated 
into PLs, while more saturated FAs are incorporated more into LD lipids.  
 
4.1.6. FA processing in HepG2 cells 
 
The liver is the key organ in lipid metabolism. Therefore, we investigated uptake and 
metabolism of FAs also in HepG2 cells, which are widely used as a model system for hepatic 
lipid metabolism. These cells are human hepatoma cells and known to exert a number of 
human liver functions, including lipid uptake, synthesis, VLDL assembly and VLDL 
secretion (Lin, et al. 1995). 
When incubated with different FAs in medium, the incorporation of 1-[
14
C]FA into TAG and 
DAG increased with incubation time. Delivery of SA, OA, LA, and LOA as BSA complex 
resulted in incorporation of 2.2, 2.6, 4.4, and 8.8 pmol/mg protein into TAG after 120min 
incubation (Fig. 4.3D), respectively. Furthermore, when HepG2 cells were incubated with 
radiolabeled C18-FAs of different structure, the level of FAs incorporated into polar lipids 
was much greater for unsaturated FAs than for saturated FAs. Both LA and LOA were 
markedly incorporated into polar lipids of HepG2 cells. Delivery of OA, LA, and LOA as 
BSA complex resulted in incorporation of 15.6, 28.8, and 29.3 pmol/mg protein into PLs 
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after 120min incubation (Fig. 4.4D), respectively. We observed a positive relationship 
between the number of double bonds and the incorporation both into nonpolar and polar 
lipids. 
The results show that in HepG2 cells, the incorporation of FAs into cellular lipids is increased 
with increasing number of double bonds. The uptake values also show (table 4.1) that more 
unsaturated FAs are taken up compared to saturated FAs. 
 
4.1.7. FAs processing in fibroblasts 
 
Human fibroblasts readily take up FAs and incorporate them into cellular polar and nonpolar 
lipids (Spector, 1986; Rosenthal, et al. 1981). When human skin fibroblasts were cultured in 
the presence of FAs, only a minor incorporation of FAs into nonpolar lipids was observed 
compared to polar lipids. Within the nonpolar lipid fraction in fibroblasts (Fig. 4.3A), but also 
in A431 cells (Fig. 4.3C), we observed the predominant incorporation into DAG after 120min 
incubation. An exception was SA in A431 cells, where a predominant incorporation into 
TAG was detected after 120min incubation. The major FAs incorporated into the nonpolar 
lipid fraction of fibroblasts was LOA, which comprised 24% of the total LOA that where 
incorporated into the nonpolar lipid fractions (TAG, DAG, and CE), or were recovered as 
free LOA.  
In the PL fraction of fibroblasts (Fig. 4.4A), the major incorporated FA was OA. It comprised 
87% of the total OA incorporated into PLs and sphingolipids (ceramide, glucosylceramide, 
and sphingomyelin). From this value, 50% and 25% of OA incorporated into the polar lipids 
were incorporated into PC and PG, respectively. 
The results show that in fibroblasts, the incorporation of SA, OA, LA, and LOA into 
nonpolar lipids occurred predominantly into DAG, and the incorporation of OA into PG is 
increased compared with other FAs.  
 
4.1.8. FA processing in A431 cells 
 
After 120min incubation, incorporation of OA, LA, and LOA into nonpolar lipids of A431 
cells occurred predominantly into DAG, while SA was more incorporated into TAG than 
DAG (Fig. 4.3C). Within the polar lipid fraction, these FAs have been preferentially 
incorporated into PC (Fig. 4.4C). LA was more incorporated into the polar lipids than the 
other FAs, it comprised 72%, followed by OA which comprised 71% of total FAs 
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incorporated into the polar lipids. Moreover, OA and SA were more incorporated into PG 
than LA and LOA. 
 
 
Figure 4.3: Incorporation of FAs into cellular nonpolar lipids after incubation of the cells with 10μM 
1-[
14
C]-FAs delivered as BSA complex in a 1:1 molar ratio for 120min in the culture medium, A. 
fibroblasts, B. macrophages, C. A431 cells, and D. HepG2 cells. Separation of lipid classes was 
achieved by using the solvent system (nHexane/Diethylether/Acetic acid 70:30:1 by vol.). 
Radioactivity found in the lipid extract of different cells was set equal 100%. Radioactivity was 
analyzed by phosphoimager analysis. All data are given as mean values of more than two different 
experiments. 
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Figure 4.4: Incorporation of FAs into cellular polar lipids after incubation of the cells with 10μM 1-
[
14
C]-FAs delivered as BSA complex in a 1:1 molar ratio for 120min in the culture medium, A. 
fibroblasts, B. macrophages, C. A431 cells, and D. HepG2 cells. Separation of lipid classes was 
achieved by using the solvent system (chloroform/methanol/water 65:25:4 by vol.). Radioactivity 
found in the lipid extract of different cells was set equal 100 %. Radioactivity was analyzed by 
phosphoimager analysis. All data are given as mean values of more than two different experiments. 
 
4.1.9. FA processing in different cell types 
 
Fig. 4.5 shows the incorporation of FAs in cellular PLs, nonpolar lipids, and the recovery of 
free FAs in pmol/µg protein.  
 
 
Figure 4.5: Incorporation and/or recovery of 1-[
14
C] 18:0, 18:1n-9, 18:2n-6, and 18:3n-3 FA into 
cellular lipid classes given as pmol 
14
C-FAs/μg protein. Free FA (A), nonpolar lipids (B), and polar 
lipids (C). Nonpolar lipids include diacylglycerol, triacylglycerol and sterol ester.  Polar lipids 
includes ceramide, glucosylceramide, phosphatidylethanolamine, phosphatidylglycerol, 
phosphatidylcholine, phosphatidylinositol, sphingomyelin, bis(monoacylglycero)phosphate, and 
phosphatidic acid. 
 
In fibroblasts and A431 cells, all FAs were mainly esterified to polar lipids (0.07 - 0.1 
pmol/µg protein), whereas (0.007 - 0.034 pmol/µg protein) was incorporated into the neutral 
lipid fraction, and (0.0025 - 0.013 pmol/µg protein) were recovered as free FAs. 
In A431 cells, LA was mainly incorporated into cellular nonpolar lipids, followed by LOA, 
OA, and SA. The incorporation into polar lipids was not significantly different between the 
FAs, ranging from 0.07 - 0.1 pmol/µg protein.  
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In fibroblasts, the recovery of 18:0 as FFA was significantly higher than other FAs, followed 
by LOA, LA, and OA. The incorporation into neutral and polar lipids was not significantly 
different between the FAs. 
In macrophages, SA and OA, but not LA and LOA were mainly esterified into nonpolar 
lipids (> 0.014 pmol/µg protein), whereas in polar lipids, LA and LOA, but not SA and OA 
were mainly incorporated (0.055 pmol/µg protein), and the lowest amounts were recovered as 
free FA. 
In HepG2 cells, LOA was mainly incorporated into both, cellular neutral and polar lipids, 
followed by LA, OA, and SA. This is in agreement with a previous report in atlantic salmon 
hepatocytes (Stubhaug, et al. 2005) where the main proportion of [1-
14
C]FAs taken up was 
incorporated into cellular lipids in order 16:0<18:1<18:2<18:3.  
 
4.1.10. Pulse-chase studies 
 
In order to compare fate of a FA after their initial incorporation into different lipids, four 
types of cultured cells were pulsed with medium containing 10μM of BSA-[14C]oleic acid at 
37 
0
C  and 4 
0
C. After 2h incubation time, radiolabeled oleic acid was removed, followed by 
incubation with medium containing 10% FCS (chase) for a variable period of time (24, 48, 
72, 122, and 144h) at 37 
0
C, as described in chapter 6.   
In macrophages, the pulse–chase experiments showed that, after 24h, radioactivity was 
largely confined to TAG. By the end of the chase period, substantially more radiolabeled 
oleic acid accumulated in TAG compared to the other lipids (Fig. 4.6B). In the same cell type 
(Fig. 4.7B), more labeled FA was incorporated into PG after 72h. At 4 
0
C, the labeled oleic 
acid was much less incorporated into TAG after 24h than at 37 
0
C (data not shown). 
When cultured fibroblasts were incubated in the presence of 10μM of BSA-[14C]oleic acid at 
37 
0
C for 2h, in the nonpolar lipid fractions, labeled oleate was preferentially incorporated 
into DAG (Fig. 4.6A), and most of the oleate incorporated into phospholipids was in PC and 
PG (Fig. 4.7A). During the chase period, more of the labeled oleate was found in TAG 
instead of DAG, with relatively little accumulation of free FA after 48h incubation. In polar 
lipids, there was incorporation of labeled oleate mainly in PC, PA, and PG using 2h pulse. In 
the chase experiment, the labeled oleate in PC and PA decreased after 24h, with an increase 
of label in PG, GlcCer, and PI. At 4 
0
C, free FA was significantly decreased after 2h 
incubation with increased incorporation in TAG (data not shown). 
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Figure 4.6: Pulse-chase experiments with [
14
C]oleic acid  at 37 
0
C . Incorporation of [
14
C]oleic acid 
into different nonpolar lipids after different chase times are shown A. fibroblasts; B. macrophages; C. 
A431 cells; and D. HepG2 cells. Cells were either collected for lipid extraction after 2h labeling 
(pulse), or washed and incubated without labeled OA in medium containing 10% FCS for different 
incubation time (chase). 
 
Figure 4.7: Pulse-chase experiments with [
14
C]oleic acid  at 37
0
C . Incorporation of [
14
C]oleic acid 
into different polar lipids after different chase times are shown A. fibroblasts; B. macrophages; C. 
A431 cells; and D. HepG2 cells. Cells were either collected for lipid extraction after 2h labeling 
(pulse), or washed and incubated without labeled OA in medium containing 10% FCS for different 
incubation time (chase). 
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In A431 cells, the [
14
C]oleic acid was incorporated predominantly into phospholipids. During 
the chase period, the labeled oleate in PC, PA, and PG decreased after 24h, with an increase 
of lable PE, GlcCer, and PI. However, after 24h chase, the amount of radioactivity in the 
DAG fraction decreased. By the end of the chase period, substantially more radiolabeled 
oleic acid accumulated into TAG compared to the other lipids (Fig. 4.6C). At 4 
0
C, free FA 
was significantly decreased after 24h incubation with increased incorporation of TAG (data 
not shown). 
In HepG2 cells, the incorporation of [
14
C]oleate into TAG increased during the chase period 
(Fig. 4.6D). The incorporation of labeled oleate into polar lipids increased during the 24h 
chase in PI and GlcCer (Fig. 4.7D). Incorporation of label oleate into TAG during the 24h 
chase was accompanied by concomitant decrease in radioactivity in the phospholipid.  
In summary, most FAs were initially incorporated in polar lipids, presumably via Lands' 
cycle. After longer chase time, they end up on the TAGs. 
 
4.1.11. The effect of cationic amphiphilic drug, desipramine on FAs uptake 
and processing 
 
CADs are known to interfere with the processing of complex lipids within the endolysosomal 
system. There are no data on the impact of CADs on FA processing in the literature. 
Although it is not expected that endosomes and lysosomes are involved in FA uptake and 
metabolism, we investigated the impact of the tricyclic antidepressant, desipramine, on 
uptake and processing of SA, OA, LA, and LOA. Desipramine is known to cause 
phospholipidosis in humans and animals by inducing premature degradation of acid 
sphingomyelinase.  
Surprisingly, in the presence of 10µM and 20µM desipramine in the medium, the 
incorporation of 1-[
14
C]FA into TAGs was drastically reduced in cultured A431 cells (Fig. 
4.8) and macrophages (Fig 4.9), and slightly in HepG2 cells (data not shown). The small 
effect on processing of FAs in HepG2 cells may be attributed to the low uptake of 
desipramine (Fig. 4.13). In A431 cells, the incorporation of SA, OA, LA, and LOA into TAG 
was decreased by 97, 83, 94, and 93% when treated with 20µM desipramine, respectively. In 
macrophages, the effects of desipramine are less than in A431 cells. It decreases the 
incorporation of SA, OA, LA, and LOA into TAG by 77, 73, 66, and 45%, respectively. 
Desipramine also affects the incorporation of FAs into DAG, but to a lesser extent. In A431 
cells, the incorporation of SA, OA, LA, and LOA into DAG was decreased 74, 29, 49, and 
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63%, when treated with 20µM desipramine, respectively. In macrophages, the incorporation 
into DAG was decreased by only 17, 19, 42, and 44%, respectively. 
In contrast to the other cell types, the incorporation of 1-[
14
C]FA into TAGs was drastically 
increased in cultured fibroblasts treated with 10µM and 20µM desipramine (Fig. 4.10). The 
incorporation of SA, OA, LA, and LOA into TAG was increased by 83, 80, 87, and 88% in 
the presence of 20µM desipramine, respectively. Furthermore, the incorporation into DAG 
also increased by 65, 77, 73, and 67% in presence of 20µM desipramine, respectively. 
In contrast to the nonpolar lipid fractions of A431 cells, in the polar lipid fractions, 
incorporation of linoleic acid was drastically increased into PC, PE, and PG in the presence 
of 10µM and 20µM desipramine in the medium (Fig. 4.11). The other fatty acids were only 
slightly incorporated into polar lipids of A431 cells.  
In fibroblasts, incorporation of all FAs into PI and ceramide was significantly increased in the 
presence of desipramine (Fig. 4.12). In macrophages, the incorporation of SA and OA into 
PC, PG, and SM was increased slightly in the presence of 10µM and 20µM desipramine, but 
the incorporation into PE was not affected. Furthermore, in the same cell type, the 
incorporation of LA and LOA into PC, PG, PE, and SM was not affected (data not shown).  
The cell viability in the presence of 10µM and 20µM desipramine was not affected and 
ranged from 88 to 100% of untreated cells (Fig. 4.38). Therefore, the reduced incorporation 
of FAs into TAG and DAG in the presence of desipramine in A431 cells and macrophages 
cannot be attributed to toxicity. 
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Figure 4.8: Incorporation of A. [
14
C]stearic acid, B. [
14
C]oleic acid, C. [
14
C]linoleic acid, and D. 
[
14
C]linolenic acid into nonpolar lipids of A431 cells in the absence and presence of two different 
concentrations of desipramine. Statistical significance between desipramine treatment and matched 
control is determined using statistical student’s t-test. * represents p < 0.05, and ** represents p < 
0.005.  
 
 
Figure 4.9: Incorporation of A. [
14
C]stearic acid, B. [
14
C]oleic acid, C. [
14
C]linoleic acid, and D. 
[
14
C]linolenic acid into nonpolar lipids of macrophages in the absence and presence of two different 
concentrations of desipramine. Statistical significance between desipramine treatment and matched 
control is determined using statistical student’s t-test. * represents p < 0.05, and ** represents p < 
0.005. 
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Figure 4.10: Incorporation of . [
14
C]stearic acid, B. [
14
C]oleic acid, C. [
14
C]linoleic acid, and D. 
[
14
C]linolenic acid into nonpolar lipids of fibroblasts in the absence and presence of two different 
concentrations of desipramine. Statistical significance between desipramine treatment and matched 
control is determined using statistical student’s t-test. * represents p < 0.05, and ** represents p < 
0.005. 
 
Figure 4.11: Incorporation of A. [
14
C]stearic acid, B. [
14
C]oleic acid, C. [
14
C]linoleic acid, and D. 
[
14
C]linolenic acid into polar lipids of A431 cells in the absence and presence of two different 
concentrations of desipramine. Statistical significance between desipramine treatment and matched 
control is determined using statistical student’s t-test. * represents p < 0.05, and ** represents p < 
0.005. 
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Figure 4.12: Incorporation of A. [
14
C]stearic acid, B. [
14
C]oleic acid, C. [
14
C]linoleic acid, and D. 
[
14
C]linolenic acid into polar lipids of fibroblasts in the absence and presence of two different 
concentrations of desipramine. Statistical significance between desipramine treatment and matched 
control is determined using statistical student’s t-test. * represents p < 0.05. 
 
Figure 4.13 shows the uptake of [
3
H]-desipramine into four different cell types after 48h 
incubation time. The uptake of [
3
H]-desipramine by A431 cells and HepG2 cells was slightly 
decreased, but only with 40µM desipramine. Uptake of [
3
H]-desipramine into macrophages 
was slightly increased. In contrast, the uptake was significantly decreased in the presence of 
20µM and 40µM desipramine by fibroblasts. The cell viability in the presence of 40µM 
desipramine was reduced 28% compared to untreated cells (Fig. 4.38); while the amount of 
cellular protein was reduced by 8%. Therefore, the reduced incorporation of FAs into TAG 
and DAG in the presence of desipramine in macrophages and A431 cells cannot be attributed 
only to toxicity. 
 
 
Figure 4.13: Uptake of [
3
H]-desipramine 
into different cultured cells  
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4.2. Analysis of two lipid delivery methods towards lipid uptake and 
processing 
 
As probes for lipid uptake and processing via the endolysosomal system, suitably labeled 
complex lipids can be added to cells. Lipids like cholesterol, cholesterol ester, and 
triacylglycerol are nearly insoluble in blood. In the circulatory system, they are transported 
by lipoproteins, and are also found in complex with albumins. Therefore, we used albumin 
and low density lipoprotein as carriers for TAG, CE, and cholesterol in the medium of 
cultured cells. This should mimic the physiological situation in which these lipids enter cells 
via endocytosis and other pathways. TAG and CE are then degraded by lysosomal acid 
lipase, and the FA moiety is liberated and degraded or re-utilized for lipid biosynthesis and 
protein modification. 
In this part, the effects of two different ways for lipid delivery, either with albumin or 
lipoprotein complexes, were examined in different cell types. We used cholesterol, 
cholesterol ester, and triacylglycerol labeled with [
14
C]oleic acid, since oleic acid is one of 
the major FAs of cholesterol esters and triacylglycerol 
(http://lipidlibrary.aocs.org/Lipids/cholest/index.htm). 
To study possible differences in uptake and metabolism in dependence of the lipid delivery 
method, we used [4-
14
C]cholesterol, [1-
14
C]cholesteryloleate, and [1-
14
C]trioleoylglycerol in 
complex with LDL or BSA.  
 
4.2.1. Cholesteryl ester uptake and processing 
 
[1-
14
C]Cholesteryloleate (1µM) was added to four different types of cultured cells, human 
fibroblasts, macrophages, A431 cells, and HepG2 cells, either as a complex with LDL, or 
with BSA. As shown in figure 4.14, the uptake of both complexes, [
14
C]CE-LDL and 
[
14
C]CE-BSA, by fibroblasts is higher than by the other cell types. Compared to [
14
C]CE-
BSA, the uptake of [
14
C]CE-LDL is 4-fold higher in fibroblasts and A431 cells, 3-fold higher 
in macrophages, and 2-fold higher in Hep-G2 cells during an 24h incubation at 37 °C. 
The incorporation of the oleate moiety derived from CE into lipids of the nonpolar lipid 
fraction of different cell types is illustrated in figure 4.15. There were significant differences 
in the incorporation of 1-[
14
C]oleate into total neutral lipids (except [
14
C]CE) between the 
types of the cells incubated with [
14
C]CE and LDL as shown in Fig. 4.15A. After 24h 
incubation, the incorporation of cholesterol ester-derived [
14
C]oleate into nonpolar lipids 
remained largely unchanged in fibroblasts and macrophages. In HepG2 cells and A431 cells, 
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CE-LDL derived 1-[
14
C]oleate is more incorporated into TAG than in the other cell types. 
When compared to BSA, delivery via LDL leads to an increased formation of metabolic 
products derived from the fatty acid part. Also the dependence of the cell type is visible. This 
result indicates that the differences in metabolism of cholesteryloleate depend on the delivery 
method. If the function of the endolysosomal system is assayed by processing of [1-
14
C]cholesteryloleate, it should be delivered as LDL-complex and the incorporation of 
labeled oleic acid into TAG, PE, and PC should be chosen as read-out. 
The incorporation of [
14
C]oleate derived from CE delivered as LDL-complex into lipid 
classes of the nonpolar lipid fraction in dependence of incubation time and cell type is shown 
in figure 4.16. In HepG2 cells, after 24h of incubation at 37 °C, the major fraction of CE-
derived [
14
C]oleate is incorporated into TAG (Fig. 4.16B) and, to a lesser extent, into 
phospholipids (Fig. 4.21B). A small fraction of label is recovered as non-esterified fatty acid 
and found in diacylglycerol. In HepG2 cells, the incorporation of the CE-derived [
14
C]oleate 
into TAG was 3-fold higher than in macrophages. Furthermore, in macrophages, the re-
incorporation into and/or recovery of cholesteryl[
14
C]oleate is 2-fold higher than in HepG2 
cells. 
 
 
 
Figure 4.14: Uptake of [
14
C]CE (1µM) delivered as complex with LDL (A) or BSA (B) by four types 
of cultured cells. The uptakes were measured 1, 6, and 24h after addition of the CE-complexes. 
Uptake was determined by scintillation counting of the lipid extract after different incubation time.  
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Figure 4.15: A. Incorporation of CE-derived [
14
C]oleate delivered as LDL-complex into lipids of the 
nonpolar lipid fraction. B. Incorporation of CE-derived [
14
C]oleate delivered as BSA-complex into 
lipids of the nonpolar lipid fraction. In both cases, CE-was present in 1µM concentration in the 
medium; incubation time: 24h. Lipid classes were separated using the solvent system 
(nHexane/Diethylether/Acetic acid 70:30:1 by vol.). 
 
 
Figure 4.16: Incubation of different types of cultured cells with 1µM [
14
C]CE-LDL complex in the 
culture medium for 1, 6, and 24h, A. macrophages, and B. HepG2 cells. Lipid classes were separated 
by tlc using the solvent system (nHexane/Diethylether/Acetic acid 70:30:1 by vol.). Radioactivity 
found in the lipid extract of different cells was set equal 100%. Radioactivity was analyzed by 
phosphoimager analysis.  
 
4.2.2. Cholesterol uptake and processing 
 
[4-
14
C]cholesterol was added to four different types of cultured cells, human fibroblasts, 
macrophages, A431 cells, and HepG2 cells either as a complex with LDL or with BSA in a 
concentration of 1µM. When compared to [4-
14
C]cholesterol delivered as BSA-complex, the 
uptake of [4-
14
C]cholesterol delivered as LDL-complex is 3-fold higher in macrophages, 2.5-
fold higher in fibroblasts, Hep-G2 cells, and A431 cells. Furthermore, uptake of [4-
14
C]cholesterol delivered as LDL by fibroblasts is higher than by the other cell types, and 
uptake of [4-
14
C]cholesterol delivered as BSA-complex by A431 cells is higher than by the 
other cell types (Fig. 4.17).  
The incorporation of the [4-
14
C]cholesterol delivered as LDL-complex into CE of 
macrophages is higher than in the other cell types, as shown in figure 4.18A. Compared to [4-
14
C]cholesterol delivered as BSA complex, the incorporation of [4-
14
C]cholesterol into CE 
after 24h incubation time is 10-fold higher when [4-
14
C]cholesterol is delivered as LDL-
complex. The ability of [4-
14
C]cholesterol delivered as LDL-complex to be incorporated in 
cholesteryloleate of macrophages can be related to atherosclerosis. If the function of the 
endolysosomal system is assayed by transport of [4-
14
C]cholesterol, it should be delivered as 
LDL-complex and the incorporation of labeled cholesterol into CE of macrophages should be 
chosen as read-out. 
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Figure 4.17: Uptake of [4-
14
C]cholesterol (1µM) delivered as complex with LDL (A) or BSA (B) by 
four types of cultured cells. The uptakes were measured 1, 6, and 24h after addition of the Chol-
complexes. Uptake was determined by scintillation counting of the lipid extract after different 
incubation time. 
 
 
Figure 4.18: A. Incorporation of [4-
14
C]cholesterol delivered as LDL-complex into lipids of the 
nonpolar lipid fraction. B. Incorporation of [4-
14
C]cholesterol delivered as BSA-complex into lipids of 
the nonpolar lipid fraction. In both cases, [4-
14
C]cholesterol was present in 1µM concentration in the 
medium; incubation time: 24h. Lipid classes were separated using the solvent system 
(nHexane/Diethylether/Acetic acid 70:30:1 by vol.). 
 
4.2.3. Triacylglycerol uptake and processing 
 
[1-
14
C]Trioleoylglycerol was added to four different types of cultured cells, human 
fibroblasts, macrophages, A431 cells, and HepG2 cells, either as a complex with LDL or with 
BSA, in a concentration of 1µM in the culture medium. As shown in figure 4.19, the uptake 
of [
14
C]TAG-LDL and  [
14
C]TAG-BSA by fibroblasts is higher than by the other cell types. 
Compared to [
14
C]TAG-BSA, the uptake of [
14
C]TAG-LDL is 4-fold higher in A431  cells, 
Hep-G2 cells, and  macrophages, and 3-fold higher in fibroblasts. 
When TAG is delivered as LDL-complex, TAG-derived [
14
C]oleic acid is mainly 
incorporated into neutral lipids. When macrophages are exposed to 1μM TAG-LDL–
complex, the incorporation of TAG-derived [
14
C]oleate into CE is higher compared to the 
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other investigated cell types (Fig. 4.20A). In addition, the incorporation of [
14
C]oleate into 
CE after 24h incubation time is 11-fold higher when TAG is delivered as LDL-complex than 
when delivered as BSA complex (Fig. 4.20C, Fig. 4.20D). Incorporation of TAG-derived 
[
14
C]oleate into DAG was 10- fold lower than into TAG,  suggesting that DAG might be an 
intermediate in the process of FA-incorporation into TAGs. On the other hand, the labeled 
oleic acid derived from TAG-BSA was incorporated only slightly into the nonpolar lipid 
fractions of the four investigated cell types (Fig. 4.20B). In cultured cells exposed to 1μM 
TAG-BSA–complex, levels of free [14C]oleic acid were higher in fibroblasts than that of the 
other cell types (Fig. 4.20B). If the function of the endolysosomal system is assayed by 
processing of TAG-derived [
14
C]oleate, it should be delivered as LDL-complex and the 
incorporation of labeled oleic acid into PC (Fig. 4.21A) should be chosen as read-out.  
We demonstrated that lipid complexes with LDL show higher uptake and processing 
compared to lipid complexes with albumin. We also demonstrated that the uptake of [
14
C]CE-
LDL, [
14
C]Chol-LDL, and [
14
C]TAG-LDL in fibroblasts is higher compared to other cell 
types. 
 
 
Figure 4.19: Uptake of [1-
14
C]trioleoylglycerol (1µM) in complex with  A. LDL, B. BSA by cultured 
cells. The uptakes were measured 1, 6, and 24h after addition of the trioleoylglycerol-complexes. 
These diagrams were determined by scintillation counting of the lipid extract after different 
incubation time. 
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Figure 4.20: Incubation of cells with A. [
14
C]TAG-LDL , B. [
14
C]TAG-BSA complexes (1µM) (upper 
panel) in the culture medium for 24h. Incubation of macrophages with C. [
14
C]TAG-LDL, D. 
[
14
C]TAG-BSA (bottom panel) for 1, 6, and 24h. Lipid classes were separated using the solvent 
system (nHexane/Diethylether/Acetic acid 70:30:1 by vol.). Radioactivity found in the lipid extract of 
different cells was set equal 100%. Radioactivity was analyzed by phosphoimager analysis. 
 
The polar lipid pattern that arise from the utilization of CE- and TAG-derived [
14
C]oleic acid 
were also compared (Fig. 4.21). Both complex lipids were applied as LDL- and BSA-
complexes with an incubation time of 24h and a concentration of 1µM. Our results 
demonstrate that even though the oleate in cholesteryl oleate and trioleoylglycerol was 
delivered in the same carrier as LDL particles, oleic acid-incorporation into polar lipids leads 
quantitatively to different pattern. 
 
 
Figure 4.21: illustrates the incorporation of A. 1μM TAG-LDL-derived [14C]oleate B. 1μM CE-LDL-
derived [
14
C]oleate into polar lipids of different cell types after 24h incubation. Lipid classes were 
separated using the solvent system (chloroform/methanol/water 65:25:4 by vol.). 
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4.3. Analysis of lipid processing in Niemann-Pick disease, type A cells 
(NPA) compared to normal fibroblasts 
 
NPA is one of the lysosomal storage disease in which sphingomyelin accumulates in cells 
and tissues. To assess the role of the endolysosomal system in the processing of LDL-
associated [
14
C]cholesterol and LDL-associated [
14
C]phosphatidylcholine, human fibroblasts 
and fibroblasts from patients with NPA disease, were investigated after 6h and 24h 
incubation.  
Incubation with LDL-associated [
14
C]cholesterol shows that there were no detectable 
differences in cholesterol uptake between normal fibroblasts and NPA disease after 6h 
incubation. Whereas, after 24h incubation, cholesterol uptake increased 21% in NPA cells 
compared to normal cells as shown in figure 4.22A.  
Incubation with LDL-associated [
14
C]phosphatidylcholine shows that 
[
14
C]phosphatidylcholine is largely hydrolyzed in both normal fibroblasts and NPA disease 
cells. Some of the labeled fatty acids that results from lysosomal hydrolysis are effluxed into 
the media, and other incorporated into polar and nonpolar lipids (Groener, et al. 1996). After 
6h and 24h incubation, levels of [
14
C]phosphatidylcholine that are presumably trapped in 
lysosomes increased by 20%, and 25%, respectively, compared to normal cells (Fig. 4.22B). 
We also observed that the PC-derived FA is incorporated into polar lipids or recovered as 
free fatty acid to a lesser extent in NPA disease cells compared to normal cells after 24h 
incubation time. We found that the relative levels of labeled fatty acids and polar lipids in 
NPA disease cells after 24h were 10% and 8% lesser than that in normal fibroblasts, 
respectively, as shown in figure 4.23. In summary, these observations indicate an impaired 
processing of lipids via the endolysosomal system in NPA disease. 
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Figure 4.22: Cells were incubated for 6h and 24h with 1µM A. LDL-associated [
14
C]cholesterol; B. 
LDL-associated [
14
C]phosphatidylcholine in normal fibroblasts and NPA disease cells. Normal 
fibroblasts and NPA disease cells were grown as described under experimental procedures (Chapter 
6).  
 
 
Figure 4.23: Cells were incubated for 6h and 24h with 1µM LDL-associated 
[
14
C]phosphatidylcholine. The figure shows the incorporation of PC-derived [
14
C]palmitate in A. 
nonpolar lipids, and B. polar lipids in normal fibroblasts and NPA disease cells. Normal fibroblasts 
and NPA disease cells were grown as described under experimental procedures (Chapter 6).  
 
4.4. Effect of cationic amphiphilic drugs on uptake and processing of 
choline-containing phospholipids by different types of cultured cells 
 
Phospholipidosis induced by CADs impairs cellular function to an unknown extent. The best 
investigational example for a molecular effect of CADs is the premature degradation of acid 
sphingomyelinase, which leads primarily to SM-accumulation. Therefore, uptake and 
processing of PC containing [
14
C]palmitic acid (Table 4.3) and SM containing [
14
C]stearic 
acid (Table 4.4) as lipid probes was determined in four different types of cultured cells. To 
target the endolysosomal system, the lipid probes were delivered to the cells as part of LDL 
particles. In the absence of additional drugs added to the culture medium, both probes were 
taken up to a similar extent by macrophages, fibroblasts, A431 cells, and HepG2 cells as 
shown in figure 4.24.  
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Figure 4.24: Uptake of A. [
14
C]-PC, B. [
14
C]-SM delivered as complex with LDL by four types of 
cultured cells. Concentration = 1µM. The uptakes were measured 1, 6, and 24h after addition of the 
SM-complexes. Uptake was determined by scintillation counting of the lipid extract after different 
incubation time. 
 
4.4.1. Differences between cell types 
 
The impact of the different CADs on uptake and processing of the SM- and the PC-probe was 
investigated in the four different cell types. The average uptake of the SM-probe in the 
presence of 0, 20, and 40µM CADs is shown in tables 4.3, and that of the PC-probe in table 
4.4.  
 
Table 4.3: Cellular SM-probe uptake by four different types of cultured cells. 
 Table 4.4: Cellular PC-probe uptake by four different types of cultured cells. 
 
Fibroblasts, macrophages, A431 cells, and HepG2 cells were cultured as described in the materials 
and methods section in serum-free medium supplemented with 1μM of the [14C]SM-probe (Table 4.3) 
and the [
14
C]PC-probe (Table 4.4). Both were added as lipid-LDL complexes. After treatment with 
different CADs in different concentrations (0, 10, 20 and 40µM) and incubation for 24h, cells were 
harvested and lipids were extracted. The incorporation of the labeled FA derived from the lipid probe 
into nonpolar and polar lipids was determined as pmol of lipids per μg of protein. Cell viability was 
not significantly influenced by 10µM or 20µM CADs as shown in figure 4.38. 
 
 
Cellular SM-probe 
uptake (pmol/µg of 
protein) 
Fibroblasts Macrophages A431 cells HepG2 cells 
0µM 20µM 40µM 0µM 20µM 40µM 0µM 20µM 40µM 0µM 20µM 40µM 
Desipramine 1.70 1.69 1.70 1.09 0.77 0.70 1.17 0.85 0.77 0.82 0.29 0.27 
Imipramine 1.78 1.70 1.66 1.45 1.41 1.36 1.37 1.31 1.19 1.09 1.07 1.07 
Chlorpromazine 1.73 1.49  1.35 1.34  1.35 1.17  1.16 1.06  
FTY720 1.82 1.62  1.30 0.78  1.36 0.94  0.87 0.73  
Chloroquine 1.79 1.74 1.63 1.42 1.35 1.30 1.46 1.42 1.40 1.07 1.01 0.90 
Cellular PC-probe 
uptake (pmol/µg of 
protein) 
Fibroblasts Macrophages A431 cells HepG2 cells 
0µM 20µM 40µM 0µM 20µM 40µM 0µM 20µM 40µM 0µM 20µM 40µM 
Desipramine 1.60 1.62 1.56 0.97 0.42 0.38 1.22 1.15 0.94 0.79 0.47 0.42 
Imipramine 1.76 1.72 1.65 1.34 1.21 1.08 1.52 1.50 1.49 1.11 1.09 1.07 
Chlorpromazine 1.90 1.41  1.26 1.11  1.46 1.15  0.87 0.81  
FTY720 1.82 1.72  1.30 1.10  1.42 1.34  0.97 0.93  
Chloroquine 1.82 1.70 1.68 1.42 1.29 1.20 1.59 1.52 1.55 1.01 0.88 0.73 
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4.4.2. Impact of desipramine on SM and PC uptake 
 
The uptake of the SM- and the PC-probe in terms of pmol per μg cell protein was dependent 
on the identity and the concentration of the investigated CADs, on the incubation time, and 
on the cell type. In cultured cells that were pre-incubated for 24h with 0, 10, 20, and 40µM 
desipramine, the uptake of the lipid probes per µg protein decreased with increasing 
concentrations of desipramine in the culture medium. This decrease in lipid uptake was 
visible after 24h and was dose dependent. In cultured cells pre-treated with different 
concentrations of desipramine (Fig. 4.25), the uptake of [
14
C]PC and [
14
C]SM was 
significantly decreased in macrophages and HepG2 cells compared to in the control cells. 
From the SM probe or PC probe present in the medium, 23% and 22% were taken up without 
treatment with DMI, 21% and 15% were taken up after treatment with 20µM DMI, and 19% 
and 10% after treatment with 40µM DMI, respectively. 
 
4.4.3. Effect of desipramine on SM and PC processing 
 
When macrophages were cultured in the presence of different concentrations of desipramine, 
10μM desipramine had only a slight effect on [14C]SM processing. 10µM desipramine led to 
a decrease in labeled total neutral lipids and free fatty acids by 24% and 18%, respectively. 
40µM desipramine led to a decrease in labeled total neutral lipids and free fatty acids by 39% 
and 55%, respectively. TAG, CE, and DAG were reduced by 47%, 80%, and 13%, 
respectively. Treatment of macrophages with 20µM desipramine resulted in an increased 
level of the exogenously added SM probe consistent with the effect of desipramine on 
premature degradation of acid sphingomyelinase, and a reduced intracellular capacity to 
release the radiolabeled fatty acid from the incorporated lipid probe. At 10 and 20µM 
desipramine, levels of labeled ceramide also increased 1.5-fold compared to control cells 
(Fig. 4.26B). This is in agreement with the reported induction of degradation of acid 
ceramidase by desipramine and other CADs (Elojeimy, et al. 2006). These results support the 
dual effects of desipramine on both acid sphingomyelinase and acid ceramidase also in this 
cell type. Incubation with 40µM desipramine led to a 7-fold increase in labeled SM compared 
to untreated cells.  
The effect of desipramine on the incorporation of [
14
C]PC-derived palmitic acid into PLs of 
macrophages is shown in figure 4.27B. In cultured cells treated with 10µM desipramine, PC-
derived [
14
C]palmitic acid was incorporated approximately to the same extent into complex 
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cellular lipids as in the control. A slight increase of labeled PC was observed in the presence 
of 20µM desipramine, whereas a significant increase of labeled PC, PA, and lysoPC was 
visible in the presence of 40μM desipramine. Labeling of PA and LysoPC was increased 2.5- 
and 2-fold, respectively.  
In macrophages and HepG2 cells, after treatment with 10µM and 20μM desipramine, the 
incorporation of [
14
C]PC-derived palmitic acid into[
14
C]TAG appeared to be higher than that 
of other nonpolar lipids. After treatment with 40μM desipramine, the reverse was observed. 
In A431 cells, the incorporation of [
14
C]PC-derived palmitate into TAG was decreased 
slightly, but increased slightly in fibroblasts treated with 40µM desipramine (data not 
shown). Furthermore, 40μM desipramine inhibits significantly the incorporation of [14C]PC-
derived palmitate into total neutral lipids and free fatty acids of macrophages by 33% and 
28%, respectively. TAG, CE, and DAG were reduced by 39%, 21%, and 23%, respectively. 
These data suggest that only higher concentration (40μM) of desipramine significantly inhibit 
the incorporation of [
14
C]PC-derived palmitate into TAG of cultured macrophages, A431 
cells and HepG2 cells, but not of fibroblasts.  
 
 
Figure 4.25: Uptake of labeled A. PC, B. SM administered as part of LDL particles by cultured cells 
after 24h incubation time in the absence and presence of different concentrations of desipramine. 
Cells were pre-incubated with different concentration of desipramine for 24h before the addition of 
the complexes. Uptake was determined by scintillation counting of the lipid extract, so that the given 
values represent the sum of unchanged phospholipid and hydrophobic metabolites derived from it. 
Statistical significance between desipramine treatment and matched control is determined using 
statistical student’s t-test. * represents p < 0.05. 
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Figure 4.26: Effect of desipramine on the incorporation of SM-derived 1-[
14
C]stearic acid into 
nonpolar lipids (left) and polar lipids (right) of macrophages after 24h incubation time (pre-incubation 
with desipramine for 24h before the addition of the complexes). Statistical significance between 
desipramine treatment and matched control is determined using statistical student’s t-test. * represents 
p < 0.05, and ** represents p < 0.005. 
 
 
Figure 4.27: Effect of desipramine on the incorporation of PC-derived 1-[
14
C]palmitic acid into 
nonpolar lipids (left) and polar lipids (right) of macrophages after 24h incubation time (pre-incubation 
with different concentrations of desipramine 24h before the addition of the complexes). Statistical 
significance between desipramine-treatment and matched control is determined using statistical 
student’s t-test: * represents p < 0.05, and ** represents p < 0.005. 
 
4.4.4. Impact of chlorpromazine on SM and PC uptake 
 
Chlorpromazine has been demonstrated to inhibit the formation of clathrin-coated pits (Nawa, 
et al. 2003) and acts as an inhibitor of receptor-mediated endocytosis. Therefore it should also 
reduce the uptake of lipids delivered as part of LDL particles via the LDL-receptor. We 
examined the role of chlorpromazine in four cell types and measured the uptake of PC and 
SM as part of LDL complexes. Uptake of the PC- and SM-probe delivered as LDL complex 
was determined in the presence of (0, 10, and 20µM) of chlorpromazine. Concentrations of 
more than 20µM reduced the cell viability and amount of cellular protein (Fig. 4.38A). As 
shown in figure 4.28A, in the presence of 20µM chlorpromazine no big effects of 
chlorpromazine on lipid uptake were detected in macrophages and HepG2 cells. Independent 
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of this, uptake of LDL-associated PC and LDL-associated SM was lower in fibroblast and 
A431 cells compared to other cell types.  
 
4.4.5. Effect of chlorpromazine on SM and PC processing 
 
The incorporation of SM-derived [
14
C]stearic acid into nonpolar lipids was depressed 
markedly in the presence of chlorpromazine (Fig. 4.29A). This includes the incorporation 
into DAG, which is the intermediate for the synthesis of TAG, PC and PE and is formed 
primarily by the action of phosphatidic acid phosphohydrolase, an enzyme that can be 
inhibited by CADs (Leli, at al. 1987; Pappu, et al. 1984). Also levels of labeled TAG were 
decreased by 65%. Furthermore, chlorpromazine had an inhibitory effect on the synthesis of 
PC and other phospholipids from [
14
C]SM-Stearate. In macrophages, SM-derived [
14
C]stearic 
acid was predominantly recovered as SM, which comprised 95% of the total labeled 
phospholipids of the polar lipid fraction. These data suggest that chlorpromazine may act by 
inhibiting CTP:phosphocholine cytidylyltransferase (Fig. 5.3), as shown by Pelech, et al.  
1984, and decrease the incorporation of [
14
C]SM-derived stearate precursors into PC and PE 
as seen in our data (Fig. 4.29B).  
When PC-derived [
14
C]palmitic acid was added to the cells as part of LDL-complexes, 
chlorpromazine at 10μM did not alter lipid metabolism significantly. However, at 20μM there 
was a slightly decreased incorporation of PC-derived [
14
C]palmitate into neutral lipids of 
macrophages. The incorporation of [
14
C]palmitic acid derived from PC into TAG and DAG 
decreased 22%, and 25%, respectively (Fig. 4.30A). Level of PC-derived palmitic acid 
increased with increasing concentration of chlorpromazine (Fig. 4.30B). Labelling of PE, 
Cer, and SM decreased in response to the same dose. In the presence of 20μM 
chlorpromazine, the level of labeled PC increased 50% after 24h incubation. On the other 
hand, the incorporation of PC-derived [
14
C]palmitate into neutral lipids of A431 cells was 
decreased by 22% on treatment with 20µM chlorpromazine. This concentration has no 
significant effects on the incorporation of [
14
C]palmitate into neutral lipids of HepG2 cells 
(data not shown). 
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Figure 4.28: Uptake of labeled A. PC, B. SM administered as part of LDL particles into the lipid 
fraction of cultured cells after 24h incubation time. Cells were pre-incubated with different 
concentrations of chlorpromazine for 24h before the addition of the complexes. Uptake was 
determined by scintillation counting of the lipid extract, so that the given values represent the sum of 
unchanged phospholipid and hydrophobic metabolites derived from it.  
 
 
 
Figure 4.29: Effect of chlorpromazine on the incorporation of SM-derived 1-[
14
C]stearic acid into 
nonpolar lipids (left) and polar lipids (right) of macrophages after 24h incubation time (pre-incubation 
with different concentrations of chlorpromazine for 24h before the addition of the complexes). 
Statistical significance between chlorpromazine treated and matched controls is determined using 
statistical student’s t-test. * represents p < 0.05, and ** represents p < 0.005. 
 
 
 
Figure 4.30: Effect of chlorpromazine on the incorporation of PC-derived 1-[
14
C]palmitic acid into 
nonpolar lipids (left) and polar lipids (right) of macrophages after 24h incubation time (pre-incubation 
with different concentrations of chlorpromazine for 24h before the addition of the complexes). 
Statistical significance between chlorpromazine treated and matched control is determined using 
statistical student’s t-test. * represents p < 0.05, and ** represents p < 0.005. 
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4.4.6. Impact of imipramine on SM and PC uptake 
 
Figure 4.31 shows the uptake of radiolabeled PC and SM after 24h incubation with 
imipramine in different types of cultured cells. In macrophages, increasing concentrations of 
imipramine in the culture medium cause an decreased uptake of PC by the cells, which is 
observed in the other cell types to a much lesser extent (Fig. 4.31A). The uptake of 
radiolabeled SM delivered as part of LDL particles in the absence and in the presence of 10, 
20 and 40μM imipramine by macrophages, fibroblasts, and HepG2 cells is shown in figure 
4.31B. At higher concentrations of imipramine in the culture medium, uptake of SM was 
slightly decreased in A431 cells. 
 
4.4.7. Effect of imipramine on SM and PC processing 
 
Cultured cells were pre-incubated with medium containing 0, 10, 20 and 40μM imipramine 
for 24h and then treated with SM labeled by [
14
C]-stearic acid, still in the presence of drug for 
24h. We observed an increase of labeled phospholipids per μg of protein during imipramine 
exposure. This phospholipid accumulation appeared after 24h and was dose dependent. The 
effect of imipramine on the incorporation of SM-derived [
14
C]stearic acid into nonpolar and 
polar lipids of macrophages is shown in figure 4.32A and figure 4.33A. In the presence of 
10µM imipramine in the culture medium, the incorporation of SM-derived [
14
C]stearic acid 
into phospholipids was nearly the same as in control cells. However, a significant increase of 
label in acidic phospholipids was observed after treatment with 20μM imipramine. The 
highest incorporation was observed into phosphatidic acid. It can be assumed that this is due 
to a decreased degradation of phosphatidic acid in the presence of imipramine, since labeling 
of PC and PE were two times lower. The incorporation of SM-derived [
14
C]stearic acid into 
neutral lipids and recovery of free fatty acid was decreased by 45% and 67%, respectively, 
when macrophages were treated with 40μM imipramine.  
The incorporation of PC-derived [
14
C]palmitic acid into cholesteryl ester and diacylglycerol 
were lower in macrophages pre-treated with 40μM imipramine compared to control cells, i.e. 
1.4 and 1.1 vs 0.2 and 0.5 pmol/mg protein in CE and DAG, respectively. No significant 
change in the incorporation of PC-derived [
14
C]palmitic acid into TAG pre-treated with 
40μM imipramine was observed in comparison to control cells (Fig. 4.32B). Furthermore, the 
incorporation of PC- derived [
14
C]palmitic acid into neutral lipids and its recovery as free 
fatty acid was decreased by 15% and 27%, respectively, when cells were treated with 40μM 
imipramine. There were no significant differences in the incorporation of the labeled fatty 
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acid derived from PC in phospholipids between control cells and macrophages pre-treated 
with 10μM imipramine. The incorporation of PC-derived [14C]palmitic acid into PC was 
increased by 16% in the presence of 40µM imipramine (Fig. 4.33B).  
 
 
Figure 4.31: Uptake of labeled A. PC, B. SM. Both lipids were administered as part of LDL particles. 
Labelling of the lipid fraction of cultured cells after 24h incubation time with imipramine was 
determined in the absence and presence of different concentrations of imipramine. Cells were pre-
incubated with different concentrations of imipramine for 24h before the addition of the complexes. 
Uptake was determined by scintillation counting of the lipid extract, so that the given values represent 
the sum of unchanged phospholipid and hydrophobic metabolites derived from it. Statistical 
significance between imipramine treatment and matched control is determined using statistical 
student’s t-test. * represents p < 0.05. 
 
 
Figure 4.32: Effect of imipramine on the incorporation of SM-derived [
14
C]stearic acid (left) and PC-
derived [
14
C]palmitic acid (right) into nonpolar lipids of macrophages after 24h incubation time (pre-
incubation with different concentrations of imipramine for 24h before the addition of the complexes). 
Statistical significance between imipramine-treated and matched controls is determined using 
statistical student’s t-test. * represents p < 0.05, and ** represents p < 0.005. 
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Figure 4.33: Effect of imipramine on the incorporation of SM-derived [
14
C]stearic acid (left) and PC-
derived [
14
C]palmitic acid (right) into polar lipids of macrophages after 24h incubation time (pre-
incubation with different concentrations of imipramine for 24h before the addition of the complexes). 
Statistical significance between imipramine treatment and matched control is determined using 
statistical student’s t-test. * represents p < 0.05, and ** represents p < 0.005. 
 
4.4.8. Impact of chloroquine on PC and SM uptake 
 
Chloroquine is known to cause inhibition of LDLR recycling (Minahk, et al. 2008). This 
offers the possibility to investigate the importance of LDLR on the uptake of radiolabeled PC 
and SM delivered as LDL particles. The four cell types were cultured in the presence of 1µM 
of the lipid probe and different concentrations of chloroquine. PC uptake assays revealed a 
significant reduction in [
14
C]PC uptake by macrophages and HepG2 cells (Fig. 4.34A). 
Analysis of [
14
C]PC uptake by fibroblasts treated with chloroquine showed a slight reduction 
in uptake in the presence of 40µM chloroquine (Fig.4.34A). This result is in agreement with 
previous result which suggest that PC as part of LDL-particles can be delivered to mouse 
hepatocytes by an LDLR independent pathway (Minahk, et al. 2008). Furthermore, the 
uptake of [
14
C]SM by macrophages, fibroblasts, and HepG2 cells was slightly decreased in 
the presence of chloroquine compared to control cells. Chloroquine has no significant effects 
on lipid uptake of both the PC and the SM-probe by A431 cells (Fig. 4.34).  
These data also supports the previous results which represent that chloroquine may disturb 
LDLR recycling pathways. 
 
4.4.9. Effect of chloroquine on PC and SM processing 
 
The addition of chloroquine induced a decrease in the incorporation of fatty acids released 
from PC or SM into TAGs in macrophages (Fig. 4.35A, Fig. 4.35B).  
When macrophages were incubated with [
14
C]PC in the absence of chloroquine, (69%, 11%, 
and 14%) of the radioactivity was found in phospholipids, neutral lipids, and free fatty acid, 
respectively. PC represents about 50% of the radioactivity of the total phospholipids. When 
macrophages were incubated with [
14
C]SM in the absence of chloroquine, (64%, 14%, and 
18%) of the radioactivity was found in phospholipids, neutral lipids, and free fatty acid, 
respectively. Here, SM represents about 70% of radioactivity of the phospholipids. When 
macrophages were incubated for 24h in the presence of 40µM chloroquine, (82%, 4%, and 
8%) and (76%, 8%, and 12%) of the radioactivity was found in phospholipids, neutral lipids, 
and free fatty acid after labeling with both, the PC- and the SM-probe, respectively (Fig. 
4.35). PC represents about 58% of radioactivity of the total phospholipids after labeling with 
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the PC-probe, while SM represents about 78% of radioactivity of the total phospholipids after 
labeling with the SM-probe. The effects of 40µM chloroquine to decrease the incorporation 
into neutral lipids were also observed with other cell types, when LDL associated PC and 
LDL associated SM probes were used (data not shown).  
 
 
Figure 4.34: Uptake of labeled A. PC, B. SM. Both lipids were administered as part of LDL particles. 
Concentration = 1µM. Cells were pre-incubated with different concentrations of chloroquine for 24h 
before the addition of the complexes. Uptake was determined after 24h incubation by scintillation 
counting of the lipid extract, so that the given values represent the sum of unchanged phospholipid 
and hydrophobic metabolites derived from it. Statistical significance between chlorpromazine 
treatment and matched control is determined using statistical student’s t-test. * represents p < 0.05. 
 
 
Figure 4.35: Effect of chloroquine on the incorporation of PC-derived 1-[
14
C]palmitic acid (A, C) and 
SM-derived 1-[
14
C]stearic acid (B, D) into nonpolar lipids (upper panel)  and polar lipids (bottom 
panel) of macrophages after 24h incubation time (pre-incubation with different concentrations of 
chloroquine for 24h before the addition of the complexes). Statistical significance between 
chloroquine treatment and matched control is determined using statistical student’s t-test. * represents 
p < 0.05. 
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4.4.10. Impact of FTY720 on PC and SM uptake 
 
FTY720 has been demonstrated that lead to an apparent inhibition of acid sphingomyelinase 
(Dawson, et al. 2011) and all six ceramide synthase isozymes (Berdyshev, et al. 2009). We 
examined the role of FTY720 on uptake and processing of PC and SM in four cell types. 
Both phospholipids were delivered as part of LDL-particles in concentration of 1µM in the 
presence of different concentrations of FTY720 (0, 10, and 20µM). Concentrations of more 
than 20µM FTY720 reduced cell viability and amount of cellular protein. In the presence of 
FTY720, the uptake of both, [
14
C]SM and [
14
C]PC was slightly decreased in fibroblasts and 
HepG2 cells, and the uptake of [
14
C]SM was significantly decreased in macrophages and 
A431 cells compared to in the control cells, as shown in figure 4.36. 
 
4.4.11. Effect of FTY720 on PC and SM processing 
 
When cultured macrophages were incubated with [
14
C]PC or [
14
C]SM in the presence of 
FTY720 for 24h, the effect of FTY720 on processing of the lipid probes was dependent on its 
concentration. At 10µM, FTY720 did not alter levels of labeled metabolites significantly. 
However, at 20µM concentration, FTY720 produces a significant increase in the 
incorporation of 1-[
14
C]stearic acid derived from SM into GlcCer and LacCer (Fig. 4.37D). In 
macrophages treated with 1µM LDL associated SM-stearate, 10µM FTY720 led to a 
decrease in labeled neutral lipids and PLs by 10% and 18%, respectively. While, 20µM 
FTY720 led to a decrease in labeled neutral lipids and PLs by 42% and 24%, respectively. 
Free stearic acid was increased by 34% when treated with 20µM FTY720 compared to 
control. Treatment of macrophages with 20µM FTY720 resulted in an increased level of the 
exogenously added SM probe consistent with the effect of FTY720 on premature degradation 
of acid sphingomyelinase.  
The incorporation of PC-derived [
14
C]palmitic acid into cholesteryl ester and triacylglycerol 
were decreased in macrophages by 21%, and 34% pre-treated with 20μM FTY720 compared 
to control cells, respectively. Free palmitic acid was increased by 38% when treated with 
20µM FTY720 compared to control cells (Fig. 4.37A).  There were no significant differences 
in the incorporation of the labeled palmitic acid derived from PC in polar lipids between 
control cells and macrophages pre-treated with 10μM FTY720. The level of PC-derived 
palmitic acid was increased in the presence of 20μM FTY720. The incorporation of the 
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labeled palmitic acid into PC was increased by 31% in the presence of 20µM FTY720 (Fig. 
4.37C). 
 
 
Figure 4.36: Uptake of 1µM labeled A. PC, B. SM, administered as part of LDL particles by cultured 
cells after 24h incubation time. Cells were pre-incubated in the absence and presence of different 
concentrations of FTY720 for 24h before the addition of the complexes. Uptake was determined by 
scintillation counting of the lipid extract, so that the given values represent the sum of unchanged 
phospholipid and hydrophobic metabolites derived from it. Statistical significance between 
chlorpromazine treatment and matched control is determined using statistical student’s t-test. * 
represents p < 0.05. 
 
 
 
Figure 4.37: Effect of FTY720 on the incorporation of PC-derived [
14
C]palmitic acid (A, C) and SM-
derived [
14
C]stearic acid (B, D) into nonpolar lipids (upper panel)  and polar lipids (bottom panel) of 
macrophages after 24h incubation time (pre-incubation with different concentrations of FTY720 for 
24h before the addition of the complexes). Statistical significance between imipramine treatment and 
matched control is determined using statistical student’s t-test. * represents p < 0.05, and ** 
represents p < 0.005. 
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In summary, we demonstrated that lipid-LDL complexes are taken up at a higher rate in 
fibroblasts compared to other cell types. On the other hand, Chol-BSA complexes are taken 
up at a higher rate in A431 cells compared to CE-BSA, TAG-BSA which is taken up at a 
higher rate in fibroblasts. We also demonstrated that when macrophages were treated with 
20µM CADs, [
14
C]SA derived from SM was mainly recovered as SM (1.3 pmol/µg protein) 
when treated with chlorpromazine, followed by desipramine, which comprised (0.9 pmol/µg 
protein). [
14
C]palmitic acid derived from PC was mainly recovered as PC (1.1 pmol/µg 
protein) when treated with chlorpromazine, followed by FTY720, which comprised (1.0 
pmol/µg protein). Therefore, chlorpromazine has the strongest negative impact on 
sphingomyelinase action and phosphatidylcholine degradation.  
 
4.4.12. Analysis of cell viability 
 
Analysis of cell viability in different cultured cells is one of the important means of 
evaluating in vitro drug effects in cytotoxicity essays. Our conditions were not accompanied 
by a loss of cell viability as determined by total cell protein. One of the traditional methods of 
cell viability analysis is the CellTiter Blue (CTB) assay. As shown in figure 4.38, in the 
CellTiter Blue assay, a concentration of 40µM FTY720 and chlorpromazine show a decrease 
in cell viability of more than 50 %. Therefore, effects of these concentrations of the drugs on 
lipid metabolism cannot be considered. 
 
 
Figure 4.38: Cell viability assay in A: macrophages (CADs concentrations dependence), and B: 
different cell types in the presence of desipramine.  
 
4.4.13. Analysis of lipid binding to LDL 
 
The lipid-protein complexes were examined by gel chromatography. Separation by gel-
filtration chromatography is based on differences in the size of the analyte molecules 
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(molecules with less access to the pore volume elute first, while the smallest molecules elute 
last). Lipid-LDL complexes were isolated through a sephacryl S-300 (pore size: 10-
3000kDa), column size (2 x 20cm) and equilibrated with 10mM Tris-HCl (pH 7.5) containing 
0.3mM NaCl, and 0.3mM EDTA as a running buffer, and the column was eluted with the 
same buffer. In gel chromatography column runs, more than 78% of the lipid radioactivity 
and more than 90% of the protein were recovered. 
Figure 4.39 showed that in the [
14
C]PC–LDL complex, the aggregation state was different 
from the pure [
14
C]PC. The original homogeneous distribution of [
14
C]PC aggregates 
changed to heterogeneous distribution after interacted with LDL molecules. This experiment 
was designed to show that [
14
C]PC molecules readily bound with ApoB100 in LDL 
molecules to form [
14
C]PC–LDL complex separated differentially from the sole [14C]PC 
under identical experimental conditions.  
 
 
 
Figure 4.39: Gel chromatographic elution profile of [
14
C]-PC-LDL complex and [
14
C]-PC on 
Sephacryl S-300.  
 
 
 
 
 
 
 
 
 
 
 
 
86 
 
5. Discussion 
 
5.1. Uptake and processing of C-18 fatty acid in cultured cells 
 
As far as it is known, fatty acids are taken up without contribution of the endolysosomal 
system, and fatty acid probes themselves are not suitable to assay lipid uptake and processing 
via this compartment. Nevertheless, a series of labeled FAs of different structure (saturated, 
ω-3, ω-6, and ω-9) were used to get insight into their metabolic utilization in different types 
of cultured cells. The resulting incorporation pattern can be compared to those that arise from 
hydrolyses of FA-labeled complex lipids in the lysosomes. Based upon the data reported 
before in cultured keratinocytes (Schürer, et al. 1988), FAs were applied in a concentration of 
10µM, at that concentration the uptake of all fatty acids was in the same range. At a lower 
concentration (0.1µM), the uptake of linoleic acid is reported to significantly exceed that of 
other FAs including stearic acid, oleic acid, and palmitic acid (Schürer, et al. 1988). In 
contrast, the uptake of stearic acid was significantly lower than that of the other FAs at 
concentrations of more than 10µM (Schürer, et al. 1988). In these and in our experiments, the 
reason for this might be linked to G-protein coupled receptors. For example OA binds to 
GPR43 (Briscoe, et al. 2003), and ω3-unsaturated FAs to GPR120 (Oh, et al. 2010; Ichimura, 
et al. 2012). Furthermore, in Huh-7 cells, OA stimulates rapid (15min) LD formation through 
activating the GPR120 receptor (Wakelam, et al. 2012). 
To mimic the physiological situation, we applied the FAs in complex with BSA (Pütz, et al. 
1995). The decision to use radiolabeled FAs is based on previous results from a series of tests 
with FA probes that were labeled with azide groups as chemical reporter groups or with 
stable isotopes. Both methods were not sensitive enough in our hands to determine the whole 
set of metabolic products on a background of endogenous lipids with mass spectrometry as 
readout. These control experiments with exogenously added radiolabeled FAs revealed that 
the metabolism of these lipid probes varies in part considerable with the number of Z-double 
bonds present in the probes, and with the cell type. Therefore, it is not possible to draw 
conclusions on the complete FA entry pathway with only one lipid probe and cell type. 
The dissociation constants for various FA from the FA-BSA complexes were dependent upon 
the type of fatty acid and not dependent on the FA/BSA ratio (Demant, et al. 2002). The 
values of the rate of FA dissociation from BSA increase in the order stearic acid < oleic acid 
< palmitic acid ≈ linoleic acid < arachidonic acid at 37 °C (Demant, et al. 2002). 
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Although it is not expected that endosomes and lysosomes are involved in FA uptake and 
metabolism, the impact of a cationic amphiphilic drug (CAD), desipramine (DMI), on uptake 
and processing of SA, OA, LA, and LOA that is known to cause phospholipidosis in humans 
and animals by inducing premature degradation of endosomal acid sphingomyelinase were 
also analyzed. Furthermore, there are no data on the impact of DMI on FA processing in the 
literature.  
 
5.1.1. FA uptake in cultured cells 
 
In chapter 4, the basal uptake of different FAs by four different types of cultured cells was 
determined. Both, cell type and FA structure, influence FA uptake by confluent cultured 
fibroblasts, macrophages, A431 cells, and HepG2 cells. The cellular uptake of FAs is a 
regulated process; and unsaturated FAs have shown to induce formation of lipid droplets, 
presumably by activation of the G-protein coupled receptor GPR120 (Rohwedder, et al. 2011; 
Oh, et al. 2010; Ichimura, et al. 2012) and to stimulate FA uptake . For example, in placental 
trophoblast cells, FA uptake increases by 20–50%, when the cells were pre-incubated for 24h 
with 100mM long chain polyunsaturated FAs (LCPUFA). These FAs were preferentially 
incorporated into cellular phospholipids. Stimulation of FA uptake by LCPUFA corresponds 
to the increased expression of long-chain acyl-CoA synthetase (ACSL), indicating that acyl-
CoA synthetase activity may be required for stimulation of FA uptake by LCPUFAs in this 
and in other cell types.  
The nature of the binding of exogenously FA to cultured cells may be of similar nature of 
binding of exogenously added gangliosides reported previously (Saqr, et al. 1993). It was 
demonstrated that exogenous gangliosides are present in aqueous solution either as 
monomers, aggregates (oligomers), or micelles. These are incorporated into cells but are 
mainly adherent to the surface membrane. This form represents the major portion of 
exogenous lipids bound to the plasma membrane, and is loosely associated with the cell 
surface. Another part is attached to binding proteins as monomers or micelles that can only be 
removed by trypsination, or as monomers inserted into hydrophobic regions of the 
membrane. Therefore, exogenously added FAs and lipids which are generally recovered from 
the lipid extract of cells might contain a fraction, that is only adhered to the cells. 
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5.1.2. FA processing in HepG2 cells 
 
The human hepatoma cell line (HepG2) is one of particular interest as the liver is the primary 
site for the synthesis of fatty acids. The HepG2 cell line has been shown to exhibit many 
functions of differentiated human liver cells, through the expression of secretory proteins 
such as albumin, transferrin and fibrinogen (Dixon, et al. 1993) and retains many hepatic 
metabolic functions, including lipoprotein and apolipoprotein synthesis and cholesterol 
metabolism (Javitt, 1990). We used the HepG2 cell line in this study as a model of fatty acid 
uptake and processing by liver cells.  
In HepG2 cells, SA, OA, LA, and LOA are taken up at almost identical rates, and no 
significant differences in cellular uptake were noted among these FAs. These results are in 
agreement with (Dokko, et al. 1998). In the same cell type, we observed that the more double 
bonds the FAs contained, the more they are incorporated into LD lipids. In HepG2 cells, we 
observed that both saturated, and to a greater extent, unsaturated C18-FAs, especially LOA, 
are efficiently incorporated in TAG, DAG, and CE. This is in agreement with previous work 
(Fujimoto, et al. 2006), which demonstrated that FAs with hydrocarbon chains of C12 - C18 
(saturated and unsaturated long chain FAs) were accumulated in TAG and CE, which were 
concentrated in LDs. Moreover, hepatocytes and hepatic stellate cells play a central role in 
retinoid (Fig. 5.1A) or vitamin A ((2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-
1-yl)nona-2,4,6,8-tetraenoic acid) storage and metabolism (Vogel, et al. 2000). To maintain 
plasma retinol levels, hepatocytes are responsible for the uptake of postprandial retinyl esters 
and are responsible for secretion of retinol bound to retinol-binding protein, since hepatocytes 
are essentially involved in maintaining circulating levels of retinol. Furthermore, the long-
chain FA binding protein (L-FABP) binds a broad range of hydrophobic ligands, including 
FAs, and has a preference for unsaturated FAs as opposed to saturated FAs (McArthur, et al. 
1999). L-FABP overexpression markedly increased the rate of FA uptake in hepatoma cells 
(Wolfrum, et al. 1999), and high level expression of L-FABP not only stimulated FA uptake, 
but also increased intracellular esterification of exogenously supplied FAs (Murphy, et al. 
1996). Culture of three different hepatoma cell lines (HepG2; PLC/PRF 5; Mz-Hep-1) using 
[
3
H]OA in the presence of various concentrations of albumin showed that cellular uptake of 
[
3
H]OA over the initial 30sec incubation period was maximal, and the uptake of FAs by 
human hepatoma cell lines is, at least in part, mediated by a membrane FA binding protein 
(Stremmel, et al. 1989). These data suggest a significant role of fatty acid in regulating the 
incorporation into polar and nonpolar lipids by HepG2 cells.  
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The LD formation was effectively blocked by a long-chain acyl-CoA synthetase (ACSL) 
inhibitor, triacsin C (Fig. 5.1B); therefore, long chain FAs and ACSLs are significant factors 
for LD formation in hepatocytes. Also caveolae, but not clathrin-coated pits, have been 
implicated in uptake and intracellular trafficking of LCFA in HepG2 cells (Pohl, et al. 2002). 
Inhibition of caveolae formation by filipin III resulted in a reduction of [
3
H]OA and  [
3
H]SA 
uptake by 54%, and 44%, respectively. 
In our experiments, all FAs were more incorporated into polar lipids (PLs), especially into PC 
than into the other PLs, while the ratio of labeled PC/PE with SA and OA was less than with 
the other FAs. This is in agreement with previous work (Marra, et al. 1992), which 
demonstrated that when SK-Hep-1 cells were incubated with [
14
C]LA, the unaltered FA was 
mainly incorporated into PC. Examination of the total FA of HepG2 cells revealed a high 
level of OA (Woldseth, et al. 1993). The ability of HepG2 cells to incorporate 0.66µM of 
different saturated and unsaturated FAs from the cultured medium was determined for 
following 1-[
14
C]FAs: 16:0, 18:0, 18:2(n-6), 18:3(n-3), and 20:3(n-6) (Angeletti, et al. 1995). 
These results are in agreement with our results.  
 
 
Figure 5.1: Chemical 
structure of A. retinoic 
acid, B. triacsin C. 
 
 
 
 
5.1.3. FA processing in macrophages 
 
The phospholipid FA compositions of cellular membranes alter their fluidity and induce 
changes in cell signaling leading to altered gene expression and lipid mediator production 
(Calder, 2010). In macrophages, the phospholipid FA composition influences processes such 
as apoptosis, production of cytokines, release of inflammatory mediators, and NO production. 
In macrophages, there is a strong positive correlation between phagocytosis and the content 
of polyunsaturated FA (Calder, et al. 1990). Macrophages enriched with polyunsaturated FAs 
showed 25-55% enhancement of phagocytic capacity. We observed that SA and OA are 
markedly incorporated in nonpolar lipids. Among unsaturated FAs, OA was more 
incorporated in nonpolar lipids, followed by LA and LOA. In contrast, we observed that LA 
and LOA are markedly incorporated in polar lipids compared to SA and OA. Furthermore, 
within the time frame used in our study, labeling of PC was always greater than that of PE, 
90 
 
except for LOA, which was incorporated into PE to a larger extent than into the other PL 
classes. These results are in agreement with previous work, which showed that in 
macrophages the content of polyunsaturated FAs in the PL fraction was higher than in the 
neutral lipid fraction (Calder, et al. 1990). Our results are also in agreement with previous 
results obtained in isolated rat liver cells, which show that FAs were incorporated in the PL 
fraction to a very different extent, and in the order 18:0 > 16:0 (Woldseth, et al. 1993).  
 
5.1.4. FA processing in A431 cells 
 
In A431 cells, the incorporation of OA, LA, and LOA into nonpolar lipids occurred 
predominantly into DAG, while SA was more incorporated into TAG than DAG (Fig. 4.3C). 
DAG originates either from the hydrolysis of phosphatidic acid, from TAG, or from PL 
hydrolysis. Among the nonpolar lipids, FAs were more incorporated into diacylglycerols than 
into TAG in fibroblasts. In macrophages and HepG2 cells, in which more incorporation into 
nonpolar lipids occurred, FAs were mainly incorporated into TAGs. 
To explain these results, Pulse-chase studies were carried out. Results indicate that DAGs are 
only transiently formed during the formation of TAGs. During short-time pulse periods (2h) 
we observed a major incorporation of radiolabeled oleate into diacylglycerol in fibroblasts, 
and A431 cells. In the other cell types, the major incorporation of labeled oleate was 
observed into TAG. In chase experiments, the level of labeled triacylglycerol was increased 
after 72h incubation in macrophages and fibroblasts. Similarly, the labeled triacylglycerol 
increased with time in HepG2 cells, and A431cells. Moreover, the incorporation of labeled 
PC was decreased during the chase periods in all cell types (Fig. 4.7). These observations 
indicated a role of the Lands' cycle to remodel phospholipids during the chase period.  
 
5.1.5. FA processing in fibroblasts 
 
Different FAs were added to cultured human fibroblasts. These cells are easy to prepare and 
are available in larger quantities. Human skin fibroblasts readily take up exogenous free FAs 
and incorporate them into cellular TAGs and PLs (Spector, et al. 1979: Rosenthal, et al. 
1981). We found that within two hours, human skin fibroblasts incorporate all long chain FAs 
studied into diacylglycerol. SA was less incorporated into DAG than the other unsaturated 
FAs, and compared to unsaturated FAs, more SA was detected in free form. A previous study 
(Rosenthal, et al. 1981) has shown a progressive incorporation into diacylglycerols in 
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fibroblasts incubated in the presence of exogenous long chain saturated FAs. Incubation of 
fibroblasts with saturated FAs lead to increased levels of neutral lipids into lipid droplets. 
Into phospholipids, OA was incorporated to a greater extent than other FAs. LOA is less 
incorporated into PLs, while LOA was found to a greater extent in nonpolar lipids than the 
other FAs. Our results show that between 82% (SA) and 76% (LOA) of the applied FAs were 
incorporated into PLs and much less into TAGs (7.9% for SA and 12% for LOA). These 
results are in agreement with previous work (Rosenthal, et al. 1981), which showed that when 
G10-fibroblasts were incubated with 2µM concentration of different FAs for 24h, about 89% 
(SA) and 66% (LOA) of the applied FAs were incorporated into PLs, and much less into 
TAGs (8.3% for SA and 26% for LOA). Furthermore, in G10-fibroblasts, more [
14
C]OA, 
[
14
C]LA, and [
14
C]LOA was incorporated into TAGs than radiolabeled SA (Rosenthal, et al. 
1981). These values are also in agreement with our cell culture experiments  
Previous studies in hamster fibroblasts with 0.2µCi/mL of 1-[
14
C]-labeled fatty acid 
(Maziere, et al. 1982) are in agreement with our results. The authors demonstrated an 
enhanced incorporation of saturated FA into SM and ceramide compared to unsaturated FAs. 
OA was more incorporated into polar lipids than the other FAs, and its incorporation into 
phosphatidylglycerol (PG) was higher than that observed for the other FAs. Previous work in 
normal fibroblasts (Daniel, et al. 1980) revealed a lower incorporation of polyunsaturated 
FAs in ethanolamine glycerophospholipids in normal cells. This is in agreement with our 
results, which show that the unsaturated FAs were less incorporated into PE compared with 
saturated fatty acid. When human skin fibroblasts were incubated in serum-free medium with 
up to 100nmol/mL OA bound to albumin in a 4.6:1 ratio, the rate of [
14
C]OA incorporation 
into TAG was approximately 5-fold higher than that of radiolabeled eicosapentaenoic acid 
(EPA). The mass of TAG formed after incubation of fibroblasts with EPA was also 
significantly lower than that formed with OA (Miller, et al. 1993). Among the C18-FAs, 
human skin fibroblasts incorporate more OA than LA into membrane lipids. The percentage 
of exogenous FA incorporated is dependent on cell density, length of incubation, and 
concentration of serum protein in the culture medium, but not on the concentration of OA 
(Rosenthal, 1980). Uptake of LA and OA bound in varying molar ratios to albumin (ranging 
between 0.25:1 and 2:1, and in 173µM concentration in the medium) by dermal fibroblasts 
was linear over an incubation period of 5min, with similar low uptake rates for both OA and 
LA over the initial phase (Schurer, et al. 1994). Thus, fibroblasts demonstrate no initial rapid 
influx of FA, and FA-uptake in fibroblasts was more consistent with uptake entirely by 
92 
 
passive diffusion. It was suggested that the ability to synthesize TAG plays a critical role in 
protection from lipotoxicity (Listenberger, et al, 2003).  
In fibroblasts, the incorporation of 10µM FA into polar and nonpolar lipids has shown to be 
higher than macrophages and HepG2 cells as shown in table 4.2. Previous studies 
demonstrated that overexpression of the FA binding proteins FATP1 and FABPpm in 3T3 
fibroblasts (Isola, et al. 1995) not only stimulated FA uptake, but also increased intracellular 
esterification of exogenously supplied FAs (Murphy, et al. 1996). Furthermore, expression of 
FAT/CD36 in fibroblasts (Ibrahimi, et al. 1996) and muscle cells (Bastie, et al. 2004) 
increased FA uptake rates. On the other hand, caveolin-1 expression is necessary for post-
translational stabilization and membrane expression of CD36. Caveolin-1 ablation in 
fibroblasts reduced the plasma membrane content of CD36 in parallel with a reduction of 
cellular FA uptake (Ring, et al. 2006). Furthermore, dysfunctional NPC1 (the protein 
involved in the subcellular trafficking of cholesterol out of late endosomes and lysosomes) 
does not lead to aberrant fatty acid efflux from late endosomes and lysosomes in human 
fibroblasts (Passeggio, et al. 2005). In contrast, NPC1 mutation shows a decreased 
incorporation of LDL-derived fatty acid into phospholipids in macrophages (Leventhal, et al. 
2004). 
 
5.1.6. The effect of the cationic amphiphilic drug, desipramine, on FA 
uptake and processing 
 
Desipramine as a prototypical CAD is able to induce phospholipidosis in humans (Hurwitz, et 
al. 1994; Kölzer, et al. 2004; Nioi, et al. 2008; Reasor, et al. 2006). Influences of desipramine 
on FA uptake and metabolic incorporation into cellular lipids have not been reported before. 
Since desipramine targets lipid processing in the endolysosomal system, an effect of 
desipramine on uptake and processing of FAs was not expected. Therefore, it was a surprise 
that profound changes are produced in FA metabolism by desipramine, when administered in 
different concentrations to various cell types.  
Other CADs have been reported (Fig. 5.2), such as tianeptin (Frumenty, et al. 1989) and 
amineptin (Le Dinh, et al. 1988), to inhibit mitochondrial β-oxidation of short and medium-
chain FAs. 
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Figure 5.2: Chemical structure 
of A. tianeptin, B. amineptin. 
 
 
 
CADs enter the cells and then lysosomes depending on the logP and pKa-values within 
minutes to many hours (Kornhuber, et al. 2010). Desipramine has a fast lysosomal uptake 
kinetics (equilibrium within 30min), and a moderate lysosomal accumulation (accumulation 
ratio lysosome:extracellular ˂ 100:1) (Kornhuber, et al. 2010). An effect of CADs on steps 
downstream of lysosomal depends on the applied CAD, on the identity of the FA, and on the 
cell type, as indicated by our experiments. In macrophages and A431 cells, treatment with 
desipramine leads to a drastically reduced incorporation of all FAs investigated into TAG and 
DAG, without reduction of FA uptake. In HepG2 cells, the effect of desipramine on saturated 
FA processing was less pronounced on the incorporation into TAG. 20µM desipramine 
decreases the incorporation of SA, OA, LA, and LOA into TAG by 10%, 14%, 35%, and 
44%, but incorporation into polar lipids was significantly increased for unsaturated FAs 16%, 
30%, 46%, and 54% when treated with 20µM desipramine, respectively (data not shown). In 
macrophages, pre-incubation with 20µM desipramine in the culture medium reduced the 
incorporation of radiolabeled SA, OA, LA, and LOA into TAG by 77%, 73%, 66%, and 45%, 
respectively. Also the level of intracellular free FA, and FA incorporation into DAG was 
reduced by 17%, 19%, 42%, and 44%, respectively, but to a lesser extent than into TAG (Fig. 
4.9). In macrophages, when the concentration of desipramine increased, the incorporation of 
1-[
14
C]FA into neutral and acidic polar lipid increased in the presence of SA and OA, but is 
less affected with LA and LOA (data not shown). A possible explanation for the observed 
metabolic alterations is a reduced availability of DAG due to a desipramine-induced increase 
in endogenous sphingomyelin concentrations not only in the endolysosomal compartment, 
but also in the Golgi-apparatus (Fig. 5.4). This can drive the formation of PC from DAG, and 
deplete the DAG-pool available for TAG synthesis (Deevska, et al. 2009).  
Another possible explanation is that phosphatidic acid phosphatase can be inhibited by 
desipramine in rat brain (Koul, et al. 1987) and by desipramine and other CADs in 
macrophages (Perry, et al. 1992). The resulting decreased availability of the DAG precursors 
might be the reason for the decreased incorporation of FAs into DAG, as shown in figure 5.3. 
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Figure 5.3: Desipramine-inhibits the activity of phosphatidic acid phosphohydrolase.  This explains 
the decreased incorporation of FA into DAG, TAG, PC, and PE. 
 
 
 
Figure 5.4: Model for the desipramine-induced reduction of incorporation of exogenous FAs into the 
neutral lipids DAG and TAG, and their increased incorporation into PC.  
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In A431 cells, 20μM desipramine reduced the incorporation of radiolabeled SA, OA, LA, and 
LOA into TAG by 97%, 83%, 94%, and 93%, respectively, while the levels of FAs 
incorporated into DAG were reduced by 74%, 29%, 49%, and 63 %, respectively (Fig. 4.8). 
Unexpectedly, desipramine had a different effect on the uptakes of FAs in cultured 
fibroblasts. This was significantly increased in contrast to the other cell types (data not 
shown). The incorporation of the FAs into all analyzed lipids increased with increasing 
concentrations of desipramine. Treatment with 20μM desipramine increased the 
incorporation of SA, OA, LA, and LOA into TAG by 83%, 80%, 87%, and 88%, 
respectively, while the incorporation into DAG was increased by 65%, 77%, 73%, and 67%, 
respectively (Fig. 4.10). This is completely different from the uptake and processing by the 
other investigated cell types. The molecular reason for this phenomenon is unknown. 
[
3
H]-desipramine was used to measure desipramine uptake in the various cell types and to 
investigate if differential desipramine uptake accounts for the observed cell-type specific 
effects. Uptake of [
3
H]desipramine by fibroblasts is much lower than by macrophages, A431 
cells, and HepG2 cells (Fig. 4.13), so that this can only account for quantitative differences in 
its impact on FA processing. Antidepressants such as desipramine exhibit anticancer 
properties, although the mechanism for this is not clear (Ma, et al. 2011). Since some tumors 
cells depend on fatty acid uptake (Zhan, et al. 2008; Hess, et al. 2010), our new data on 
disturbance of fatty acid uptake in the presence of desipramine offer another possible mode of 
action of such antidepressants. 
 
5.2. Analysis of two lipid delivery methods towards lipid uptake and 
processing 
 
This work is the first comparative study of the uptake and metabolism of lipid probes 
delivered either as part of LDL-particles or in complex with BSA in four representative types 
of cultured cells. Despite the considerable attention devoted to studying the metabolism of 
LDL-lipids and apoB100, less is known about the uptake and metabolism of lipids associated 
with albumin. The ability of cargoes to bind to receptors at the cell surface is a fundamental 
cellular mechanism of specific transport into cells. LDL (from human) and delipidated BSA 
(from cattle) were loaded with [
14
C]cholesteryloleate, [4-
14
C]cholesterol, and 
[
14
C]trioleoylglycerol. Incubation time of 6h or less led only to minor uptake and small 
values that were not high enough to allow reasonable experiments. 24h incubation time was 
suitable to demonstrate the significant differences in uptake and processing between the cell 
types. Therefore, this value was chosen for the experiments. 
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5.2.1. Cholesterol 
 
Cholesterol is a major constituent of mammalian cell membranes. Hypercholesterolemia 
coupled with low HDL is a major risk factor for cardiovascular disease, CVD (Deng, et al. 
2012). Accumulation of LDL-cholesterol in the blood is directly involved in the development 
of atherosclerosis. Most endocytic pathways like clathrin-dependent and clathrin-independent 
pathways are inhibited by the loss of cholesterol (Rodal, et al. 1999). Cholesterol itself shows 
only low solubility in blood and is transported in the circulatory system bound to 
lipoproteins. Therefore, in our study, we used low density lipoprotein as a carrier for 
cholesterol to address the receptor-mediated endocytic pathway, and compared it to albumin 
as an extracellular cholesterol carrier. Different types of cultured cells had an influence on the 
incorporation of the cholesterol into CE. This study asked to which extent the vehicle that 
delivers cholesterol to cells has an influence on its conversion to cholesteryl ester of lipid 
droplets. 
It is known that LDL particles are internalized by cells via receptor-mediated endocytosis and 
are then sorted to endosomes and lysosomes. In our experiments, the uptake of [4-
14
C]cholesterol delivered as LDL-complex is 3-fold higher in macrophages, 2.5-fold higher in 
fibroblasts, Hep-G2 cells, and A431 cells, when compared to [4-
14
C]cholesterol delivered as 
BSA-complex. To explain these results, previous studies have reported that the LDL-receptor 
and the scavenger-receptor SR-BI have a specific role for the uptake of lipoprotein-associated 
cholesterol by various cell types (Urban, et al. 2000; Temel, et al. 1997; Goldstein, et al. 
1987). In normal fibroblasts, the LDL receptor remained bound to LDL on the surface of cell 
membrane for less than 10min, within this time most of the surface bound LDL particles 
entered the cells, and the protein component of LDL was completely digested within another 
60min (Goldstein, et al. 2009). SR-BI is participates in intracellular cholesterol trafficking 
(Silver, et al. 2001) and is also believed to facilitate the excretion of excess cholesterol into 
bile (Kozarsky, et al. 1997). Furthermore, the LDL particle is degraded in the endolysosomal 
compartment and free cholesterol is released by hydrolysis of cholesteryl esters in the core of 
LDL (Goldstein, et al. 2009). Cholesterol is sorted out of endosomes with the aid of the 
proteins NPC1 and NPC2 (Abdul-Hammed, et al. 2010), and then loaded on a cytoplasmic 
oxysterol-binding protein–related protein Orp-protein (Du, et al. 2011). 
The incorporation of the 1µM [4-
14
C]cholesterol delivered as LDL-complex into CE of 
macrophages is higher compared to other cell types. The incorporation of [4-
14
C]cholesterol 
delivered as LDL-complex into CE of fibroblasts, macrophages, A431 cells, and HepG2 cells 
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were increased by 0.2%, 15%, 2%, and 4%, respectively (Fig. 4.18A). These results are in 
agreement with previous work (Wong, et al. 1987), which demonstrated that cholesterol is 
significantly esterified with endogenous FAs for the formation of cholesteryl ester droplet by 
macrophages. Furthermore, a previous study showed that in HeLa cells, BODIPY-labeled 
cholesterol analog (BODIPY-chol) moved from the plasma membrane (PM) to lipid droplets 
(LDs) with a half-time value of approximately 30min (Jansen, et al. 2011). 
 
5.2.2. Cholesteryloleate 
 
As shown in our results (Fig. 4.14), the uptake of [
14
C]CE-LDL is 4-fold higher in fibroblasts 
and A431 cells, 3-fold higher in macrophages, and 2-fold higher in Hep-G2 cells during an 
24h incubation at 37 °C, compared to [
14
C]CE-BSA. Previous studies demonstrated that 
LDL-receptor and SR-BI are important for the delivery of LDL-CE to cultured cells (Minahk, 
et al. 2008). Minahk and co-workers demonstrated that LDL is internalized by cells via 
receptor-mediated endocytosis, in which CE-LDL complexes are taken up mainly by LDL 
receptor to 60-70% by primary hepatocytes. On the other hand, the uptake of the remaining 
30-40% of CE-LDL complexes is mediated by the scavenger receptor class B, type I, which 
is considered an important receptor not only for LDL (Swarnakar, et al. 1999) but also for 
HDL (Rhainds, et al. 2003). Furthermore, various ligands, including native lipoproteins 
(LDL, VLDL, HDL, and chylomicrons) and modified lipoproteins (acetylated LDL, oxidized 
LDL, and oxidized HDL) are bound by specific amino acid residues of plasma membrane 
SRBI, which facilitates CE transport down its concentration gradient into the plasma 
membrane via a hydrophobic channel (Connelly, et al. 1999). SR-BI appears to have different 
binding sites for apolipoproteins and phospholipids (Urban, et al. 2000).  
It has been observed that clathrin-dependent endocytosis is sensitive to low temperature 
(Wileman, et al. 1985; Baluška, et al. 2002). In our experiments, the effect of temperature on 
the lipid uptake was tested by adding lipid probe to cultured cells previously incubated at 4 
0
C for 30min and kept for a further 2h. The uptake of  [
14
C]CE,  [
14
C]Chol, and [
14
C]TAG 
were significantly decreased by 83%, 78%, and 80%, when cells were incubated with the 
[
14
C]CE-LDL,  [
14
C]Chol-LDL, and [
14
C]TAG-LDL at 4 °C compared to control at 37 °C, 
respectively, (data not shown). These data demonstrate that the classical endocytic process 
mainly affected the uptake of [
14
C]CE, [
14
C]Chol, and [
14
C]TAG and its transfer to early 
compartments, which is effectively inhibited by low temperature. These results support the 
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previous work (Minahk, et al. 2008) which demonstrated that LDL-receptor and SR-BI are 
important for the delivery of LDL-CE to cultured cells. 
The metabolic processing of labeled oleic acid released from CE by lysosomal acid lipase in 
four types of cultured cells was followed. Liberated labeled oleate was incorporated 
significantly into glycerolipids, especially into phosphatidylcholine (Fig. 4.21B), and to a 
lesser extent into TAG. Similar results were previously reported in human fibroblasts 
(Groener, et al. 1996) and macrophages (Li, et al. 1995).  
On the other hand, the incorporation of cholesteryl ester-derived [
14
C]oleate delivered as 
BSA-complex into nonpolar and polar lipids is significantly lower in all cell types compared 
to cholesteryl ester-derived [
14
C]oleate delivered as LDL-complex. Stromhaug et al. 
demonstrated that albumin is taken up by non-receptor fluid phase endocytosis (Stromhaug, 
et al. 1997) compared to the lipoprotein, which is taken up by receptor mediated endocytosis 
(Minahk, et al. 2008).  
 
5.2.3. Triacylglycerol 
 
A comparison of [1-
14
C]trioleoylglycerol associated with LDL with that associated with BSA 
containing equimolar amounts by cultured cells has been investigated (Fig. 4.20). The 
experiments show that the incorporation of OA derived by the hydrolysis of TAG into other 
neutral and polar lipids was higher in macrophages compared to other cells. A possible 
explanation is that [1-
14
C]trioleoylglycerol is hydrolysed by different enzyme capacities 
involved in different cell types. Previous studies have reported that J774 macrophages have 
very active triacylglycerol lipases that appear to be distinct from that of other cell types 
(Khoo, et al. 1984). 
Our major findings are as follows: (i) lipid complexes with LDL show higher uptake 
compared to lipid complexes with albumin; (ii) LDL-lipids are metabolized differently than 
that delivered by BSA.  
It is known that mammalian cells can take up macromolecules of a considerable size range. It 
has been suggested that within limits, an increase in molecular size may determine an 
increase in cellular uptake (Ryser, 1967). Since albumin and low density lipoprotein have not 
too different isoelectric points (4.7 and 5.4, respectively), but different molecular weight 
(66.5kDa and 3000kDa, respectively) (Chaiyasut, et al. 2001; Jachimska, et al. 2008), it is 
likely that the molecular size is a contributing factor in this case. Key factor, however, 
appears to be that a receptor-mediated pathway exists for LDL (Goldstein, 2009). 
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In contrast to FAs bound to BSA, many data suggest that there BSA-lipid complexes are 
taken up by the cell through a process independent of receptor-mediated endocytosis (Synnes, 
et al. 1999; Kobuna, et al. 2010; Berger, et al. 1994). Therefore, it is understandable that 
uptake and metabolism of the examined lipid probes depend on the mode of the delivery 
(LDL, BSA). These findings indicate that LDL-associated (CE, TAG, and Chol) are taken up 
into cells via a pathway that differs from that of BSA-associated (CE, TAG, and Chol). 
Essentially, lipid-BSA complexes were taken up at a lower rate compared to lipid-LDL 
complexes. With the exception of FA-BSA complexes, BSA-lipid complexes are largely 
taken up by fluid-phase endocytosis (Stromhaug, et.al 1997). Furthermore, we suspect that 
both the oleate derived from cholesteryl oleate and trioleoylglycerol delivered as LDL, are 
processed by the cell in a similar fashion. Only slightly different pattern were observed (Fig. 
4.21) for metabolic products of cholesteryl oleate and trioleoylglycerol. We observed that 
there was a difference in the distribution of oleate among phospholipids even though oleate in 
cholesteryl oleate and trioleoylglycerol was delivered by the same carriers.  A previous study 
(Teruya, et al. 1995) demonstrated different rates of lysosomal hydrolysis of oleate from 
cholesteryl oleate and from trioleoylglycerol in the lysosomes. Also in our experiments, free 
oleate delivered as albumin complexes (Fig. 4.3) shows pattern different from oleate derived 
from cholesteryl oleate and trioleoylglycerol delivered as LDL. Oleate delivered as 
trioleoylglycerol and cholesteryl oleate must first be hydrolyzed from the lipid probes, and 
can then be converted to fatty acyl-CoA for esterification. On the other hand, free oleate 
enters the cytoplasm of the cell without any metabolic step and is converted to fatty acyl-CoA 
for esterification into cellular complex lipids. The extra metabolic step in the lysosomes may 
account for differences in the rate of cellular metabolism of oleate. Moreover, the uptake of 
fatty acids from lipoproteins is receptor mediated, as opposed to the uptake of free oleate 
bound to albumin, which is predominantly non-receptor mediated uptake (Rosenthal, 1987). 
Furthermore, in both lipid probe delivered as LDL and free oleate delivered as BSA, the 
incorporation of oleate was predominantly into PC with all cell types. These results are also 
in agreement with previous results in human umbilical vein endothelial cells (Teruya, et al. 
1995). 
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5.3. Analysis of lipid processing in Niemann-Pick A cells compared to 
normal fibroblasts. 
 
Lysosomal storage diseases are a family of at least 40 inherited metabolic disorders that 
collectively have an incidence of 1 per 7700 live births (Meikle, et al. 1999). In most 
lysosomal storage diseases, multiple substrates accumulate. Some result from a distinct 
blockage in a metabolic pathway, whereas others appear to be secondary. Cholesterol 
accumulation represents a secondary metabolic defect that is observed in human patients with 
NPA disease, since sphingomyelin has a strong affinity for cholesterol (Leventhal, et al. 
2001; Lönnfors, et al. 2011). Once sphingomyelin is degraded by lysosomal ASM, 
cholesterol can efflux from the lysosomal compartment (Leventhal, et al. 2001, Abdul-
Hammed, et al. 2010). 
Our results indicate that the processing of cholesterol and phosphatidylcholine through NPA 
is slightly reduced compared to normal cells. Nutrient uptake via endosomes and lysosomes 
is an important function of these organells. In mouse models of both GM1 and GM2 
gangliosidoses, an impaired iron uptake via the endolysosomal system leads to progressive 
depletion of iron in brain tissue. Administration of iron prolonged survival in the diseased 
mice by up to 38% (Jeyakumar, et al. 2009). Our results indicate that also lipid uptake and 
processing is impaired in NPA, which might contribute to pathogenesis. 
 
5.4. Effect of cationic amphiphilic drugs on uptake and processing of 
choline-containing phospholipids by cultured cells 
 
5.4.1. Effect of CADs on SM uptake and processing 
 
Several side-effects of clinically used CADs can be attributed to a drug-induced impairment 
of lysosomal function. It is known that the antidepressant desipramine leads to premature 
degradation of acid sphingomyelinase in the endolysosomal compartment and subsequently 
to SM accumulation (Kölzer, et al. 2004). Desipramine interferes with the binding of acid 
sphingomyelinase (ASMase) to intraendosomal membranes and lipid aggregates and thereby 
displaces the enzyme from the membranes where it is protected from degradation (Kölzer, et 
al. 2004). ASMase contributes to lysosomal SM turnover and is also secreted upon cellular 
treatment with inflammatory stimuli (Smith, et al. 2008; Gulbins, et al. 2003). Desipramine 
remains a useful medication for the treatment of several conditions, although many other 
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antidepressants have been developed since 1964. Displacement of ASMase from 
intraendosomal and intralysosomal membranes can be expected also for the antidepressant 
imipramine that shows a structure similar to desipramine, and has also been reported to lead 
to an apparent reduction of ASMase activity (Albouz, et al. 1981; Jensen, et al. 1999). The 
neuroleptic drug chlorpromazine interferes with clathrin-mediated endocytosis by inhibiting 
the relocation of clathrin (Wang, et al. 1993), so that it had to be expected that the amount of 
incorporated SM delivered as LDL-complex was reduced in the presence of this drug. 
Chlorpromazine is a cell-permeable CAD that inserts into lipid bilayers and binds to anionic 
lipids including polyphosphoinositides, and in this way influences a variety of cellular 
processes that depends on phosphoinositides (De Filippi, et al. 2007). Chloroquine has been 
reported to block LDLR recycling to the plasma membrane (Minahk, et al. 2008), and to an 
apparent inhibition of acid ceramidase (Elojeimy, et al. 2006). Chloroquine has been 
demonstrated to elevate the intracellular pH, thus altering lysosomal function and perturbing 
endosomal/recycling pathways (Anderson, et al. 2006). Moreover, chloroquine can affect the 
activity of lysosomal phospholipases (Matsuzawa, et al. 1980) that have an optimal pH in the 
acidic range. FTY720, a functional antagonist of one of the receptors of sphingosine-1-
phosphate and currently used for the treatment of multiple sclerosis leads to an apparent 
inhibition of acid sphingomelinase by a mechanism similar to that exerted by tricyclic 
antidepressants (Dawson, et al. 2011). FTY720 and chlorpromazine also have been reported 
to inhibit ceramide synthases (Berdyshev, et al. 2009). It is noteworthy that we have only 
measured the affect of cationic amphiphilic drugs in hours, and the treatment of human 
patients with cationic amphiphilic drugs can be over many years. For example, most patients 
take desipramine for 6 months to a year. 
For all cell types, we observed a dose-dependent (10, 20 and 40µM) and time-dependent 
reduction of the incorporation of SM-derived stearic acid and PC-derived palmitic acid into 
nonpolar lipids and polar lipids.  
The impact on phospholipid processing of the investigated CADs was assessed at 20µM and 
40µM concentration, because some changes in phospholipid turnover were clearly visible 
only at these concentrations. The effect of the drugs on PC and SM processing were 
dependent on its concentration: at 10μM, the drugs did not significantly alter lipid 
metabolism. High concentrations of more than 20µM chlorpromazine and FTY720 were 
found to be toxic. Concentrations of the CADs can reach millimolar levels in the lysosomal 
lamellar bodies isolated from the liver of rats treated with the drugs (Hostetler, et al. 1985). 
Prolonged incubation of the cells with PC-containing LDL or SM-containing LDL was 
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necessary to detect changes in the incorporation of PC-derived palmitic acid or SM-derived 
stearic acid into cellular lipids. Experiments with incubation time of 6h or less showed only 
effects too small to be observable, while 24h incubation time was suitable to demonstrate the 
impact of CADs on PC or SM uptake and metabolism.   
In our experiments, all investigated drugs lead to an impaired SM processing in macrophages, 
but to a different extent. The incorporation of SM-derived 1-[
14
C]stearic acid into neutral 
lipids (triacylglycerol and diacylglycerol) and into different glycerophospholipid classes was 
drastically reduced in the presence of the drugs.  
Decreased degradation of exogenously added SM in the presence of FTY720, and also 
enhanced levels of SM-derived ceramide are in agreement with a premature degradation of 
acid ceramidase. Since increase of intracellular ceramide concentrations has been claimed to 
be a general measure to treat cancer (Radin, et al. 2004), the investigated CADs might be 
combined with radiation or chemotherapy to enhance ceramide levels and produce a more 
potent therapeutic effect. 
A previous study demonstrated that FTY720 reduces cholesterol toxicity in primary human 
macrophages, e.g. by facilitating its release to extracellular physiological acceptors (Blom, et 
al. 2010). Our results show that the incorporation of SM-derived 1-[
14
C]stearic acid or PC-
derived [
14
C]palmitic acid into cholesterylstearate or cholesteryloleate were drastically 
reduced in the presence of the 20µM FTY720. Our experiment shows that CE decrease 48% 
and 67% in the presence of 20µM FTY720, respectively, compared to control. 
The different drugs used by us caused phospholipidosis in terms of labeled SM accumulation 
to a different extent. For example, macrophages showed a 54% and 21% increase in labeling 
of SM in the presence of 20µM chlorpromazine and FTY720, respectively, in the culture 
medium, and a 25% and 52% increase in the presence of 20µM imipramine and desipramine, 
respectively. When treated with 40μM of imipramine or desipramine, levels of labeled SM 
increased by 34% and 68%, respectively. These results indicate that our method is able to 
detect metabolic steps that are affected in the presence of CADs and to predict the potential 
of CADs to induce phospholipidosis.  
The cells also showed increased levels of radiolabeled ceramide, when treated with 20µM 
desipramine, imipramine, and FTY720. This was not observed when the cells were treated 
with chlorpromazine and chloroquine. Increased levels of ceramide can result from reduced 
degradation of ceramide by acid ceramidase. FTY720 also causes a drastically reduced 
incorporation of SM-derived stearic acid into triacylglycerol. This was observed in all 
examined cell types supplemented with an SM-LDL complex at 1µM.  
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Macrophages treated with 20µM desipramine showed the similar effect on the incorporation 
into TAG, when [
14
C]stearic acid or  SM-derived 1-[
14
C]stearic acid are used as a tracers. 
Previous experiments by us, in which macrophages were incubated with 1-[
14
C]stearic acid, 
showed a substantial labeling of TAG (Fig. 4.3B). This labeling was reduced significantly by 
62% and 54% in the presence of 20µM desipramine when cell treated with1-[
14
C]stearic acid 
(Fig. 4.9) and SM-derived 1-[
14
C]stearic acid (Fig. 4.26A), respectively. These data suggest 
that desipramine may affect the activity of phosphatidic acid-phosphatase (Koul, et al. 1987; 
Perry, et al. 1992) by decrease the incorporation of SM-derived 1-[
14
C]stearic acid into TAG, 
as shown in figure 5.3. 
Furthermore, in macrophages, CADs reduce the incorporation of radiolabeled stearate into 
TAG by 47%, and 20% with 40µM desipramine and imipramine, respectively, while further 
increasing that in SM by 68%, and 34%, respectively. A previous study reported that 
desipramine affects the de novo synthesis of sphingolipids by reducing the incorporation of 
radiolabeled fatty acid into TAG by 40% while further increasing that in ceramide and 
sphingomyelin (Deevska, et al. 2009) when HepG2 cells are supplemented with palmitic acid 
at different concentrations ranged between 0.1 - 1.0mM . 
 
5.4.2. Effect of CADs on PC uptake and processing 
 
PC is the most abundant phospholipid in numerous cell types and is generally thought to be 
essential for membrane structure and cellular function. Since there is only limited information 
on the fate of LDL-derived PC in cultured cells and the effect of CADs on their uptake and 
processing, we studied uptake and processing on LDL-derived PC in different cultured cells 
in the presence of CADs. Incorporation of PC-derived [
14
C]palmitic acid into polar and 
nonpolar lipids of different cell types were studied in the presence of chlorpromazine (CPZ), 
chloroquine (CQ), desipramine (DMI), imipramine (IM), and fingolimod (FTY720).  
Recent evidence had indicated that the consumption of diet rich in saturated fats, palmitate 
(but not other free fatty acids), can stimulate not only the rate of TAG accumulation but also 
stimulation of the de novo synthesis of ceramide, SM and generate excessive amounts of 
sphingolipid metabolites in a variety of cells (Deevska, et al. 2011). The flux through the 
sphingolipid synthetic pathway depends upon the availability of palmitate (Merrill, et al. 
1988). Serine palmitoyl transferase (SPT) catalyzes the rate-limiting step in the synthesis of 
sphingolipids (Ikushiro, et al. 2011). Inhibition of SPT in animals by myriocin blocks the flux 
of palmitate through the de novo pathway (Holland, et al. 2008). 
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Previous studies demonstrated that dipalmitoyl PC is associated with phospholipidosis 
induced by amphiphilic drugs (Chatelain, et al. 1985; Miles, et al. 1986). Various amphiphilic 
drugs either bind to the hydrophobic moiety or hydrophilic head group of dipamitoyl PC with 
different potencies. The order of binding strength was chlorpromazine > imipramine > 
chloroquine (Joshi, et al. 1988). The drugs may interact with either or both of the hydrophilic 
and lipophilic sites of dipalmitoyl PC. Chlorpromazine and imipramine showed two binding 
affinities of these drugs to dipalmitoyl PC, whereas chloroquine displayed a single binding 
affinity site to dipalmitoyl PC (Joshi, et al. 1988). 
In cultured macrophages, the incorporation of PC-derived palmitic acid into TAG was 
increased in cells pre-treated with 10µM desipramine (Fig. 4.27A). Minahk and co-worker 
(Minahk, et al. 2008) demonstrated that in cultured primary hepatocytes, 50% of LDL-
[
3
H]oleate-PC is converted to triacylglycerol via phospholipase C and DGAT2 rather than via 
lysosomal degradation. A recent study also demonstrated that PC plays a significant role to 
supply DAG for TAG synthesis via a PLC- mediated pathway (Robichaud, et al. 2009) , since 
desipramine has been demonstrated to stimulate PLC activity (Bouron, et al. 1999). Chinese 
hamster ovary cells can metabolize lipoprotein-associated PC to generate DAG by PLC that 
can be directly incorporated into TAG without prior formation of phosphatidic acid as the 
precursor (Igal, et al. 2001).  
Our results show that after 24h incubation of cultured macrophages with 40μM DMI, the 
total phospholipid labeling of DMI-treated macrophages was increase compared to the 
untreated cells (Fig. 4.27B). More specifically, a marked accumulation of label in PC, 
phosphatidic acid (PA) and lysoPC (LPC) occurred in a concentration-dependent manner in 
the DMI-treated macrophages. We also observed a significantly decrease in the incorporation 
into TAG by 39%, and a 56% increase into PA with 40µM DMI compared to control. Several 
cationic amphiphilic drugs have been shown to inhibit soluble phosphatidate 
phosphohydrolase in C6 glioma cells (Leli, et al. 1987), rat liver, and rat brain (Koul, et al. 
1987). These data suggest that desipramine at 40µM may affect the activity of PA 
phosphohydrolase with increased formation of phosphatidyl-CMP, the intermediate for the 
synthesis of acidic phospholipids (F.g. 5.3). This may explain the marked increase in PA and 
decrease in DAG labeling, which are translated into decreased labeling of PE and TAG when 
treated with 40µM DMI (Fig. 4.27B). The cell viability in the presence of 40µM desipramine 
was reduced 28% compared to untreated cells (Fig. 4.38); the amount of cellular protein was 
reduced by 8%. Therefore, the reduced incorporation of FAs into TAG and DAG in the 
presence of 40µM desipramine in macrophages cannot be attributed only to toxicity. 
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In cells pre-treated with CPZ or DMI for 24h, levels of labeled PC were increased 3- and 2-
fold in the presence of 20µM CPZ or DMI, respectively. Furthermore, all drugs significantly 
reduced the amount of label in SM compared to the control cells and the experiments clearly 
show reduced processing of exogenously added PC with higher concentration of drugs. Some 
increase in FA was seen in macrophages treated with FTY720.  
In macrophages, the recovery of [
14
C]stearic acid derived from SM and [
14
C]palmitic acid 
derived from PC as free FAs was significantly higher in cells treated with 20µM FTY720 
than in cells treated with other CADs. One hypothetical explanation is that FTY720 might 
cause an elevated intralysosomal pH and lead to a lower degree of protonation of the fatty 
acid, which, in turn, will cause the fatty acid to diffuse more slowly across the lysosomal 
membrane since the pKa values of FTY720 is lower (7.8) than those of the other CADs, 
which have pKa values of 10.4, 9.4, 9.2, and 8.1 for desipramine, imipramine, 
chlorpromazine, and chloroquine, respectively. Other possible explanation assumed that this 
might be caused by the formation of complexes between positively charged FTY720 and the 
negatively charged fatty acid, which become trapped in the lysosomes. 
Despite the difference in chain length of only two methylene groups, the saturated FAs 
present in our PC- and SM- probes should not necessarily undergo the same metabolic 
reaction. The metabolic fate of a saturated fatty acid derived from PC was significantly 
different from that derived from SM. For example, levels of palmitic acid derived from PC 
incorporated into TAG are increased in the presence of 10µM, and 20µM desipramine, while 
the opposite was observed for SM in the presence of desipramine. Furthermore, the 
incorporation of PC-derived [
14
C]palmitic acid into TAG decreased slightly, but not 
significantly in fibroblasts and A431cells pre-treated with chlorpromazine compared to 
controls, while there were no significant differences in the incorporation of PC-derived 
[
14
C]palmitic acid into TAG in HepG2 cells pre-treated with different concentrations of 
chlorpromazine and untreated control cells (data not shown). 
In general, CADs are lysosomotropic agents that accumulate in lysosomes, can lead to pH 
elevation of the acidic compartment, and to the mis-localization of soluble lysosomal 
enzymes (Nanoyams, et al. 2008). Some CADs induce an inhibition of phospholipid 
catabolism in lysosomes and increase cellular phospholipids in human and other mammalian 
tissues. Effects of CADs on steps downstream of lysosomal release of the fatty acid from the 
lipid probe depend on the applied CAD, on the identity of the fatty acid and the cell type, as 
indicated by previous experiments. Independent studies in cultured primary hepatocytes 
demonstrated that PC present in LDL is taken up not only by LDL receptors (30%) and 
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scavenger receptors (class B, type I) (20-30%), but also by additional unknown mechanisms 
that are responsible for the remaining (40-50%) (Minahk, et al. 2008). Therefore, CADs 
might impact only processing of that fraction of LDL-derived PC, which enters the acidic 
compartments and not on that fraction for which the interaction between LDL and its receptor 
proteins are irrelevant (Truong, et al. 2000). Ishikawa et al. showed that in smooth muscle 
cells only a fraction of LDL-PC was degraded in lysosomes. They found 25% of LDL-
derived PC in the lysosome-rich fraction and 25% in the cytosol-rich fraction. They 
concluded that LDL-derived PC was sorted equally between lysosomal and extralysosomal 
compartements (Ishikawa, et al. 1989) and also suggested that phospholipase A on plasma 
membranes, which can hydrolyze LDL-PC before LDL binds to LDL receptor, might affect 
the apoB epitope and the cellular uptake of LDL via the receptor. In addition, the authors 
found that phospholipases A1 and A2 are optimally active at neutral or alkaline pH ranges as 
well and might react with LDL-PC (Ishikawa, et al. 1988). 
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6. Material and Methods  
 
6.1. Material  
 
6.1.1. Analytical equipment  
 
Autoclave  Systec V-150,  Wettenberg, Germany  
Blotter  Mini-TransBlot, BioRad, München, Germany  
Centrifuges  Eppendorf, Hamburg, Germany  
L 8-80, mit SW-28-Ti-Rotor, Beckmann, Palo 
Alto, USA  
Centrifuge tubes  12 mL: Costar, Cambridge, USA  
15 mL: Greiner, Nürtingen, Germany  
50 mL: Falcon/BectonDickinson, Bedford, 
USA  
Glass tools  Schott-Duran, Jenaglas, Mainz, Germany  
Incubator  Binder CO2, Tuttlingen, Germany  
Microscope  Helmut Hund GmbH, Typ h500, Germany  
pH-meter  pH 537, WTW, Weinheim, Germany  
Phosphoimager Fujix BAS 1000 Bio Imaging Analyzer, 
Raytest, Straubenhardt, Germany  
Phosphoimaging plates  
14
C-screen BAS MS 2040, 
3
H-Screen BAS Tr 
2040, Raytest, Straubenhardt, Germany  
Scintillation counter  Tri-Carb 2900TR, Packard Instruments Co., 
Inc, Downers Grove, USA  
Shaker water bath  Gesellschaft für Labortechnik, Burgwedel, 
Germany  
Sterile benches  LaminAirHA 2472 GS, Heraeus, Düsseldorf, 
Germany  
TLC-tank  Desaga, Heidelberg, Germany  
TLC-heater  TLC-Plate Heater III, Camag, Berlin, Germany  
Ultrasound bath  
Heating-stirring module 
Sonorex RK 100, Bandelin, Berlin, Germany  
Pierce, Therm III, Rockford 
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FLUO-STAR plate reader 
Cell culture hood 
BMG, Germany 
Lamin Air, HB 2448, Heraeus, Hanau 
Ultrasound  Cap horn, Sonifer B-12, Branson Ultrasonic 
Corp., Danbury, USA  
Vortex MS Minishaker, IKA-Werk, Staufen, Germany  
Water purification  
 
 
Balance 
Micropipette 
Pipette controllers 
Oven 
Washer disinfectors for laboratory glassware 
Multiskan photometer 
Water bath 
Refrigerator (4 
0
C, -20 
0
C) 
 
Millipore-Pelicon filtration device with 
polysulfone filter cassette, Millipore, 
Molsheim, France 
Sartorius AG, Göttingen,  Germany 
Eppendorf 
Brand, accu-jet, Wertheim, Germany 
Memmert, Germany 
Miele G7783, Gütersloh, Germany 
Thermo scientific, Ascent, Vantaa, Finland 
GFI, Burgwedel, Germany 
Liebherr, Switzerland 
6.1.2. Consumables and chemicals  
 
Centrifuge Falcon tube (15 mL, 50 mL) 
Safe-lock tube (0.5mL, 1.5mL, 2mL) 
Glass fiber wadding, silanized 
Micropipette tips (20µL, 200µL, 1000µL) 
Cell culture petri-dish 
Cell culture flask 
Vivaspin, 3.000 MWCO 
96-microplates 
Stripette, serological pipettes 
Greiner Bio-one, Solingen 
Eppendorf, Germany 
Macherey-Nagel, Düren, Germany 
Brand, Wertheim, Germany 
BD Falcon, USA 
BD Falcon, USA 
Sartorius, Germany 
Greiner Bio-one, Solingen 
Sigma-aldrich, Germany 
Pasteur pipette 
Bovine serum albumin 
Low density lipoprotein 
Lipoprotein deficient serum 
VWR, Germany 
Sigma, Taufenkirchen, Germany  
Invitrogen  
Sigma, Germany  
DEAE sephadex A-25  
Sepharose CL-2B 
GE Healthcare, Uppsala, Sweden  
GE Healthcare, Uppsala, Sweden  
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Copper (II) sulfate solution 
Bicinchoninic acid solution 
Sigma-Aldrich, Germany 
Sigma-Aldrich, Germany 
LiChroprep® RP18 (40-63 μM)  Merck, Darmstadt, Germany  
Lipid standards  Sigma, Taufkirchen, Germany  
Screw cap glass  Pyrex, BibbySterlin Ltd, Stone, Great 
Britain  
Sterile filters    Sartorius, Göttingen, Germany  
Scintillation polyethylene vials (6mL, 20mL) Perkin Elmer, USA 
TLC plates (glass coated with silica gel 60)  
Tris-(hydroxymethyl)-aminomethan 
Hydrochloride (Tris-HCl) 
Acetic acid 99.8% 
Chloroform 
Ethanol 100% 
Methanol 
Diethyl ether 
n-Hexane 
Merck, Darmstadt, Germany  
 
Applichem, Darmstadt, Germany 
BDH Prolabo, Darmstadt, Germany 
Fisher chemical 
Merck 
J.T.Baker 
BDH Prolabo, Darmstadt, Germany 
Merck 
 
6.1.3. Radiolabeled markers 
 
[4-14C]Cholesterol Perkin Elmer, Boston, USA 
Cholesteryl [14C]-oleate Perkin Elmer, Boston, USA 
[14C]Trioleoylglycerol Perkin Elmer, Boston, USA 
[1-14C]-Stearic acid GE Health Care, Amersham, UK  
[1-14C]-Oleic acid GE Health Care, Amersham, UK  
[1-14C]-Linoleic acid American Radio Labeled, USA 
[1-14C]-Linolenic acid Perkin Elmer, Boston, USA 
Phosphatidyl ethanol amine, 
[1-14C-dioleoyl] 
 
American Radio Labeled, USA 
Phosphatidyl choline, [L-α-1-14C- 
dipalmitoyl] 
 
Perkin Elmer, Boston, USA 
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Phosphatidyl choline, [1-14C-dioleoyl] Perkin Elmer, Boston, USA 
Sphingomyelin [Stearoyl-1-
14
C] American Radio Labeled, USA 
Desmethyl imipramine hydrochloride, 
[benzene ring, 10, 11-
3
H] 
 
Perkin Elmer, Boston, USA 
  
6.2. Biological materials  
 
6.2.1. Cells and additives  
 
Human skin fibroblasts  Kinderklinik St. Augustin, Germany  
Mouse leukaemic monocyte macrophages, 
(Raw264.7) 
 
DSMZ, Braunschweig, Germany 
A431 cells DSMZ,Braunschweig, Germany 
Hep-G2 cells DSMZ, Braunschweig, Germany 
Niemann Pick A cells  
DMEM, RPMI  
Universitätsklinik, Münster, Germany 
Gibco, Eggenstein, Germany  
Foetal calf serum (FCS)  Cytogen, Berlin, Germany  
Leupeptinhemi sulfate Sigma, Taufkirchen, Germany  
Streptomycin  Sigma, Deisenhofen, Germany  
Trypsin  Cytogen, Berlin, Germany  
N-Acetyl-L-Alanine-L-Glutamine  Seromed, Biochrom, Berlin, Germany  
 
6.2.2. Kits  
 
CellTiter Blue (CTB) assay Promega, Germany  
 
6.3. Methods 
 
6.3.1. Cell culture  
 
Fibroblasts, macrophages, and Hep-G2 cells were grown in DMEM, A431 cells were grown 
in RPMI-1640, supplemented with 2mM glutamine, 10% (v/v) heat-inactivated fetal bovine 
serum, and 100mg/L streptomycin. Cells were collected from liquid nitrogen storage 
(appropriate protective equipment). The frozen screw-cap vials were thawed immediately in a 
water bath at 37 
0
C and the vials were wiped with 70% ethanol before transferring to the cell 
culture hood to reduce bacterial contamination. The cell suspensions in the vial were 
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transferred to a 15mL Falcon tube with 2mL FCS. The cells were centrifuged at 300g for 
5min at room temperature. After the supernatant was discarded, 1mL 10% DMEM was added 
and mixed with the cells by pipetting. The cell mixture was transferred to 25cm
2
 flasks 
containing 1mL FCS and mixed. Growth medium (5 mL 10% DMEM) was added drop-wise 
and the flasks were incubated at 37 
0
C in a humidified atmosphere of 95% air and 5% CO2. 
After reaching a confluent state, the cells were sub-cultured 1:2 in 75cm
2 
culture flasks. For 
passaging of cells, the medium was removed and the cells were washed with PBS to remove 
the residual medium. To detach them from the flasks surface, the cells were incubated for 1-
2min with 2mL trypsin/EDTA at 37 °C, upon gently shaking. 3mL DMEM containing 10% 
FBS was added to stop the digestion and pipetted to detach all cells from the flask wall. The 
cell suspension was transferred to a new Falcon tube and the cells were centrifuged at 300g 
for 5min, the supernatant was discarded, and the cells were re-suspended in growth medium. 
For our experiments, cells were grown until confluence in 35mm Petri-dishes or 25cm
2
 flasks 
and were seeded to a density of 1 x l0
6
 cells/mL (average count per square*dilution 
factor*10
4
). The medium was replaced with fresh culture medium every 2-3 days. Cells were 
examined using an inverted microscope to check confluence and confirm the absence of 
contaminations. All procedures with cells were carried out under sterile conditions using 
aseptic techniques. 
 
6.3.2. Protein determination 
 
Cell protein was determined using the Bicinchoninic acid method with bovine serum albumin 
(BSA) as a standard (Smith et al., 1985). Prior to lipid extraction, cell pellets were 
homogenized 3 times (30sec) by ultrasonic treatment (120W) in 800μL of water, and aliquots 
were used for protein determination. 5μL of cell homogenate were diluted to 20μL with water 
in a multiwell plate (96-micro-plates). 200μL of freshly prepared reagent working solution 
(BicinChoninic Acid/copper (II) sulfate 50:1 by vol.) were added. After 30min incubation at 
60 
0
C, the absorption of samples was measured at 562nm. Protein content was calculated on 
the basis of a standard curve, obtained by diluting BSA standard (0.25-5μg BSA/20μL).  
 
6.3.3. Lipid extraction and analysis 
 
Cell pellets were suspended in 0.86mL water by ultrasonic treatment (120W; 3 times, 30sec). 
60μL aliquots for protein determination and radioactivity measurement were issued, and the 
remainder was extracted by adding chloroform/methanol/water (1:2:0.8, v/v/v) to the cell 
homogenate. The mixture was vortexed and incubated for 12h at 40 °C in a water bath. 
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Insoluble cellular components were separated by filtration through wadding and the extract 
was dried under a stream of nitrogen. 1mL chloroform/methanol (1:1, v/v) was added to re-
dissolve the dried lipids in a glass tubes, vortexed and sonicated by ultrasound bath for 5min. 
10μL of cell suspension in 1mL solvent mixture were mixed with 10mL liquid scintillation 
cocktails in plastic scintillation vials to count the radioactivity in the scintillation counter. 
Incorporation of radioactivity into the lipid extract was determined using a Packard 2900 TR 
scintillation counter (Packard, Frankfurt) with a counter efficiency of 90-92% for 
14
C. Then, 
lipids were separated by thin layer chromatography (tlc). 
 
6.3.4. Anion-exchange chromatography 
 
Ion exchange chromatography was carried out to separate acidic and neutral lipids according 
to differences in their net charge. This was done with an anion exchanger, Diethylaminoethyl 
(DEAE) Sephadex A-25, in which negatively charged ions bind to a positively charged resin. 
First, the matrix was converted from the chloride to the acetate form to obtain maximum 
affinity of acidic lipids. 500g of ion exchanger was first slurred with 1L methanol for 12h to 
allow the resin to swell. Then, it was suspended in 0.5L water and allowed to stand for 24h. 
Then the resin was transferred into a glass column and suspended in 0.5L 1M sodium acetate 
solution. To eliminate chloride ions, the resin had to be washed several times with 1M 
sodium acetate solution, until no chloride was detectable by silver nitrate test. Then the 
acetate form was washed first with 1L water and then with 1L methanol and was stored as 1:1 
suspension in methanol at 4 °C before use.  
Small pieces of silanized glass fiber wadding were introduced into glass Pasteur pipettes and 
1mL of DEAE-Sephadex A-25 (in acetate form)/methanol suspension (1:1) was added and 
equilibrated with 3mL of chloroform-methanol-water (3:7:1, v/v/v). Samples were dissolved 
in 2mL with the same solvent, sonicated for 5min and applied to the column. The column was 
rinsed with 6mL of the same solvent. The fractions that passed through the column contained 
the neutral sphingo and phospholipids. 8mL of chloroform-methanol-0.8M ammonium 
acetate (3:7:1, v/v/v) were applied to column to elute acidic lipids. The lipid fractions were 
evaporated to dryness under a nitrogen stream. 
 
6.3.5. Alkaline hydrolysis  
 
Alkaline hydrolysis is used to remove phospholipids from lipid mixtures. Lipid samples were 
first dissolved in 1mL of chloroform-methanol (1:1, v/v), vortexed, and then the glass of the 
reaction vessel were rinsed with 1.5mL of the same solvent. After 5min ultrasonic treatment, 
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62μL of 4N NaOH were added, and further 5min ultrasound, then the solution was incubated 
for 2h at 37 °C in a water bath. After the reaction mixture was cooled and neutralized with 
10μL glacial acetic acid, the lipid fractions were evaporated to dryness under a stream of 
nitrogen. 
 
6.3.6. Reversed-phase chromatography (RP18)  
 
Desalting of lipid samples was performed according to the method described by (Williams 
and McCluer, 1980). In brief, small pieces of silanized glass fiber wadding were introduced 
into glass Pasteur pipettes and the Pasteur pipettes were clamped vertically. 1.5mL of 
LiChroprep RP-18 (40-63μm) (1:1) was added into the pipettes. The column was washed 
with solvents in the following order: 1mL methanol, 2mL water, 1mL methanol, 2mL of 
chloroform/methanol (1:1 (v/v)), 1mL methanol and 2mL of chloroform/methanol/0.1M KCl 
in water (3:48:47 (v/v/v)). After the washing process, lipid samples were dissolved in 1mL 
methanol, and sonicated for 5min. After further addition of 1mL ammonium acetate (300mM 
in water), the mixture was directly applied to the column. The glass vial was rinsed two times 
with 1mL ammonium acetate (200mM in methanol/water 1:1 (v/v)), and applied to the 
column. This was followed by washing with 6mL double distilled water to remove salt 
particles from the sample. 400µL methanol was added to the column. Glass tubes were 
placed under each column for lipid collection. Lipids were eluted with 600µL methanol 
followed by 8mL of chloroform/methanol (1:1 (v/v)). After the elution, the lipid fractions 
were evaporated to dryness under a stream of nitrogen. 
 
6.3.7. Thin-layer chromatography 
 
The dried lipids in the glass tubes were re-dissolved with 1mL chloroform/methanol (1:1, 
v/v), vortexed and sonicated by ultrasound bath for 5min. An aliquot of the re-dissolved lipid 
was then transferred to corresponding safe-lock tubes (Eppendorf), and evaporated to dryness 
under a stream of nitrogen. The dried lipids inside the safe-lock tubes were re-dissolved in 
40μL chloroform-methanol (1:1, v/v) and applied to silica gel 60-precoated glass plates with 
glass capillaries. Each of the safe-lock tubes was rinsed with 25μL of the same solvent and 
again applied on the TLC plates. The TLC-plates were dried in an evacuated desiccator over 
sodium hydroxide. The chromatography tank was lined with filter paper and filled with 
200mL of mobile phase using a one-dimensional system. For the separation of lipids, two 
developing systems were used:  
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To separate non-polar lipids, polar lipids and free FAs, the following solvent systems were 
used as the mobile phase: 
Neutral lipids and free FAs:   n-hexane/diethyl ether/acetic acid 70:30:1 (v/v/v) 
Phospholipids and sphingolipids:  chloroform/methanol/water 65:25:4 (v/v/v) 
Lipid classes were assigned to visualized spots by co-chromatography with authentic 
standard substances (Schürer, et al. 1993). For monitoring and visualizing a radiolabeled 
lipid, the plate was exposed on a 
14
C-Screen for 2-4 days. The radiolabeled spots were 
visualized using a phosphoimager (FUJIX BAS 1000, Raytest, Straubenhardt, Germany). 
Lipid spots were quantified using Tina software. Standard lipids were applied to the TLC 
plates along with the radiolabeled lipids, and the standards were visualized by immersing the 
area of the plate containing the standards spots in CuSO4*5H2O/H3PO4 (85%)/H2O 
(15.6:9.4:75 (w/v/v)) Yao and Rastetter, 1985  followed by heating on a heater plate. 
 
6.3.8. Feeding with Lipid-BSA complexes 
 
Stock solutions of 100nmol radiolabeled lipids in 300μL were complexed with FA-free 
bovine serum albumin (BSA; 7 mg) under vigorous stirring (Pütz and Schwarzmann, 1995). 
The lipid-BSA or FA-BSA complexes were diluted to a final concentration of 1μM for CE-
BSA, Chol-BSA, and TAG-BSA, and to 10μM for FA-BSA complexes in the culture 
medium (DMEM in the case of fibroblasts, macrophages, and Hep-G2 cells; and RPMI 
medium in the case of A431 cells). The molar ratio of lipid to albumin was kept at 1:1. The 
cells were seeded in 25cm
2
 plastic flasks with lipid-BSA complexes or 35mm Petri-dish with 
FA-BSA complexes. 1mL of radiolabeled lipid-BSA complexes were added to the cells for 
various incubation times as follows: 
CE-BSA, TAG-BSA, and Chol-BSA  1h, 6h, and 24h.  
SA-BSA, OA-BSA, LA-BSA, LOA-BSA  15min, 30min, and 120min. 
The cells were rinsed two times with 1mL PBS, and harvested after trypsinization by a 
trypsin/EDTA solution. All procedures with cells were carried out under sterile conditions. 
All solutions were prepared freshly prior to the experiments. All experiments were conducted 
in duplicate and repeated two times. 
 
6.3.9. Feeding with lipids-LDL complexes 
 
Lipid-LDL complexes were prepared according to a modified procedure based on (Brown S., 
and Goldstein L. 1975). The probe (100nmol) was incorporated into LDL by a solvent 
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exchange technique (Howard, 1979). The dried lipid was dissolved in 30µL of MeOH, 
vortexed, sonicated by ultrasound bath for 5min, and added to 4mL of LDL (750µg) in Tris-
Buffer. The resulting suspension was stirred for 4h at 37 
0
C in a water bath, and then filtered 
through a 3.000 MWCO Vivaspin filter (Howard, 1979). 30µL of the lipid-LDL suspension 
were taken before and after the filtration for scintillation counting and protein determination. 
The lipid-LDL complexes in suspension buffer were diluted to a final concentration with 
medium to yield 1μM for lipid-LDL complexes in medium containing 0.8% lipoprotein 
deficient serum (LPDS) in DMEM (0.8% LPDS in RPMI for A431cells). After adding 1mL 
of radiolabeled lipid-LDL complexes for various incubation times (1h, 6h, and 24h) to the 
medium, the cells were rinsed two times with 1mL PBS, and harvested after trypsinization by 
trypsin/EDTA solution. Although the lipid-LDL complex suspension appeared to be stable 
for more than a week, all lipid-LDL complexes were prepared freshly prior to the 
experiments. 
 
6.3.10. Feeding with cationic amphiphilic drugs (CADs) 
 
Fibroblasts, macrophages, and HepG2 cells were maintained in dulbecco´s modified eagle 
medium (DMEM), A431 cells were maintained in roswell park memorial institute (RPMI) 
medium, cultured in 25cm
2
 culture flasks, and supplemented with 0.8% lipoprotein deficient 
serum. CADs (0, 10, 20, and 40µM), were added to the medium for 24h before the addition 
of the complexes. The lipid-LDL complexes were added to the medium and incubated for 
another 24h so that the drug was still present. Cells were maintained in an incubator 
containing 95% nitrogen and 5% CO2. Control cells, cultured at the same time, were treated 
under the same conditions. After 24h the cells were harvested and the lipids were extracted 
using chloroform/methanol (1:2, v/v). 60µL aliquots of harvested cells were used for protein 
determination and counting. Radiolabeled polar and non-polar lipids were quantified after 
lipid extraction and separation by tlc using the following mobile phases: First, in n-
hexane/diethylether/acetic acid (70:30:1, v/v/v) to separate non-polar lipids and free fatty 
acid, and chloroform/methanol/water (65:25:4, v/v/v) to separate polar lipids. Then, the 
separated lipids were visualized by phosphoimaging. Radioactivity of each lipid class was 
calculated from the distribution and the total radioactivity applied to each lane. 
Radioactivities in the homogenates were measured in a liquid scintillation counter. Lipid 
uptake was measured and the levels of the most prominent metabolites that did arise from 
incorporation of fatty acid derived from the exogenously added lipids into different lipid 
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classes were determined. A 24h incubation period was chosen for more detailed evaluation of 
the effects of the exogenously added lipids, because the changes during this period were more 
readily distinguishable. 
 
6.3.11. Cell viability assay 
 
In order to evaluate if the addition of inhibitors affected the cells viability or induced stress 
resulting in apoptosis of the cells, cell viability was measured using the CellTiter Blue (CTB) 
assay (Evans, et al. 2001, Brien, et al. 2000), following the manufacturer's instruction 
(Promega). The assay is based on the ability of living cells to convert the dye resazurin into 
the fluorescent product resorufin.  Nonviable cells rapidly lose metabolic capacity, do not 
reduce the indicator dye, and thus do not generate a fluorescent signal. Therefore, the 
fluorescence produced is proportional to the number of viable cells. In brief, cells were 
cultured in 100μL DMEM medium per well in 96-well microplates (10,000 cells/well) 
supplemented with 5% fetal calf serum and 2mM L-glutamine. Cells were grown in the 
presence of 0µM (control), 10µM, 20µM, and 40μM CADs for 48h. Medium was removed, 
and 100µL CTB medium (85µL fresh medium and 15µL CTB reagent) were added directly 
to the cells of each well. After 90min incubation at 37 
0
C, the fluorescence was determined at 
excitation/emission wavelengths of 544/590nm using a FLUO-STAR plate reader (BMG, 
Germany). For each compound, the average value of the duplicate samples was calculated. 
Data were processed using an Excel spreadsheet. The cell viability ranged from 70 to 112 ± 
20% in the presence of inhibitors.  
 
6.4. Control experiments 
 
The following experiments were used as a control. 
 
6.4.1. Gel-filtration chromatography 
 
Gel-filteration was carried out for separation non-bound lipids from lipid incorporate into 
lipoproteins by passing them through Sephacryl S-300. The column was packed with 
Sephacryl S-300 and equilibrated with 10mM Tris-HCl (pH 7.5) containing 0.3mM NaCl, 
and 0.3mM EDTA as a running buffer, and the column was eluted with the same buffer. The 
lipid-LDL complexes were loaded to the column, and the lipoproteins were eluted with Tris-
buffer. Then, 2mL fractions were collected. 
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6.4.2. Pulse-chase experiment 
 
Radiolabeled oleic acid was tracked in selected cells (fibroblasts, macrophages, A431 cells, 
and Hep-G2 cells) to determine the fate of incorporated radiolabeled fatty acids at various 
incubation times. Cells were incubated at different temperatures, either at 37 
0
C, or at 4 
0
C 
(which blocks the endocytosis pathways). 
After 2h incubation time, the radiolabeled fatty acids were removed immediately from the 
culture medium. The cultured cells were rinsed three times with 1mL PBS to remove un-
incorporated radiolabeled FA. Fresh 10% FCS in DMEM were added, and the cells were 
incubated again in chase medium at 37 °C. The medium was removed with five interval 
chase time points (24, 48, 72, 120, and 144h). At each time point, the cells were collected, 
washed with 1mL PBS, then trypsinized and transfered to a screw cup glass. After centrifuge 
for 5min, washed again with 1mL PBS. Centrifuge the cells again at 1000rpm for 5min, the 
pellet were store at –20°C until all time points have been completed. 
 
6.4.3. Feeding with radiolabeled desipramine 
 
[
3
H]-Desipramine was used as a control to determine its uptake by different cell types. [
3
H]-
Desipramine (0.45nmol; 40µL in ethanol) was pipetted into Falcon tubes, dried to half 
contents under a stream of nitrogen, and then diluted with 12mL DMEM solution (containing 
different concentrations of unlabeled desipramine) to yield a 0.1µM [
3
H]-desipramine in 
1.5mL medium. After incubation of the cells with 1.5mL of various concentrations of [
3
H]-
desipramine (10, 20, and 40µM) for 48h incubation time, the cells were washed 3 times with 
1mL PBS. After addition of 1mL trypsin/EDTA, the cells were incubated for 1-2min at 37 
°C. Cells were carefully detached by gently tapping and the cell suspensions were transferred 
into a screw cap glass. The vials were washed with 1mL PBS, and the cell suspension was 
collected into a screw cap glass. The cells were centrifuged at 1000rpm for 5min, and washed 
again with 1mL PBS. After centrifugation of the cells at 1000rpm for 5min, the pellets were 
stored at –20 °C until use. Cell pellets were suspended in 0.86mL water and by ultrasonic 
treatment (120W; 3 times, 30sec). The amounts of protein and the radiolabeled [
3
H]-
desipramine taken up were determined. 
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8. ABBREVIATIONS 
 
ACSL    acyl-CoA synthetase 
BSA    bovine serum albumin 
PBS    phosphate buffered saline 
DMEM   dulbecco’s modified eagle’s medium  
RPMI    roswell park memorial institute 
TLC    thin layer chromatography 
LDL    low density lipoprotein 
LPDS    lipoprotein deficient serum 
CAD    cationic amphiphilic drug 
CE    cholesteryl ester 
DAG    diacylglycerol 
TAG    triacylglycerol 
Chol    cholesterol 
LD    lipid droplet 
FA    fatty acid  
FABP    fatty acid binding protein 
LCPUFA   long chain polyunsaturated fatty acid 
PL    polar lipid 
SA    stearic acid 
OA    oleic acid 
LA    linoleic acid 
LOA    linolenic acid 
PC    phosphatidylcholine  
PG    phosphatidylglycerol 
PA    phosphatidic acid 
PE    phosphatidylethanolamine 
BMP    bis(monoacylglycero)phosphate 
PI    phosphatidylinositol 
SM    sphingomyelin 
Cer    ceramide  
GlcCer   glucosylceramide 
LacCer   lactosylceramide 
